Document:

exv10w1

 

EXHIBIT 10.1

General Separation and Release Agreement

     THIS GENERAL SEPARATION AND RELEASE AGREEMENT (“Agreement”) is entered into as of the
17th day of August, 2005, between COSI, INC., a Delaware corporation, and any successor
thereto (collectively, the “Company”), and CYNTHIA JAMISON, an Illinois resident
(“Employee”).

Employee and the Company agree as follows:

     1. Termination of Employment. The employment relationship between Employee and
the Company shall terminate on August 17, 2005 (the “Termination Date”). The Employee shall
be paid an amount equal to her pro rata bi-weekly salary and accrued 2005 bonus, payable over
the period commencing August 17, 2005, through February 20, 2006, as set forth in Section
2 below (collectively, the “Severance Payments”). The Company shall reimburse the
Employee for all reimbursable expenses incurred by the Employee through the Termination Date,
and submitted to the Company with the proper receipts, in accordance with the Company’s
then-current expense policy. The Company will pay the Employee for any vacation accrued
between January 1, 2005, and the Termination Date, but then unused, in accordance with the
Company’s then-current vacation policy. Except for the amounts expressly set forth in this
Section 1 and Section 2 below, no other compensation or benefits are due to
the Employee under this Agreement or that certain letter dated as of July 7, 2004 (the “2004
Letter”) or otherwise.

     2. Severance and Benefits. Subject to the terms of this Agreement, and
providing Employee executes and does not revoke this Agreement and complies with the terms of
this Agreement, the Company agrees to pay to Employee the Severance Payments and other
benefits as set forth below. The Company shall have the right, upon due notice to Employee
to set off any amounts due and owing by Employee to the Company against any amounts due and
owing by the Company to Employee.

     (a) Severance Payments. Employee shall be paid Severance Payments in the
total gross amount of: (i) One Hundred Twenty-Five Thousand and 00/100 Dollars
($125,000), less applicable withholding taxes and deductions, representing an amount
equal to six (6) months’ gross salary, plus (ii) Sixty-Two Thousand Nine
Hundred Three and 22/100 Dollars ($62,903.22), representing an amount equal to accrued
bonus for fiscal year 2005 pro rated through the Termination Date. In no event shall
Employee’s aggregate gross Severance Payments exceed One Hundred Eighty Seven Thousand
Nine Hundred Three and 22/100 Dollars ($187,903.22), less applicable withholding taxes
and deductions, payable in bi-weekly equal installments and subject to the Company’s
right of set off to the extent set off is permitted under Section 4(b) below.

     (b) Medical and Health Benefits. Employee’s medical and health benefits
shall continue on the same or substantially the same terms through February 20, 2006.
Thereafter, in the event that Employee elects continuing benefits coverage pursuant to
her rights under the Consolidated Omnibus Budget Reconciliation Act (“COBRA”),
Employee shall be responsible for payment of Employee’s COBRA premiums.

     3. Return of Company Materials. Employee, or her heirs, agrees to and shall
promptly return to the Company, at the Company’s corporate offices or such other location as
may be directed by the Company, all property of the Company in Employee’s control or
possession, including, without limitation, confidential or proprietary information of the
Company, files and documents, keys, key cards, personal computer and software, blackberry,
and cell phone.

     4. Release.

     (a) Release by Employee. For and in consideration of the payments and/or
other benefits to be provided to and/or on behalf of Employee pursuant to this
Agreement, the sufficiency of which Employee hereby acknowledges, Employee, on behalf
of Employee and Employee’s heirs, executors and assigns, hereby releases and forever
discharges the Company, its affiliates and

1

 

subsidiaries, and its and their current and former directors, officers,
executives and agents, heirs, executors, representatives, successors and assigns, and
any and all pension benefit or welfare benefit plans of the Company, including current
and former trustees and administrators of such pension benefit and welfare benefit
plans, from all claims, charges, or demands, in law or in equity, whether known or
unknown, which may have existed or which may now exist from the beginning of time to
the date of this Agreement, including, without limitation, any claims Employee may
have arising from or relating to Employee’s employment or termination from employment
with the Company, including a release of any rights or claims Employee may have under
Title VII of the Civil Rights Act of 1964, as amended, and the Civil Rights Act of
1991 (which prohibit discrimination in employment based upon race, color, sex,
religion, and national origin); the American with Disabilities Act of 1990, as
amended, and Family and Medical Leave Act of 1993 (which prohibits discrimination
based on requesting or taking a family or medical leave); Section 1981 of the Civil
Rights Act of 1866 (which prohibits discrimination based upon race); Section 1985(3)
of the Civil Rights Act of 1871 (which prohibits conspiracies to discriminate); the
Employee Retirement Income Security Act of 1974, as amended (which prohibits
discrimination with regard to benefits); any other federal, state or local laws
against discrimination’ or any other federal, state, or local statute, or common law
relating to employment, wages, hours, or any other terms and conditions of employment.
This includes a release by Employee of any claims for wrongful discharge, breach of
contract, torts or any other claims in any way related to Employee’s employment with
or resignation or termination from the Company. This release also includes a release
of any claims for age discrimination under the Age Discrimination in Employment Act,
as amended (“ADEA”). The ADEA requires that Employee be advised to consult with an
attorney before Employee waives any claim under ADEA. In addition, the ADEA provides
Employee with at least 21 days to decide whether to waive claims under ADEA and seven
(7) days after Employee executes this Agreement to revoke that waiver.
Notwithstanding the foregoing provisions of this Section 4(a), the release
given by Employee hereunder shall not apply to, and Employee shall retain and shall be
entitled to enforce by litigation or otherwise, all rights arising under or with
respect to (i) the obligations of the Company to indemnify and hold harmless Employee
in Employee’s capacity as a former executive of the Company, (ii) all directors and
officers liability insurance coverage applicable to Employee, (iii) Employee’s rights
to enforce the terms of this Agreement, and (iv) any and all benefits to which
Employee shall be entitled under the terms of the Company’s employee benefit plans.

     (b) Release by the Company. For and in consideration of the agreements
set forth in this Agreement, the sufficiency of which the Company hereby acknowledges,
the Company, on behalf of the Company and its affiliates and subsidiaries and its and
their respective officers, directors, managers, successors and assigns, hereby
releases and forever discharges Employee from all claims, charges, or demands, in law
or in equity, whether known or unknown, which may have existed or which may now exist
from the beginning of time to the date of this Agreement but expressly excluding any
such claims arising out of Employee’s intentional or willful misconduct or fraud. As
of the date of this Agreement, the Company has no actual knowledge of any acts by
Employee of intentional or willful misconduct or fraud giving rise to, or that could
in the future give rise to, any such claims. Notwithstanding the foregoing provision
of this Section 4(b), the release given by the Company hereunder shall not
apply to, and the Company shall retain and shall be entitled to enforce by litigation
or otherwise, all rights arising under or with respect to (i) any claims arising out
of Employee’s intentional or willful misconduct or fraud, and (ii) the Company’s
rights to enforce the terms of this Agreement.

     5. Stock Options. Any stock options held beneficially and of record by the
Employee as of the Termination Date which are fully vested as of such date shall be
exercisable through and including the date set as the twelve (12) month anniversary of the
Termination Date, such date being August 17, 2006. Any stock options which are not fully
vested as of the Termination Date shall terminate in accordance with the terms of the
respective stock incentive plan under which any such options were granted.

     6. No Admission. This Agreement is not an admission by either Employee or the
Company of any wrong doing or liability.

2

 

     7. No Disparagement. Employee agrees not to make, or to cause any other person
to make, any false, disparaging or derogatory statements regarding the Company or its
affiliates or subsidiaries or any of their respective current or former shareholders,
directors, officers, employees, agents or representatives (in their respective capacities as
current or former shareholders, directors, officers, employees, agents or representatives of
the Company or its affiliates or subsidiaries). Employee further agrees not to take any
action or make any statement the effect to which would be directly or indirectly to
materially impair the goodwill of the Company, including but not limited to any action or
statement intended, directly or indirectly, to benefit a competitor of the Company. The
Company shall take all reasonable measures to cause the senior officers and directors of the
Company (in their respective capacities as senior officers and directors of the Company) not
to make any false, disparaging or derogatory statements in any form regarding Employee.

     8. Confidentiality and Nondisclosure of Confidential Information..

     (a) Employee acknowledges and agrees that she has had access to Confidential
Information (as defined below) of the Company, which has been developed at
considerable risk and expense of the Company. Employee agrees that for so long as any
information received by Employee remains Confidential Information, she shall not at
any time copy, or disclose to any person or entity, or use for her own benefit or the
benefit of any third party, or otherwise exploit, such Confidential Information.

     (b) “Confidential Information” includes the terms of this Agreement and
information, documents and materials which contain confidential, proprietary and/or
trade secrets of Cosi, its affiliates and subsidiaries, its business partners, its
vendors, and/or its franchisees, or are otherwise of a confidential nature and which
are proprietary to Cosi, its affiliates and subsidiaries, its customers, its business
partners, its vendors, and/or its franchisees that are not otherwise part of the
public domain (whether or not reduced to writing or other tangible medium of
expression), including, without limitation, information relating to business and
marketing plans and strategies (including, without limitation, development and
expansion plans, new markets, new store openings and store closings), historical and
projected financial information, revenues, costs, personnel information, processes and
procedures, products, recipes, formulae, other trade secrets pertaining to products,
goods, services, inventions, discoveries, improvements, innovations, designs, ideas,
manufacturing processes, methods and activities, costs, sources of supply, advertising
and marketing plans and activities, distribution and sales methods, employee
information, wage, salary and bonus information, customer lists and customer
information, sales, profits, pricing and pricing methods, personnel, business
relationships, litigation, business concepts, patents, copyrights, trademarks, trade
names, trade secrets, formulae, patent, trademark and copyright applications,
agreements, and any and all other information, records, knowledge or data of a
confidential, proprietary and/or trade secret nature. Notwithstanding the foregoing,
Confidential Information does not include information which Employee can prove: (i)
at the time of disclosure to Employee was already known to Employee prior to its
disclosure by the Disclosure (as established by written records) without an obligation
of confidentiality; (ii) is or becomes generally available to the public other than
through a breach of this Agreement; or (iii) is at any time furnished to Employee by a
third party who is lawfully in possession of such information and who lawfully conveys
such information to Employee.

     (c) Employee covenants and agrees that disclosure of any or all of the
Confidential Information in violation of this Agreement will cause the Company
irreparable injury and that, in the event of a breach by Employee her obligations
pursuant to this Section 8, the Company shall be entitled to any remedy
available at law or equity, including, without limitation, specific performance and
injunctive relief (without bond or proof of damages but upon due notice) and all
reasonable costs incurred in seeking any such remedy, including, without limitation,
attorneys’ fees and costs.

     9. Company Indemnification; Employee Cooperation; D&O Insurance. The Company
shall indemnify Employee to the fullest extent permissible under its by-laws in effect on the
day hereof, the Delaware General Corporation Law and other applicable laws. Employee agrees
to cooperate reasonably with

3

 

the Company and its counsel in regard to any litigation, investigation, or similar
action presently pending or subsequently initiated involving matters of which the Employee
has knowledge as a result of Employee’s employment with the Company. Such reasonable
cooperation shall consist of the Employee making herself available at reasonable times for
consultation with officers of the Company and its counsel and for depositions or other
similar activity. The actual costs incurred with respect to Employee’s reasonable
cooperation shall be borne by the Company. Such costs shall not include Employee’s
compensation. For at least a period of two (2) years following the Termination Date of this
Agreement, the Company shall maintain directors and officers liability insurance, or
insurance providing similar coverage, in an amount and on the terms as may be reasonably
determined from time to time by the executive officers and directors of the Company, which
coverage shall include Employee in Employee’s capacity as a former officer of the Company.

     10. Waiver of Reinstatement. Employee waives any right to reinstatement or
future employment with the Company following the date of Employee’s separation from the
Company as set forth herein.

     11. Employee Agreement. Employee agrees not to engage in any act after
execution of this Agreement that is intended, or may reasonably be expected to, harm the
reputation, business, prospects or operations of the Company, its affiliates or subsidiaries,
or its or their respective officers directors, stockholders or executives. Employee will
take no action which would reasonably be expected to lead to unwanted or unfavorable
publicity to the Company.

     12. Governing Law. This Agreement shall be governed by and construed in
accordance with the laws of the State of Illinois, without reference to the principles of
conflict of laws.

     13. Entire Agreement; Severability. This Agreement represents the complete
agreement between Employee and the Company concerning the subject matter in this Agreement
and supersedes all prior agreements or understandings, written or oral, including, without
limitation the 2004 Letter. This Agreement may not be amended or modified otherwise than by
written agreement executed by the parties hereto or their respective successors and legal
representatives. The provisions of this Agreement are severable, and if any part of this
Agreement is found to be unenforceable, the other provisions of this Agreement shall remain
fully valid and enforceable to the fullest extent permitted by law.

     14. Revocation Period. It is further understood that for a period of seven (7)
days following the execution of this Agreement in duplicate originals, Employee may revoke
this Agreement, and this Agreement shall not become effective or enforceable until this
revocation period has expired. No revocation of this Agreement by Employee shall be
effective unless the Company has received within the seven (7) day revocation period, written
notice of any revocation, all monies received by Employee under this Agreement and all
original copies of this Agreement.

     15. Voluntary Execution. This Agreement has been entered into voluntarily and
not as a result of coercion, duress, or undue influence. Employee acknowledges that Employee
has read and fully understands the terms of this Agreement and has been advised to consult
with an attorney before executing this Agreement. Additionally, Employee acknowledges that
Employee has been afforded the opportunity of at least twenty-one (21) days to consider this
Agreement.

     16. Counterparts. This Agreement may be executed in counterparts, each of which
shall be deemed an original but all of which taken together shall be deemed to constitute one
and the same instrument.

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK; SIGNATURE PAGE FOLLOWS]

4

 

     The parties hereto have executed this Agreement as of the day and year first above written.

	 	 	 
	 

	 	EMPLOYEE:
	 
	 	 
	 

	 	/S/ CYNTHIA JAMISON
	 

	 	 
	 

	 	Cynthia Jamison
	 
	 	 
	 

	 	COMPANY:
	 
	 	 
	 

	 	COSI, INC., a Delaware corporation

	 	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 

5exv10w1

 

EXHIBIT 10.1

AGREEMENT AND PLAN OF MERGER

BETWEEN

GOLD BANC CORPORATION, INC.

AND

MARSHALL & ILSLEY CORPORATION

Dated as of November 9, 2005

 

 

TABLE OF CONTENTS

	 	 	 	 	 
	 	 	Page	 
	ARTICLE I — THE MERGER
	 	 	 	 
	1.1 The Merger
	 	 	1	 
	1.2 The Closing; Effective Time
	 	 	1	 
	1.3 Effect of the Merger
	 	 	2	 
	1.4 Articles of Incorporation; By-Laws
	 	 	2	 
	1.5 Directors and Officers
	 	 	2	 
	1.6 Conversion of Securities; Dissenting Shares
	 	 	2	 
	1.7 Exchange of Certificates
	 	 	4	 
	ARTICLE II — REPRESENTATIONS AND WARRANTIES OF SELLER

	 	 	 	 
	2.1 Organization and Qualification; Subsidiaries
	 	 	7	 
	2.2 Articles of Incorporation and By-Laws
	 	 	8	 
	2.3 Capitalization
	 	 	8	 
	2.4 Authority
	 	 	9	 
	2.5 No Conflict; Required Filings and Consents
	 	 	10	 
	2.6 Compliance; Permits
	 	 	10	 
	2.7 Securities and Banking Reports; Financial Statements
	 	 	11	 
	2.8 Absence of Certain Changes or Events
	 	 	14	 
	2.9 Absence of Litigation
	 	 	14	 
	2.10 Employee Benefit Plans
	 	 	16	 
	2.11 Registration Statement; Proxy Statement/Prospectus
	 	 	18	 
	2.12 Title to Property
	 	 	18	 
	2.13 Environmental Matters
	 	 	18	 
	2.14 Absence of Agreements
	 	 	20	 
	2.15 Taxes
	 	 	20	 
	2.16 Insurance
	 	 	21	 
	2.17 Brokers
	 	 	21	 
	2.18 Tax Matters
	 	 	21	 
	2.19 Seller Material Adverse Effect
	 	 	21	 
	2.20 Material Contracts
	 	 	21	 
	2.21 Opinion of Financial Advisor
	 	 	21	 
	2.22 Vote Required
	 	 	22	 
	2.23 Stock Options
	 	 	22	 
	2.24 Rights Agreement
	 	 	22	 
	ARTICLE III — REPRESENTATIONS AND WARRANTIES OF THE COMPANY

	 	 	 	 
	3.1 Organization and Qualification; Subsidiaries
	 	 	22	 
	3.2 Articles of Incorporation and By-Laws
	 	 	23	 
	3.3 Capitalization
	 	 	23	 
	3.4 Authority
	 	 	24	 
	3.5 No Conflict; Required Filings and Consents
	 	 	24	 
	3.6 Compliance; Permits
	 	 	25	 
	3.7 Securities and Banking Reports; Financial Statements
	 	 	25	 

i

 

	 	 	 	 	 
	 	 	Page	 
	3.8 Absence of Certain Changes or Events
	 	 	28	 
	3.9 Absence of Litigation
	 	 	28	 
	3.10 Registration Statement; Proxy Statement/Prospectus
	 	 	29	 
	3.11 Compliance; Permits
	 	 	29	 
	3.12 Title to Property
	 	 	30	 
	3.13 Brokers
	 	 	30	 
	3.14 Tax Matters
	 	 	30	 
	3.15 Company Material Adverse Effect
	 	 	30	 
	ARTICLE IV — COVENANTS OF SELLER

	 	 	 	 
	4.1 Affirmative Covenants
	 	 	30	 
	4.2 Negative Covenants
	 	 	31	 
	4.3 Letter of Seller’s Accountants
	 	 	34	 
	4.4 No Solicitation of Transactions
	 	 	34	 
	4.5 Update Disclosure; Breaches
	 	 	37	 
	4.6 Affiliates; Tax Treatment
	 	 	38	 
	4.7 Delivery of Stockholder List
	 	 	38	 
	4.8 Loan and Investment Policies
	 	 	38	 
	4.9 Access and Information
	 	 	39	 
	4.10 Confidentiality Agreement
	 	 	39	 
	4.11 Rights Agreement
	 	 	39	 
	ARTICLE V — COVENANTS OF THE COMPANY
	 	 	 	 
	5.1 Affirmative Covenants
	 	 	39	 
	5.2 Negative Covenants
	 	 	39	 
	5.3 Breaches
	 	 	40	 
	5.4 Stock Exchange Listing
	 	 	40	 
	5.5 Tax Treatment
	 	 	40	 
	5.6 Confidentiality Agreement
	 	 	40	 
	5.7 Stock Options
	 	 	40	 
	ARTICLE VI — ADDITIONAL AGREEMENTS

	 	 	 	 
	6.1 Proxy Statement/Prospectus; Registration Statement; Board Recommendation
	 	 	41	 
	6.2 Meeting of Seller’s Stockholders
	 	 	42	 
	6.3 Appropriate Action; Consents; Filings
	 	 	42	 
	6.4 Employee Benefit Matters
	 	 	42	 
	6.5 Directors’ and Officers’ Indemnification and Insurance
	 	 	42	 
	6.6 Notification of Certain Matters
	 	 	43	 
	6.7 Public Announcements
	 	 	43	 
	6.8 Exemption From Liability Under Section 16(b)
	 	 	44	 
	6.9 Customer Retention
	 	 	44	 
	6.10 Directorships
	 	 	44	 
	ARTICLE VII — CONDITIONS OF MERGER

	 	 	 	 
	7.1 Conditions to Obligation of Each Party to Effect the Merger
	 	 	45	 
	7.2 Additional Conditions to Obligations of the Company
	 	 	46	 
	7.3 Additional Conditions to Obligations of the Seller
	 	 	47	 
	ARTICLE VIII — TERMINATION
	 	 	 	 
	8.1 Termination
	 	 	49	 
	8.2 Notice of Termination; Effect of Termination
	 	 	51	 

ii

 

	 	 	 	 	 
	 	 	Page	 
	8.3 Fees and Expenses
	 	 	51	 
	ARTICLE IX — GENERAL PROVISIONS

	 	 	 	 
	9.1 Non-Survival of Representations, Warranties and Agreements
	 	 	52	 
	9.2 Notices
	 	 	52	 
	9.3 Certain Definitions
	 	 	53	 
	9.4 Headings
	 	 	56	 
	9.5 Severability
	 	 	56	 
	9.6 Entire Agreement
	 	 	56	 
	9.7 Assignment
	 	 	56	 
	9.8 Parties in Interest
	 	 	56	 
	9.9 Governing Law
	 	 	56	 
	9.10 Counterparts
	 	 	56	 
	9.11 Time is of the Essence
	 	 	56	 
	9.12 Specific Performance
	 	 	56	 
	9.13 Interpretation
	 	 	57	 

iii

 

	 	 	 
	ANNEX A

	 	SUBSIDIARIES OF SELLER
	ANNEX B

	 	EMPLOYEE BENEFIT MATTERS
	ANNEX C

	 	FORM OF OPINION OF COUNSEL TO SELLER
	ANNEX D

	 	FORM OF OPINION OF COUNSEL TO COMPANY
	EXHIBIT 1.1

	 	PLAN OF MERGER
	EXHIBIT 4.6

	 	AFFILIATE LETTER

iv

 

Index of Defined Terms

	 	 	 
	Acquisition Proposal

	 	SECTION 4.4(a)
	Acquisition Transaction

	 	SECTION 4.4(a)
	Additional Stock Amount

	 	SECTION 8.1(k)(ii)
	Affiliate

	 	SECTION 9.3
	Agreement

	 	PREAMBLE
	BHCA

	 	SECTION 2.1(a)
	Blue Sky Laws

	 	SECTION 2.5(b)
	Business Day

	 	SECTION 9.3
	Cash Amount

	 	SECTION 1.6(c)(i)
	Certificate or Certificates

	 	SECTION 1.7(b)
	Change of Recommendation

	 	SECTION 4.4(b)
	Closing

	 	SECTION 1.2(a)
	Closing Date

	 	SECTION 1.2(a)
	Code

	 	PREAMBLE
	Company

	 	PREAMBLE
	Company Approvals

	 	SECTION 3.1(a)
	Company Articles

	 	SECTION 1.4
	Company By-Laws

	 	SECTION 1.4
	Company Common Stock

	 	SECTION 1.6(c)(i)
	Company Disclosure Schedule

	 	ARTICLE III
	Company Material Adverse Effect

	 	SECTION 3.1(d)
	Company Reports

	 	SECTION 3.7(a)
	Company SEC Reports

	 	SECTION 3.7(a)
	Company Subsidiaries

	 	SECTION 3.1(a)
	Company Subsidiary

	 	SECTION 3.1(a)
	Company’s Board of Directors

	 	PREAMBLE
	Confidentiality Agreement

	 	SECTION 4.10
	Consent

	 	SECTION 9.3
	Contract

	 	SECTION 9.3
	Control

	 	SECTION 9.3
	Default

	 	SECTION 9.3
	D&O Policy

	 	SECTION 6.5(b)
	DFI

	 	SECTION 1.2(b)
	Dissenting Shares

	 	SECTION 1.6(e)
	Effect

	 	SECTION 2.1(d)
	Effective Time

	 	SECTION 1.2(b)
	Environmental Claims

	 	SECTION 2.13(c)
	Environmental Laws

	 	SECTION 2.13
	ERISA

	 	SECTION 2.10(a)
	Exchange Act

	 	SECTION 2.5(b)
	Exchange Agent

	 	SECTION 1.6(d)
	Exchange Fund

	 	SECTION 1.7(a)
	Existing D&O Policy

	 	SECTION 4.1(d)

v

 

	 	 	 
	FDIC

	 	SECTION 2.1(b)
	Federal Reserve Board

	 	SECTION 2.1(a)
	Financial Statements

	 	SECTION 9.3
	GAAP

	 	SECTION 2.7(b)
	GLB Act

	 	SECTION 2.1(a)
	Governmental Authority

	 	SECTION 1.7(e)
	Hazardous Materials

	 	SECTION 2.13
	HSR Act

	 	SECTION 2.5(b)
	Indemnified Parties

	 	SECTION 6.5(d)
	Insiders

	 	SECTION 6.8
	Insurance Amount

	 	SECTION 6.5(b)
	IRS

	 	SECTION 2.10(a)
	Kansas Secretary of State

	 	SECTION 1.2(b)
	KGCC

	 	PREAMBLE
	Knowledge

	 	SECTION 9.3
	Law

	 	SECTION 9.3
	Laws

	 	SECTION 2.5(a)
	Liability

	 	SECTION 9.3
	Lien

	 	SECTION 9.3
	Litigation

	 	SECTION 9.3
	Loan Property

	 	SECTION 2.13(a)
	Material Contract

	 	SECTION 9.3
	Material Weakness

	 	SECTION 2.7(e)
	Merger

	 	PREAMBLE
	NASD

	 	SECTION 2.1(b)
	Nasdaq

	 	SECTION 2.7(d)
	NYSE

	 	SECTION 1.6(c)(ii)
	OCC

	 	SECTION 3.1(a)
	Option

	 	SECTION 5.7(a)
	Option Plans

	 	SECTION 5.7(a)
	Order

	 	SECTION 9.3
	OTS

	 	SECTION 3.1(a)
	Participation Facility

	 	SECTION 2.13(b)
	Patriot Act

	 	SECTION 2.9(d)
	Permit

	 	SECTION 9.3
	Per Share Consideration

	 	SECTION 1.6(c)(i)
	Person

	 	SECTION 9.3
	Plans

	 	SECTION 2.10(a)
	Proxy Statement/Prospectus

	 	SECTION 2.11
	Registration Statement

	 	SECTION 3.10
	Regulatory Authorities

	 	SECTION 9.3
	Rights

	 	SECTION 9.3
	Rights Agreement

	 	SECTION 2.24
	RSU

	 	SECTION 2.3
	SAC

	 	SECTION 2.9(a)
	Sarbanes-Oxley

	 	SECTION 2.7(d)

vi

 

	 	 	 
	SBL

	 	SECTION 2.5(b)
	SBA

	 	SECTION 2.1(b)
	SEC

	 	SECTION 2.1(b)
	Section 16 Information

	 	SECTION 6.8
	Section 180.0622(2)(b) of the WBCL

	 	SECTION 3.3(a)
	Section 409A

	 	SECTION 2.10(e)
	Securities Act

	 	SECTION 2.5(b)
	Seller

	 	PREAMBLE
	Seller Approvals

	 	SECTION 2.1(b)
	Seller Articles

	 	SECTION 2.2
	Seller By-Laws

	 	SECTION 2.2
	Seller Common Stock

	 	SECTION 1.6(a)
	Seller Disclosure Schedule

	 	ARTICLE II
	Seller Material Adverse Effect

	 	SECTION 2.1(d)
	Seller Preferred Stock

	 	SECTION 2.3
	Seller Reports

	 	SECTION 2.7(a)
	Seller SEC Documents

	 	SECTION 2.7(c)
	Seller SEC Reports

	 	SECTION 2.7(a)
	Seller Stockholders’ Meeting

	 	SECTION 2.11
	Seller Subsidiaries

	 	SECTION 2.1(a)
	Seller Subsidiary

	 	SECTION 2.1(a)
	Seller’s Board of Directors

	 	PREAMBLE
	Seller’s Board of Directors Recommendation

	 	SECTION 2.4
	Shares

	 	SECTION 1.6(a)
	Significant Deficiency

	 	SECTION 2.7(e)
	Silver

	 	SECTION 2.9(a)
	Stock Amount

	 	SECTION 1.6(c)(i)
	Subsidiaries

	 	SECTION 9.3
	Subsidiary

	 	SECTION 9.3
	Subsidiary Organizational Documents

	 	SECTION 2.2
	Superior Offer

	 	SECTION 4.4(c)
	Surviving Corporation

	 	SECTION 1.1
	Tax or Taxes

	 	SECTION 2.15
	Tax Returns

	 	SECTION 2.15
	Termination Fee

	 	SECTION 8.3(b)
	Title IV Plan

	 	SECTION 2.10(b)
	TRUPs

	 	SECTION 2.3
	Valuation Period Market Value

	 	SECTION 1.6(c)(ii)
	WBCL

	 	PREAMBLE

vii

 

AGREEMENT AND PLAN OF MERGER

     AGREEMENT AND PLAN OF MERGER, dated as of November 9, 2005 (the “Agreement”), between Gold
Banc Corporation, Inc., a Kansas corporation (the “Seller”), and Marshall & Ilsley Corporation, a
Wisconsin corporation (the “Company”).

     WHEREAS, the Boards of Directors of the Company (the “Company’s Board of Directors”) and the
Seller (the “Seller’s Board of Directors”) have each determined that it is advisable to and in the
best interests of their respective stockholders for the Seller to merge with and into the Company
(the “Merger”) upon the terms and subject to the conditions set forth herein and in accordance with
the Kansas General Corporation Code (the “KGCC”) and the Wisconsin Business Corporation Law (the
“WBCL”);

     WHEREAS, the Company’s Board of Directors and the Seller’s Board of Directors have each
approved the Merger of the Seller with and into the Company, upon the terms and subject to the
conditions set forth herein, and approved and adopted this Agreement;

     WHEREAS, subsequent to the Seller’s approval of this Agreement and concurrently with the
execution of this Agreement and as a condition and an inducement to the willingness of the Company
to enter into this Agreement, the Company has entered into a Stockholder Voting Agreement pursuant
to which each stockholder listed on Schedule I to such Stockholder Voting Agreement has agreed to
vote the shares of the Seller Common Stock beneficially owned by such stockholder in favor of the
Merger; and

     WHEREAS, for federal income tax purposes, it is intended that the Merger shall qualify as a
reorganization under the provisions of Section 368 of the Internal Revenue Code of 1986, as amended
(the “Code”), and this Agreement shall constitute the plan of reorganization.

     NOW, THEREFORE, in consideration of the foregoing premises and the representations, warranties
and agreements contained herein, and subject to the terms and conditions set forth herein, the
parties hereto hereby agree as follows:

ARTICLE I — THE MERGER

     1.1 The Merger. Upon the terms and subject to the conditions set forth in this
Agreement, and in accordance with the KGCC, the WBCL and the Plan of Merger attached hereto as
Exhibit 1.1, at the Effective Time the Seller shall be merged with and into the Company.
As a result of the Merger, the separate corporate existence of the Seller shall cease and the
Company shall continue as the surviving corporation of the Merger (the “Surviving Corporation”).

     1.2 The Closing; Effective Time.

     (a) The closing of the Merger and the transactions contemplated hereby (the “Closing”) shall
be held at such time, date (the “Closing Date”) and location as may be mutually agreed by the
parties. In the absence of such agreement, the Closing shall be held at the offices

 

 

of Godfrey &
Kahn, S.C., 780 North Water Street, Milwaukee, Wisconsin, commencing at 9:00 a.m., Milwaukee time,
on a date specified by either party upon five (5) business days’ written notice (or at the election
of the Company on the last business day of the month) after the last to occur of the following
events: (a) receipt of all consents and approvals of government Regulatory Authorities legally
required to consummate the Merger and the expiration of all statutory waiting periods; and (b)
approval of this Agreement and the Merger by the Seller’s stockholders. Scheduling or commencing
the Closing shall not constitute a waiver of the conditions set forth in Article VII by either the
Company or the Seller.

     (b) As promptly as practicable after the Closing, the parties hereto shall cause the Merger to
be consummated by filing a certificate of merger and articles of merger, as necessary, and any
other required documents, with the Secretary of State of the State of Kansas (the “Kansas Secretary
of State”) and the Department of Financial Institutions of the State of Wisconsin (the “DFI”), in
such form as required by, and executed in accordance with the relevant provisions of, the KGCC and
the WBCL (the date and time of such filing or such date and time as the Company and the Seller
shall agree and specify in the certificate of merger and articles of merger are referred to herein
as the “Effective Time”).

     1.3 Effect of the Merger. At the Effective Time, the effect of the Merger shall be as
provided in this Agreement and the applicable provisions of the KGCC and the WBCL. Without
limiting the generality of the foregoing, and subject thereto, at the Effective Time, except as
otherwise provided herein, all the property, rights, privileges, powers and franchises of the
Company and the Seller shall vest in the Surviving Corporation, and all debts, liabilities and
duties of the Company and the Seller shall become the debts, liabilities and duties of the
Surviving Corporation.

     1.4 Articles of Incorporation; By-Laws. At the Effective Time, the Company’s Articles
of Incorporation, as amended (the “Company Articles”), and the Company’s By-Laws, as amended (the
“Company By-Laws”), as in effect immediately prior to the Effective Time, shall be the Articles of
Incorporation and the By-Laws of the Surviving Corporation.

     1.5 Directors and Officers. At the Effective Time, the directors of the Company
immediately prior to the Effective Time shall be the initial directors of the Surviving
Corporation, each to hold office in accordance with the Articles of Incorporation and By-Laws of
the Surviving Corporation and to be assigned to the class previously assigned, except that the
Chief Executive Officer of the Seller shall be appointed to the Company’s Board of Directors as
soon as practicable after the Closing Date in accordance with Section 6.10 of this Agreement. At
the Effective Time, the officers of the Company immediately prior to the Effective Time, shall be
the initial officers of the Surviving Corporation, in each case until their respective successors
are duly elected or appointed.

     1.6 Conversion of Securities; Dissenting Shares.

     (a) Subject to Section 1.6(d) regarding fractional shares, at the Effective Time, by virtue of
the Merger and without action on the part of the Company or the Seller, each share of the common
stock, $1.00 par value, of the Seller (“Seller Common Stock”), issued and outstanding immediately
prior to the Effective Time, other than shares of Seller Common Stock

 

 

(i) held in the treasury of
the Seller, (ii) owned by the Company or any Company Subsidiary for its own account, and (iii)
other than Dissenting Shares (such shares of Seller Common Stock being referred to herein as the
“Shares”), shall cease to be outstanding and shall be converted into the right to receive the Per
Share Consideration.

     (b) Each share of Seller Common Stock held by the Seller as treasury stock and each such share
held by the Company or any Company Subsidiary immediately prior to the Effective Time shall be
canceled and extinguished without any conversion thereof as otherwise provided in this Section 1.6.

     (c) For purposes of this Agreement, the following definitions shall apply:

     (i) “Per Share Consideration” means (A) an amount in cash equal to $2.78 (the “Cash
Amount”), plus (B) a number of shares of common stock, $1.00 par value, of the Company
(“Company Common Stock”) (rounded to the nearest ten thousandth of a share) (the “Stock
Amount”) determined as follows:

     (A) If the Valuation Period Market Value is less than $36.40, the Stock Amount
shall be equal to 0.4319 of a share of Company Common Stock;

     (B) If the Valuation Period Market Value is equal to or greater than $36.40 but
less than or equal to $49.24, the Stock Amount shall be equal to the quotient
determined by dividing $15.72 by the Valuation Period Market Value;

     (C) If the Valuation Period Market Value is greater than $49.24, the Stock
Amount shall be equal to 0.3192 of a share of Company Common Stock; and

     (D) Plus, to the extent the Company elects to exercise its right under Section
8.1(k)(ii), below, the Additional Stock Amount.

     Notwithstanding the foregoing, the parties acknowledge and agree that the Cash Amount may have
to be reduced and the Stock Amount may have to be increased in accordance with Section 1.6(f),
below.

     (ii) “Valuation Period Market Value” means the average of the average daily high and
low sale price per share of the Company Common Stock on the New York Stock Exchange (the
“NYSE”) for the five (5) trading days ending on and including the third trading day
preceding the Effective Time (as reported in an authoritative source).

     (d) No fractional shares of Company Common Stock shall be issued in the Merger. In lieu of a
fractional share of Company Common Stock, the holder of any Shares who would otherwise be entitled
to receive such fractional share (after taking into account all shares of Seller Common Stock
delivered by such holder) shall be entitled to receive a cash payment, without interest and rounded
up to the nearest whole cent, in an amount determined by multiplying the Valuation Period Market
Value by the fraction of a share of Company Common Stock to which the holder would otherwise have
been entitled. As promptly as practicable after the determination of the amount of cash, if any,
to be paid to holders of fractional share interests,

 

 

the bank or trust company designated by the
Company (the “Exchange Agent”) shall so notify the Company, and the Company shall deposit that
amount with the Exchange Agent and shall cause the Exchange Agent to forward payments to the
holders of fractional share interests, subject to and in accordance with the terms of this Section
1.6.

     (e) Notwithstanding anything in this Agreement to the contrary, shares of Seller Common Stock
which are issued and outstanding immediately prior to the Effective Time and which are held by
stockholders who have validly exercised appraisal rights available under Section 17-6712 of the
KGCC (the “Dissenting Shares”) shall not be converted into or be exchangeable for the right to
receive the Per Share Consideration in accordance with this Section 1.6, unless and until such
holders shall have failed to perfect or shall have effectively withdrawn or lost their appraisal
rights under the KGCC. Dissenting Shares shall be treated in accordance with Section 17-6712 of
the KGCC, if and to the extent applicable. If any such holder shall have failed to perfect or
shall have effectively withdrawn or lost such appraisal rights, such holder’s shares of Seller
Common Stock shall thereupon be converted into and become exchangeable only for the right to
receive, as of the Effective Time, the Per Share Consideration in accordance with this Section 1.6.
The Seller shall give the Company (a) prompt notice of each and every notice of a stockholder’s
intent to demand payment for the stockholder’s shares of Seller Common Stock, attempted withdrawals
of such demands, and any other instruments served pursuant to the KGCC and received by the Seller
relating to rights to be paid the “fair value” of Dissenting Shares, as provided in Section 17-6712
of the KGCC and (b) the opportunity to direct all negotiations and proceedings with respect to
demands for appraisal under the KGCC. The Seller shall not, except with the prior written consent
of the Company, voluntarily make any payment with respect to, offer to settle or settle, or approve
any withdrawal of any demands for “fair value” under Section 17-6712 of the KGCC.

     (f) If either the tax opinion referred to in Section 7.2(e) or the tax opinion referred to in
Section 7.3(d) cannot be rendered because the counsel charged with providing such opinion
reasonably determines that the Merger may not satisfy the continuity of interest requirements under
applicable federal income tax principles relating to reorganizations under Section 368(a) of the
Code, then the Company shall reduce the Cash Amount and correspondingly increase the Stock Amount
to the minimum extent necessary to enable the relevant tax opinions to be rendered.

     1.7 Exchange of Certificates.

     (a) Exchange Agent. The Company shall deposit, or shall cause to be deposited, from
time to time, with the Exchange Agent, for the benefit of the holders of Shares, for exchange in
accordance with this Article I, through the Exchange Agent, the Per Share Consideration, together
with any dividends or distributions with respect thereto, if any, to be issued in exchange for
Shares pursuant to this Article I (the “Exchange Fund”). Such deposits shall be made after the
Effective Time as requested by the Exchange Agent in order for the Exchange Agent to promptly
deliver the Per Share Consideration.

     (b) Exchange Procedures. As soon as reasonably practicable after the Effective Time,
the Exchange Agent shall mail to each holder of record of a certificate representing ownership of
Shares (a “Certificate” or “Certificates”) whose Shares were converted into the

 

 

right to receive
the Per Share Consideration pursuant to Section 1.6, (i) a letter of transmittal (which shall
specify that delivery shall be effected, and risk of loss and title to the Certificates shall pass,
only upon delivery of the Certificates to the Exchange Agent and shall be in such form and have
such other provisions as the Company may reasonably specify) and (ii) instructions for use in
effecting the surrender of the Certificates in exchange for the Per Share Consideration. Upon
surrender of a Certificate for cancellation to the Exchange Agent together with such letter of
transmittal, duly executed, the holder of such Certificate shall be entitled to receive in exchange
therefor the Per Share Consideration and any unpaid dividends and distributions thereon as provided
in this Article I, which such holder has the right to receive in respect of the Certificate
surrendered pursuant to the provisions of this Article I (after taking into account all Shares then
held by such holder), and the Certificate so surrendered shall forthwith be canceled. In the event
of a transfer of ownership of Shares which is not registered in the transfer records of the Seller,
a transferee may exchange the Certificate representing such Shares for the Per Share Consideration
and any unpaid dividends and distributions thereon as provided in this Article I if the Certificate
representing such Shares is presented to the Exchange Agent, accompanied by all documents required
to evidence and effect such transfer, and by evidence that any applicable stock transfer taxes have
been paid. In the event any Certificate shall have been lost, stolen or destroyed, upon the making
of an affidavit of that fact by the person claiming such Certificate to be lost, stolen or
destroyed and the posting by such person of a bond in such amount as the Company may direct as
indemnity against any claim that may be made against it or the Exchange Agent with respect to such
Certificate, the Exchange Agent will issue in exchange for such lost, stolen or destroyed
Certificate the Per Share Consideration and any unpaid dividends and distributions thereon as
provided in this Article I, which such holder would have had the right to receive in respect of
such lost, stolen or destroyed Certificate. Until surrendered as contemplated by this Section 1.7,
each Certificate (other than Certificates representing Shares owned by the Company or any Company
Subsidiary, and Certificates representing Dissenting Shares) shall be deemed at any time after the
Effective Time to represent only the right to receive upon such surrender the Per Share
Consideration and any unpaid dividends and distributions thereon as provided in this Article I.

     (c) Distributions with Respect to Unexchanged Shares. No dividends or other
distributions declared or made after the Effective Time with respect to Company Common Stock with a
record date after the Effective Time shall be paid to the holder of any unsurrendered Certificate
with respect to the shares of Company Common Stock represented thereby, and no cash payment in lieu
of fractional shares shall be paid to any such holder pursuant to Section 1.6(d), until the holder
of such Certificate shall surrender such Certificate. Subject to the
effect of applicable laws, following surrender of any such Certificate, there shall be paid to
the holder of the certificates representing whole shares of Company Common Stock issued in exchange
therefor, without interest, (i) promptly, the amount of any cash payable with respect to a
fractional share of Company Common Stock to which such holder is entitled pursuant to Section
1.6(d) and the amount of dividends or other distributions with a record date after the Effective
Time theretofore paid with respect to such whole shares of Company Common Stock, and (ii) at the
appropriate payment date, the amount of dividends or other distributions, with a record date after
the Effective Time but prior to surrender and a payment date occurring after surrender, payable
with respect to such whole shares of Company Common Stock.

 

 

     (d) No Further Rights in the Shares. The Per Share Consideration issued and paid upon
conversion of the Shares in accordance with the terms hereof shall be deemed to have been issued
and paid in full satisfaction of all rights pertaining to such Shares.

     (e) Termination of Exchange Fund. Any portion of the Exchange Fund which remains
undistributed to the former stockholders of the Seller for six (6) months after the Effective Time
shall be delivered to the Company, upon demand, and any former stockholders of the Seller who have
not theretofore complied with this Article I shall thereafter look only to the Company to claim the
Per Share Consideration, any cash in lieu of fractional shares of Company Common Stock and any
dividends or distributions with respect to Company Common Stock, in each case without interest
thereon, and subject to Section 1.7(g). Any portion of the Exchange Fund remaining unclaimed by
holders of Shares as of a date which is immediately prior to such time as such amounts would
otherwise escheat to or become property of any United States federal, state or local or any foreign
government, or political subdivision thereof, or any multinational organization or authority or any
authority, agency or commission entitled to exercise any administrative, executive, judicial,
legislative, police, regulatory or taxing authority or power, any court or tribunal (or any
department, bureau or division thereof), or any arbitrator or arbitral body (each a “Governmental
Authority”) shall, to the extent permitted by applicable Law, become the property of the Surviving
Corporation free and clear of any claims or interest of any Person previously entitled thereto.

     (f) No Liability. Neither the Company nor the Seller shall be liable to any former
holder of Shares for any such Shares (or dividends or distributions with respect thereto) or cash
or other payment delivered to a public official pursuant to any abandoned property, escheat or
similar laws.

     (g) Withholding Rights. Each of the Company and the Exchange Agent shall be entitled
to deduct and withhold from the consideration otherwise payable pursuant to this Agreement to any
former holder of Shares such amounts as it is required to deduct and withhold with respect to the
making of such payment under any Laws relating to Taxes and pay such withholding amount over to the
appropriate taxing authority. To the extent that amounts are so withheld by the Company or the
Exchange Agent, such withheld amounts shall be treated for all purposes of this Agreement as having
been paid to the former holder of the Shares in respect of which such deduction and withholding was
made by the Company or the Exchange Agent as the case may be.

ARTICLE II — REPRESENTATIONS AND WARRANTIES OF SELLER

     Except as disclosed in the Seller SEC Reports or in the disclosure schedule (the “Seller
Disclosure Schedule”) delivered by Seller to the Company prior to the execution of this Agreement
(which schedule sets forth items of disclosure with specific reference to the particular Section or
subsection of this Agreement to which the information in the Seller Disclosure Schedule relates);
provided, however, that any information set forth in one section or subsection of
the Seller Disclosure Schedule will be deemed to apply to each other Section or subsection of this
Agreement to which its relevance is reasonably apparent, Seller hereby represents and warrants to
the Company as follows:

 

 

     2.1 Organization and Qualification; Subsidiaries.

     (a) The Seller is a corporation duly organized, validly existing and in good standing under
the laws of the State of Kansas, a registered bank holding company under the Bank Holding Company
Act of 1956, as amended (the “BHCA”), and a financial holding company under the Graham-Leach-Bliley
Act of 1999 and the regulations promulgated thereunder (the “GLB Act”). The Seller is also subject
to regulation by the Board of Governors of the Federal Reserve System (the “Federal Reserve
Board”). Each subsidiary of the Seller (a “Seller Subsidiary,” or collectively the “Seller
Subsidiaries”) is a state banking association, corporation, limited liability company, limited
partnership, or trust duly organized, validly existing and in good standing under the laws of the
state of its incorporation or organization. Each of the Seller and the Seller Subsidiaries has the
requisite corporate power and authority to own, lease and operate the properties it now owns or
holds under lease and to carry on its business as it is now being conducted, is duly qualified or
licensed as a foreign business entity to do business, and is in good standing, in each jurisdiction
where the character of the properties owned, leased or operated by it or the nature of its business
makes such qualification or licensing necessary, except for such jurisdictions in which the failure
to be so qualified or licensed would not, individually or in the aggregate, have a Seller Material
Adverse Effect. Each Seller Subsidiary that is a Kansas bank has been in existence and actively
engaged in business for five or more years.

     (b) Each of the Seller and the Seller Subsidiaries has all franchises, grants, authorizations,
licenses, permits, easements, consents, certificates, approvals and orders (“Seller Approvals”)
necessary to own, lease and operate their properties and to carry on its business as it is now
being conducted, including all required authorizations from the Federal Reserve Board, the Federal
Deposit Insurance Corporation (the “FDIC”), the Securities and Exchange Commission (the “SEC”), the
National Association of Securities Dealers, Inc. (the “NASD”), the United States Small Business
Administration (the “SBA”), the Office of the Kansas State Bank Commissioner, the Missouri Division
of Finance, the Oklahoma Office of State Finance and the Florida Office of Financial Regulation,
and neither the Seller nor any Seller Subsidiary has received any notice of proceedings relating to
the revocation or modification of any Seller Approvals, except in each case where such revocations
or modifications, or the failure to have such Seller Approvals would not, individually or in the
aggregate, have a Seller Material Adverse Effect.

     (c) A true and complete list of the Seller Subsidiaries, together with (i) the Seller’s
percentage ownership of each Seller Subsidiary and (ii) laws under which the Seller Subsidiary is
incorporated or organized, is set forth in the Seller Disclosure Schedule and on Annex A. The
Seller or one or more of the Seller Subsidiaries owns beneficially and of record all of the
outstanding shares of capital stock or other equity interests of each of the Seller Subsidiaries.
Except for the Seller Subsidiaries, the Seller does not directly or indirectly own any capital
stock or equity interest in, or any interests convertible into or exchangeable or exercisable for
any capital stock or equity interest in, any corporation, partnership, joint venture or other
business association or entity, other than in the ordinary course of business, and in no event in
excess of 5% of the outstanding equity securities of such entity.

 

 

     (d) As used in this Agreement, the term “Seller Material Adverse Effect” means, any effect,
change, event, fact, condition, occurrence, or development (each an “Effect”), that, individually
or in the aggregate with other Effects, (i) is material and adverse to the business, assets,
liabilities, results of operations or financial condition of the Seller and Seller Subsidiaries
taken as a whole, or (ii) materially impairs the ability of the Seller to consummate the
transactions contemplated hereby; provided, however, that the term “Seller Material
Adverse Effect” shall not be deemed to include the impact of (a) changes in laws and regulations or
interpretations thereof that are generally applicable to the banking industry, (b) changes in
generally accepted accounting principles that are generally applicable to the banking industry, (c)
expenses reasonably incurred in connection with the transactions contemplated hereby, (d) changes
attributable to or resulting from changes in general economic conditions affecting banks or their
holding companies generally, (e) any Effect to the extent resulting from the announcement of this
Agreement or the transactions contemplated thereby, (f) any change in the market price or trading
volume of the Seller’s Common Stock following the execution of this Agreement, (g) the payment of
any amounts due to, or the provision of any other benefits to, any officers or employees under
employment contracts, non-competition agreements, employee benefit plans, severance agreements or
other arrangements in existence as of the date of or contemplated by this Agreement, provided that
the payment of any such amounts or the provision of any such benefits shall be made in the ordinary
course consistent with past practices, (h) the taking of any action by the Seller approved or
consented to in writing by the Company, or (i) any action taken or not taken by the Seller or
Seller’s Subsidiaries in accordance with the terms and covenants contained in this Agreement.

     (e) The minute books of the Seller and each of the Seller Subsidiaries contain true, complete
and accurate records in all material respects of all meetings and other corporate actions held or
taken since January 1, 2000, of their respective stockholders and Boards of Directors (including
committees of their respective Boards of Directors).

     2.2 Articles of Incorporation and By-Laws. The Seller has heretofore furnished or
made available to the Company a complete and correct copy of the Seller’s Articles of Incorporation
and the Seller’s By-Laws, as amended or restated (“Seller Articles” and “Seller By-Laws,”
respectively), and the Articles of Incorporation and the By-Laws, or other organizational
documents, as the case may be, of each Seller Subsidiary (the “Subsidiary Organizational
Documents”). The Seller Articles, Seller By-Laws and Subsidiary Organizational Documents are in
full force and effect. Neither the Seller nor any
Seller Subsidiary is in breach of any of the provisions of the Seller Articles, Seller By-Laws
or Subsidiary Organizational Documents.

     2.3 Capitalization. The authorized capital stock of the Seller consists of 50,000,000
shares of Seller Common Stock and 50,000,000 shares of the Seller’s preferred stock, $1.00 par
value (“Seller Preferred Stock”). As of November 4, 2005, (i) 38,205,194 shares of Seller Common
Stock were issued and outstanding, all of which were duly authorized, validly issued, fully paid
and non-assessable, and not issued in violation of any preemptive right of any Seller stockholder,
(ii) 7,058,914 shares of Seller Common Stock were held as treasury shares by the Seller, (iii) no
shares of Seller Preferred Stock were issued and outstanding, (iv) 781,379 shares of Seller Common
Stock were subject to outstanding stock options issued pursuant to the Seller’s stock option plans,
and (v) 209,100 shares of issued and outstanding Seller Common Stock were

 

 

restricted common stock,
and there were 139,400 restricted stock units (“RSU”) issued and outstanding in each case under and
subject to the Seller’s equity compensation plan. The authorized capital stock of Gold Banc Trust
III, Gold Banc Trust IV and Gold Banc Capital Trust V consists of common securities and trust
preferred securities (the “TRUPs”). As of the date of this Agreement, all of the issued and
outstanding common securities are duly authorized, validly issued, fully paid and non-assessable
and owned by the Seller. As of the date of this Agreement, $84,000,000 in TRUPs are issued and
outstanding, all of which are duly authorized, validly issued, fully paid and non-assessable and
not issued in violation of any preemptive rights of any Seller stockholder or holder of TRUPs.
Except as set forth in clauses (iv) and (v), above, and in the Rights Agreement, there are no
outstanding Rights relating to the issued or unissued capital stock or other equity interests of
the Seller or any Seller Subsidiary or obligating the Seller or any Seller Subsidiary to issue or
sell any shares of capital stock or other equity interests of, or other equity interests in, the
Seller or any Seller Subsidiary. There are no obligations, contingent or otherwise, of the Seller
or any Seller Subsidiary to repurchase, redeem or otherwise acquire any shares of Seller Common
Stock or the capital stock or other equity interests of any Seller Subsidiary or to provide funds
to or make any investment (in the form of a loan, capital contribution or otherwise) in any Seller
Subsidiary or any other entity, except for loan commitments and other funding obligations entered
into in the ordinary course of business. Each of the outstanding shares of capital stock or other
equity interests of each Seller Subsidiary are duly authorized, validly issued, fully paid and
non-assessable, and not issued in violation of any preemptive rights of any Seller Subsidiary
stockholder or other equity holder, and such shares or other equity interests owned by the Seller
or another Seller Subsidiary are owned free and clear of all security interests, liens, claims,
pledges, agreements, limitations of the Seller’s voting rights, charges or other encumbrances of
any nature whatsoever.

     2.4 Authority. The Seller has the requisite corporate power and authority to execute
and deliver this Agreement, to perform its obligations hereunder and to consummate the transactions
contemplated hereby (other than, with respect to the Merger, the approval and adoption of this
Agreement by the Seller’s stockholders in accordance with the KGCC and the Seller Articles and
Seller By-Laws). The execution and delivery of this Agreement by the Seller and the consummation
by the Seller of the transactions contemplated hereby have been duly and validly
authorized by all necessary corporate action on the part of the Seller, including, without
limitation, Seller’s Board of Directors. As of the date of this Agreement, the Seller’s Board of
Directors, at a meeting duly called, constituted and held, has by the unanimous vote of all
directors present at the meeting determined (a) that this Agreement and the transactions
contemplated thereby, including the Merger, is advisable to, fair to and in the best interests of
the Seller and its stockholders, (b) to submit this Agreement for approval and adoption by the
stockholders of the Seller and to declare the advisability of this Agreement, and (c) to recommend
that the stockholders of the Seller adopt and approve this Agreement and the transactions
contemplated thereby, including the Merger, and direct that this Agreement be submitted for
consideration by the stockholders of the Seller at the Seller Stockholders’ Meeting (collectively,
the “Seller’s Board of Directors Recommendation”). No other corporate proceedings on the part of
the Seller are necessary to authorize this Agreement or to consummate the transactions so
contemplated hereby (other than, with respect to the Merger, the approval and adoption of this
Agreement by the Seller’s stockholders in accordance with the KGCC and the Seller Articles and
Seller By-Laws). This Agreement has been duly executed and delivered by, and constitutes a valid
and binding obligation of the Seller and assuming due authorization,

 

 

execution and delivery by
Company, enforceable against the Seller in accordance with its terms, except as enforcement may be
limited by laws affecting insured depository institutions, general principles of equity whether
applied in a court of law or a court of equity and by bankruptcy, insolvency and similar laws
affecting creditors’ rights and remedies generally.

     2.5 No Conflict; Required Filings and Consents.

     (a) The execution and delivery of this Agreement by the Seller do not, and the performance of
this Agreement and the transactions contemplated hereby by the Seller will not, (i) conflict with
or violate the Seller Articles or Seller By-Laws or the Subsidiary Organizational Documents, (ii)
conflict with or violate any federal, state or local statute, ordinance, rule, regulation, order,
judgment or decree (collectively, “Laws”) applicable to the Seller or any Seller Subsidiary or by
which its or any of their respective properties is bound or affected, or (iii) result in any breach
of or constitute a default (or an event that with notice or lapse of time or both would become a
default) under, or give to others any rights of termination, amendment, acceleration or
cancellation of, or result in the creation of a lien or encumbrance on any of the properties or
assets of the Seller or any Seller Subsidiary pursuant to, any note, bond, mortgage, indenture,
contract, agreement, lease, license, permit, franchise or other instrument or obligation to which
the Seller or any Seller Subsidiary is a party or by which the Seller or any Seller Subsidiary or
its or any of their respective properties is bound or affected, except in the case of clauses (ii)
and (iii), above, for any such conflicts, violations, breaches, defaults or other occurrences that
would not, individually or in the aggregate, have a Seller Material Adverse Effect. Sections
17-1286 through 17-1298 and Sections 17-12,100 through 17-12,104 of the KGCC are inapplicable to
the execution, delivery or performance of this Agreement and the transactions contemplated thereby,
including the Merger. No other “business combination,” “control share acquisition,” “fair price”
or other anti-takeover laws or regulations enacted under Kansas state law applies to the execution,
delivery or performance of this Agreement or any of the transactions contemplated hereby by the
Seller, including the Merger.

     (b) The execution and delivery of this Agreement by the Seller do not, and the performance of
this Agreement by the Seller will not, require any consent, approval, authorization or permit of,
or filing with or notification to, any domestic governmental or regulatory authority except (i) for
applicable requirements, if any, of the Securities Act of 1933, as amended (the “Securities Act”),
the Securities Exchange Act of 1934, as amended (the “Exchange Act”), state securities or blue sky
laws (“Blue Sky Laws”), the BHCA, the banking laws and regulations of the States of Kansas,
Missouri, Oklahoma and Florida (the “SBL”), regulations promulgated by the SBA, the filing and
recordation of appropriate merger or other documents as required by the KGCC and WBCL, and prior
notification filings with the Department of Justice under the Hart-Scott-Rodino Act (the “HSR
Act”), and (ii) where the failure to obtain such consents, approvals, authorizations or permits, or
to make such filings or notifications, would not prevent or delay consummation of the Merger or
otherwise prevent the Seller from performing its obligations under this Agreement, and would not
have a Seller Material Adverse Effect. Neither the Seller nor any Seller Subsidiary are subject to
any foreign Governmental Authority or foreign law.

     2.6 Compliance; Permits. Neither the Seller nor any Seller Subsidiary is in conflict
with, or in default or violation of, (i) any Law applicable to the Seller or any Seller Subsidiary
or

 

 

by which its or any of their respective properties is bound or affected, or (ii) any note, bond,
mortgage, indenture, contract, agreement, lease, license, permit, franchise or other instrument or
obligation to which the Seller or any Seller Subsidiary is a party or by which the Seller or any
Seller Subsidiary or its or any of their respective properties is bound or affected, except for any
such violations, conflicts or defaults which would not, individually or in the aggregate, have a
Seller Material Adverse Effect.

     2.7 Securities and Banking Reports; Financial Statements.

     (a) The Seller and each Seller Subsidiary have filed all forms, reports and documents required
to be filed with (x) the SEC since December 31, 2002, and as of the date of this Agreement has
delivered or made available to the Company (i) its Annual Reports on Form 10-K for the fiscal years
ended December 31, 2002, 2003 and 2004, respectively, (ii) all proxy statements relating to the
Seller’s meetings of stockholders (whether annual or special) held since December 31, 2002, (iii)
all Reports on Form 8-K filed by the Seller with the SEC since December 31, 2002, (iv) all other
reports or registration statements filed by the Seller with the SEC since December 31, 2002 and (v)
all amendments and supplements to all such reports and registration statements filed by the Seller
with the SEC since December 31, 2002 (collectively, the “Seller SEC Reports”) and (y) the Federal
Reserve Board, the FDIC, the Kansas Office of the State Bank Commissioner, the Missouri Division of
Finance, the Oklahoma Office of State Finance, the Florida Office of Financial Regulation and any
other applicable federal or state securities or banking authorities (all such reports and
statements are collectively referred to as the “Seller Reports”). The Seller Reports (i) were
prepared in all material respects in accordance with the requirements of applicable Law and (ii)
did not at the time they were filed, after giving effect to any amendment thereto filed prior to
the date hereof, contain any untrue statement of a
material fact or omit to state a material fact required to be stated therein or necessary in
order to make the statements therein, in the light of the circumstances under which they were made,
not misleading, except that information as of a later date (but before the date of this Agreement)
will be deemed to modify information as of an earlier date. The parties agree that failure of the
Seller’s Chief Executive Officer or Chief Financial Officer to provide any certification required
to be filed with any document filed in any Seller SEC Report shall constitute an event that has a
Seller Material Adverse Effect.

     (b) Each of the audited and unaudited consolidated financial statements (including, if
applicable, any related notes thereto) contained in the Seller SEC Reports have been prepared in
accordance with generally accepted accounting principles (“GAAP”) applied on a consistent basis
throughout the periods involved (except as may be indicated in the notes thereto or required by
reason of a concurrent change to GAAP) and each fairly presents in all material respects the
consolidated financial position of the Seller and the Seller Subsidiaries as of the respective
dates thereof and the consolidated results of its operations and cash flows and changes in
financial position for the periods indicated, except (i) for any statement therein or omission
therefrom which were corrected, amended or supplemented or otherwise disclosed or updated in a
subsequent Seller SEC Report, and (ii) that any unaudited interim financial statements do not
contain the footnotes required by GAAP, and were or are subject to normal and recurring year-end
adjustments, which were not or are not expected to be material in amount, either individually or in
the aggregate. The Seller has not had any dispute with any of its auditors regarding accounting
matters or policies during any of its past three full fiscal years or during the

 

 

current fiscal
year-to-date requiring disclosure pursuant to Item 304 of Regulation S-K promulgated by the SEC.
To Seller’s Knowledge, the Seller’s auditors will deliver to the Seller an unqualified audit
opinion with respect to the Seller’s financial statements as of and for the year ended December 31,
2005, and unqualified opinions with respect to the effectiveness of the Seller’s internal controls
and with respect to the assessment of management of the Seller regarding the effectiveness of the
Seller’s internal controls.

     (c) The Seller has made available to the Company a complete copy of any amendments or
modifications which are required to be filed with the SEC, but have not yet been filed with the
SEC, to (i) the Seller SEC Reports filed prior to the date hereof, and (ii) contracts which
previously have been filed by the Seller with the SEC pursuant to the Securities Act and Exchange
Act (together with the Seller SEC Reports, the “Seller SEC Documents”). The Seller has timely
responded to all comment letters and other correspondence of the staff of the SEC relating to the
SEC Documents, and the SEC has not advised the Seller that any final responses are inadequate,
insufficient or otherwise non-responsive. The Seller has made available to the Company true,
correct and complete copies of all correspondence between the SEC, on the one hand, and the Seller
and any of the Seller Subsidiaries, on the other, occurring since January 1, 2002 and prior to the
date hereof and will, reasonably promptly following the receipt thereof, make available to the
Company any such correspondence sent or received after the date hereof. To Seller’s Knowledge,
none of the SEC Documents is the subject of ongoing SEC review or outstanding SEC comment.

     (d) To Seller’s Knowledge, the Seller and each of its officers and directors are in compliance
with and have complied in all material respects with (A) the applicable provisions of the
Sarbanes-Oxley Act of 2002 (“Sarbanes-Oxley”), including, without limitation, Section 404
thereof, and any related rules and regulations promulgated by the SEC thereunder and (B) the
applicable listing and corporate governance rules and regulations of The Nasdaq National Market
(“Nasdaq”). With respect to each Report on Form 10-K and Form 10-Q and each amendment of any such
report filed by the Seller with the SEC since December 31, 2002, the Chief Executive Officer and
Chief Financial Officer of the Seller have made all certifications required by Sections 302 and 906
of Sarbanes-Oxley and the rules and regulations promulgated thereunder at the time of such filing,
and the statements contained in each such certification were true and correct when made. Further,
the Seller has established and maintains “disclosure controls and procedures” (as defined in Rule
13a-15(e) promulgated under the Exchange Act) that are reasonably designed to ensure that material
information (both financial and non-financial) relating to the Seller and the Seller Subsidiaries
required to be disclosed by the Seller in the reports that it files or submits under the Exchange
Act is recorded, processed, summarized and reported within the time periods specified in the rules
and forms of the SEC, and that such information is accumulated and communicated to the Seller’s
principal executive officer and principal financial officer, or persons performing similar
functions, as appropriate to allow timely decisions regarding required disclosure and to make the
certifications of the principal executive officer and the principal financial officer of the Seller
required by Section 302 of Sarbanes-Oxley with respect to such reports. For purposes of this
agreement, “principal executive officer” and “principal financial officer” shall have the meanings
given to such terms in Sarbanes-Oxley.

 

 

     (e) The Seller has established and maintains a system of “internal control over financial
reporting” (as defined in Rule 13a-15(f) promulgated under the Exchange Act) (“internal controls”).
To Seller’s Knowledge, based on its evaluation of internal controls prior to the date hereof, such
internal controls are sufficient to provide reasonable assurance regarding the reliability of the
Seller’s financial reporting and the preparation of the Seller’s financial statements for external
purposes in accordance with GAAP. The Seller has disclosed, based on its evaluation of internal
controls prior to the date hereof, to the Seller’s auditors and audit committee (i) any significant
deficiencies and material weaknesses known to the Seller in the design or operation of internal
controls which are reasonably likely to adversely affect in a material respect the Seller’s ability
to record, process, summarize and report financial information and (ii) any material fraud known to
the Seller that involves management or other employees who have a significant role in internal
controls. The Seller has made available to the Company a summary of any such disclosure regarding
material weaknesses and fraud made by management to the Seller’s auditors and audit committee since
December 31, 2002. For purposes of this agreement, a “significant deficiency” in controls means a
control deficiency that adversely affects an entity’s ability to initiate, authorize, record,
process, or report external financial data reliably in accordance with GAAP. A “significant
deficiency” may be a single deficiency or a combination of deficiencies that results in more than a
remote likelihood that a misstatement of the annual or interim financial statements that is more
than inconsequential will not be prevented or detected. For purposes of this Agreement, a
“material weakness” in controls means a significant deficiency, or a combination of significant
deficiencies, that results in more than a remote likelihood that a material misstatement of the
annual or interim financial statements will not be prevented or detected.

     (f) There are no outstanding loans made by the Seller or any Seller Subsidiary to any
executive officer (as defined in Rule 3b-7 promulgated under the Exchange Act) or director of the
Seller, other than loans that are subject to Regulation O under the Federal Reserve Act.

     (g) Except (i) for those liabilities that are reflected or fully reserved against on the
consolidated balance sheet of the Seller as of September 30, 2005, and (ii) for liabilities
incurred in the ordinary course of business consistent with past practice since September 30, 2005,
neither the Seller nor any Seller Subsidiary has incurred any liability of any nature whatsoever
(whether absolute, accrued, contingent or otherwise due or to become due), that are required to be
disclosed on a balance sheet prepared in accordance with GAAP, that, either alone or when combined
with all similar liabilities, has had, or would reasonably be expected to have, a Seller Material
Adverse Effect.

     (h) The Seller has not been notified by its independent registered public accounting firm or
by the staff of the SEC that such accounting firm or the staff of the SEC, as the case may be, are
of the view that any financial statement included in any Seller SEC Report should be restated which
has not been restated in a subsequent Seller SEC Report that was filed prior to the date of this
Agreement, or that the Seller should modify its accounting in future periods in a manner that would
have a Seller Material Adverse Effect.

     (i) Since January 1, 2005, neither the Seller nor the Seller Subsidiaries nor, to Seller’s
Knowledge, any director, officer, employee, auditor, accountant or representative of the Seller or
the Seller Subsidiaries, has received any complaint, allegation, assertion or claim,

 

 

whether
written or oral, regarding the accounting or auditing practices, procedures, methodologies or
methods of the Seller or the Seller Subsidiaries or their respective internal accounting controls,
including any complaint, allegation, assertion or claim that the Seller or the Seller Subsidiaries
has engaged in questionable accounting or auditing practices. To Seller’s Knowledge, no attorney
representing the Seller or the Seller Subsidiaries, whether or not employed by the Seller or the
Seller Subsidiaries, has reported evidence of a material violation of securities laws, breach of
fiduciary duty or similar violation by the Seller or any of its officers, directors, employees or
agents to the Seller’s Board of Directors or any committee thereof or to any director or officer of
the Seller. Since January 1, 2005, there have been no internal investigations regarding accounting
or revenue recognition discussed with, reviewed by or initiated at the direction of the Chief
Executive Officer, Chief Financial Officer, the Seller’s Board of Directors or any committee
thereof.

     2.8 Absence of Certain Changes or Events.

     (a) Since January 1, 2005 to the date of this Agreement, the Seller and the Seller
Subsidiaries have conducted their businesses only in the ordinary course and in a manner consistent
with past practice and, since January 1, 2005, there has not been (i) any change in the financial
condition, results of operations or business of the Seller and any of the Seller Subsidiaries which
has had a Seller Material Adverse Effect, (ii) any damage, destruction or loss (whether or not
covered by insurance) with respect to any assets of the Seller or any of the Seller Subsidiaries
which has had a Seller Material Adverse Effect, (iii) any change by the Seller in its
accounting methods, principles or practices, (iv) any revaluation by the Seller of any of its
assets in any material respect, (v) except for regular quarterly cash dividends on the Seller
Common Stock with usual record and payment dates, to the date of this Agreement, and the
publicly-announced stock repurchase program, any declaration setting aside or payment of any
dividends or distributions in respect of shares of Seller Common Stock or any redemption, purchase
or other acquisition of any of its securities or any of the securities of any Seller Subsidiary,
(vi) any increase in the wages, salaries, bonuses, compensation, pension, or other fringe benefits
or perquisites payable to any executive officer, employee, or director or any grant of any
severance or termination pay, except in the ordinary course of business consistent with past
practices, (vii) any strike, work stoppage, slow-down or other labor disturbance, (viii) the
execution of any collective bargaining agreement, contract or other agreement or understanding with
a labor union or organization, or (ix) any union organizing activities.

     (b) To Seller’s Knowledge, no third party has used, with or without permission, the corporate
name, the trademarks, trade names, service marks, logos, symbols or similar intellectual property
of Seller or any Seller Subsidiary in connection with the marketing, advertising, promotion or sale
of such third party’s products or services. Neither Seller nor any Seller Subsidiary is a party to
any joint marketing or other affinity marketing program with a third party.

     2.9 Absence of Litigation.

     (a) There is no Litigation or other proceedings pending or, to Seller’s Knowledge, threatened,
against Seller or any Seller Subsidiary or any of their property or assets or challenging the
validity or propriety of the transactions contemplated by this Agreement, as to

 

 

which there is a
reasonable probability of an adverse determination and which, if adversely determined, would,
individually or in the aggregate, have a Seller Material Adverse Effect. To Seller’s Knowledge,
neither Seller nor any of the Seller Subsidiaries or their affiliates are liable for the payment of
any termination, break-up or other fee to Silver Acquisition Corp. (“Silver”), SAC Acquisition
Corp. (“SAC”), or any of their affiliates, advisers or representatives as a result of the Seller’s
termination of that certain Merger Agreement dated as of February 24, 2004 by and among the Seller,
Silver and SAC and no basis exists for the payment of any such termination, break-up or other fee.

     (b) There is no Order imposed upon the Seller, any of the Seller Subsidiaries or the assets of
the Seller or any of the Seller Subsidiaries which has had a Seller Material Adverse Effect.

     (c) Except as set forth in the Seller’s Annual Report on Form 10-K for the fiscal year ended
December 31, 2004 or its Quarterly Report on Form 10-Q for the quarter ended September 30, 2005
(without giving effect to any amendment filed after the date of this Agreement), neither the Seller
nor any of the Seller Subsidiaries is subject to, and, to the Seller’s Knowledge, neither the
Seller nor any of the Seller Subsidiaries is reasonably likely to become subject to, any written
order, decree, agreement (including an agreement under Section 4(m) of the BHCA), memorandum of
understanding or similar arrangement with, or a commitment letter
or similar submission to, or extraordinary supervisory letter from, or adopted any
extraordinary board resolutions at the request of, any Governmental Authority charged with the
supervision or regulation of financial institutions or issuers of securities or engaged in the
insurance of deposits or the supervision or regulation of it or any of its Subsidiaries, nor has
any Governmental Authority advised it in writing or, to Seller’s Knowledge, otherwise advised, that
it is contemplating issuing or requesting (or is considering the appropriateness of issuing or
requesting) any such order, decree, agreement, memorandum of understanding or extraordinary
supervisory letter or any such board resolutions, nor, to its knowledge, has any Governmental
Authority commenced an investigation in connection therewith.

     (d) Neither the Seller nor any Seller Subsidiary has received any order, decree, notice or
other communication from any Governmental Authority asserting or claiming that the Seller or any
Seller Subsidiary is, and to Seller’s Knowledge, no facts or circumstances exist which would cause
it or any of the Seller Subsidiaries to be deemed to be, (i) operating in violation of the Bank
Secrecy Act, the USA PATRIOT ACT of 2001 and the regulations promulgated thereunder (the “Patriot
Act”), any order issued with respect to anti-money laundering by the U.S. Department of the
Treasury’s Office of Foreign Assets Control, or any other applicable anti-money laundering statute,
rule or regulation, except where any such violation would not have a Seller Material Adverse
Effect; or (ii) not in satisfactory compliance, with the applicable privacy and customer
information requirements contained in any federal and state privacy laws and regulations,
including, without limitation, in Title V of the GLB Act, as well as the provisions of the
information security program adopted pursuant to 12 C.F.R Part 40, except where the failure to so
comply would not have a Seller Material Adverse Effect. The Seller (or where appropriate the
Seller Subsidiary) has adopted and implemented an anti-money laundering program that contains
adequate and appropriate customer identification verification procedures that comply with Section
326 of the Patriot Act and such anti-money laundering program meets the requirements in all
material respects of Section 352 of the Patriot Act and the regulations

 

 

thereunder, and it (or such
other of the Seller Subsidiaries) has complied in all material respects, except where the failure
to comply would not have a Seller Material Adverse Effect, with any requirements to file reports
and other necessary documents as required by the Patriot Act and the regulations thereunder.

     2.10 Employee Benefit Plans.

     (a) Current Plans. The Seller Disclosure Schedule lists all employee benefit plans
(as defined in Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended
(“ERISA”)), and all bonus, stock option, stock purchase, restricted stock, incentive, deferred
compensation, retiree medical or life insurance, supplemental retirement, severance or other
benefit plans, programs or arrangements, and all material employment, termination, severance or
other employment contracts or employment agreements, with respect to which the Seller or any Seller
Subsidiary has any obligation (collectively, the “Plans”). The Seller has furnished or made
available to the Company a complete and accurate copy of each Plan (or a description of the Plans,
if the Plans are not in writing) and a complete and accurate copy of each material document
prepared in connection with each such Plan, including, without limitation, and where applicable, a
copy of (i) each trust or other funding arrangement, (ii) each summary plan
description and summary of material modifications, (iii) the three (3) most recently filed IRS
Forms 5500 and related schedules, (iv) the most recently issued determination letter from the
United States Internal Revenue Service (the “IRS”) for each such Plan and the materials submitted
to obtain that letter and (v) the three (3) most recently prepared actuarial and financial
statements with respect to each such Plan.

     (b) Absence of Certain Types of Plans. No member of the Seller’s “controlled group,”
within the meaning of Section 4001(a)(14) of ERISA, maintains or contributes to, or within the five
years preceding the Effective Time has maintained or contributed to, an employee pension benefit
plan subject to Title IV of ERISA (“Title IV Plan”). No Title IV Plan is a “multiemployer pension
plan” as defined in Section 3(37) of ERISA. None of the Plans obligates the Seller or any of the
Seller Subsidiaries to pay material separation, severance, termination or similar type benefits
solely as a result of any transaction contemplated by this Agreement or as a result of a “change in
control,” within the meaning of such term under Section 280G of the Code. Except as required by
COBRA, none of the Plans provides for or promises retiree medical, disability or life insurance
benefits to any current or former employee, officer or director of the Seller or any of the Seller
Subsidiaries. Each of the Plans is subject only to the laws of the United States or a political
subdivision thereof.

     (c) Compliance with Applicable Law. Each Plan has been operated in all respects in
accordance with the requirements of all applicable Law and all persons who participate in the
operation of such Plans and all Plan “fiduciaries” (within the meaning of Section 3(21) of ERISA)
have acted in accordance with the provisions of all applicable Law, except where such operations or
violations of applicable Law would not, individually or in the aggregate, have a Seller Material
Adverse Effect. The Seller and the Seller Subsidiaries have performed all obligations required to
be performed by any of them under, are not in any respect in default under or in violation of, and
the Seller and the Seller Subsidiaries have no Knowledge of any default or violation by any party
to, any Plan, except where such failures, defaults or violations would not, individually or in the
aggregate, have a Seller Material Adverse Effect. No legal

 

 

action, suit or claim is pending or, to
Seller’s Knowledge, threatened with respect to any Plan (other than claims for benefits in the
ordinary course) and, except as disclosed in Section 2.10(c) of the Seller Disclosure Schedule, to
Seller’s Knowledge, no fact or event exists that could give rise to any such action, suit or claim.
Except as disclosed in Section 2.10(c) of the Seller Disclosure Schedule, neither the Seller nor
any Seller Subsidiary has incurred any material liability under Section 302 of ERISA or Section 412
of the Code that has not been satisfied in full and no condition exists that presents a material
risk of incurring any such liability.

     (d) Qualification of Certain Plans. Each Plan that is intended to be qualified under
Section 401(a) of the Code or Section 401(k) of the Code (including each trust established in
connection with such a Plan that is intended to be exempt from Federal income taxation under
Section 501(a) of the Code) has received a favorable determination letter from the IRS that it is
so qualified or is entitled to rely on a favorable opinion or advisory letter issued to the sponsor
of a master and prototype plan pursuant to IRS Announcement 2001-77, and the Seller is not aware of
any fact or event that could adversely affect the qualified status of any such Plan. No trust
maintained or contributed to by the Seller or any of the Seller Subsidiaries is intended to be
qualified as a voluntary employees’ beneficiary association or is intended to be exempt from
federal income taxation under Section 501(c)(9) of the Code.

     (e) Non-Qualified Deferred Compensation Plans. No Plan that is a non-qualified
deferred compensation plan subject to Section 409A of the Code (“Section 409A”) has been modified
(as defined under Section 409A) on or after October 3, 2004 and all such non-qualified deferred
compensation plans have been operated and administered in good faith compliance with Section 409A
from the period beginning January 1, 2005 through the date hereof, except modifications and
operations that, individually or in the aggregate, would not have a Seller Material Adverse Effect.

     (f) Absence of Certain Liabilities and Events. There has been no non-exempt
prohibited transaction (within the meaning of Section 406 of ERISA or Section 4975 of the Code)
with respect to any Plan. The Seller and each of the Seller Subsidiaries has not incurred any
liability for any excise tax arising under Sections 4971 through 4980G of the Code that would,
individually or in the aggregate, have a Seller Material Adverse Effect, and, to Seller’s
Knowledge, no fact or event exists that could give rise to any such liability.

     (g) Plan Contributions. All contributions, premiums or payments required to be made
with respect to any Plan have been made on or before their due dates.

     (h) Employment Contracts. Neither the Seller nor any Seller Subsidiary is a party to
any contracts for employment, severance, consulting or other similar contracts with any employees,
consultants, officers or directors of the Seller or any of the Seller Subsidiaries. Neither the
Seller nor any Seller Subsidiary is a party to any collective bargaining agreements.

     (i) Effect of Agreement. The consummation of the transactions contemplated by this
Agreement will not, either alone or in conjunction with another event, entitle any current or
former employee of the Seller or any Seller Subsidiary to severance pay, unemployment compensation
or any other payment, including payments constituting “excess parachute payments” within the
meaning of Section 280G of the Code, except as expressly provided herein,

 

 

or accelerate the time of
payment or vesting or increase the compensation due any such employee or former employee, in each
case, except as expressly provided herein.

     2.11 Registration Statement; Proxy Statement/Prospectus. The information supplied by
the Seller for inclusion or incorporation by reference in the Registration Statement will not at
the time the Registration Statement is declared effective contain any untrue statement of a
material fact or omit to state any material fact required to be stated therein or necessary in
order to make the statements therein, in the light of the circumstances under which they were made,
not misleading. The information supplied by the Seller for inclusion or incorporation by reference
in the proxy statement/prospectus to be sent to the stockholders of the Seller in connection with
the meeting of the Seller’s stockholders to consider the Merger (the “Seller Stockholders’
Meeting”) (such proxy statement/prospectus as amended or supplemented is referred to herein as the
“Proxy Statement/Prospectus”) will not at the date the Proxy Statement/Prospectus (or any amendment
thereof or supplement thereto) is first mailed to stockholders, at the time of the Seller
Stockholders’ Meeting and at the Effective Time, be false or misleading with respect to any
material fact required to be stated therein, or omit to state any material fact required to be
stated therein or necessary in order to make the statements made therein, in the light of the
circumstances under which they are made, not
misleading. If at any time prior to the Effective Time any event relating to Seller or any of
its affiliates, officers or directors should be discovered by Seller which should be set forth in
an amendment to the Registration Statement or a supplement to the Proxy Statement/Prospectus,
Seller shall promptly inform the Company. The Proxy Statement/Prospectus will comply in all
material respects as to form with the requirements of the Securities Act, the Exchange Act (to the
extent applicable) and the rules and regulations thereunder.

     2.12 Title to Property. The Seller and each of the Seller Subsidiaries has good and
marketable title to all of their respective properties and assets, real and personal, free and
clear of all mortgage liens, and free and clear of all other liens, charges and encumbrances except
liens for taxes not yet due and payable, pledges to secure deposits and such minor imperfections of
title, if any, as do not materially detract from the value of or interfere with the present use of
the property affected thereby or which, individually or in the aggregate, would not have a Seller
Material Adverse Effect; and all leases pursuant to which Seller or any of the Seller Subsidiaries
lease from others material amounts of real or personal property are in good standing, valid and
effective in accordance with their respective terms, and there is not, under any of such leases,
any existing material default or event of default (or event which with notice or lapse of time, or
both, would constitute a material default and in respect of which the Seller or such Seller
Subsidiary has not taken adequate steps to prevent such a default from occurring). Substantially
all of Seller’s and each of the Seller’s Subsidiaries’ buildings and equipment in regular use have
been reasonably maintained and are in good and serviceable condition, reasonable wear and tear
excepted.

     2.13 Environmental Matters. To Seller’s Knowledge: (i) each of the Seller, the
Seller’s Subsidiaries, properties owned or operated by the Seller or the Seller’s Subsidiaries, the
Participation Facilities (as hereinafter defined) are and have been in compliance with, and the
Loan Properties (as hereinafter defined) are and have been in substantial compliance with, all
applicable federal, state and local laws including common law, rules, guidance, regulations and
ordinances and with all applicable decrees, orders, judgments, and contractual obligations

 

 

relating
to the environment, health, safety, natural resources, wildlife or “Hazardous Materials” which are
hereinafter defined as chemicals, pollutants, contaminants, wastes, toxic substances, compounds,
products, solid, liquid, gas, petroleum or other regulated substances or materials which are
hazardous, toxic or otherwise harmful to health, safety, natural resources, or the environment
(“Environmental Laws”), except for violations which, either individually or in the aggregate, would
not have a Seller Material Adverse Effect; (ii) during and prior to the period of (a) the Seller’s
or any of the Seller’s Subsidiaries’ ownership or operation of any of their respective current
properties, (b) the Seller’s or any of the Seller’s Subsidiaries’ participation in the management
of any Participation Facility or (c) the Seller’s or any of the Seller’s Subsidiaries’ holding of a
security interest in a Loan Property, Hazardous Materials have not been generated, treated, stored,
transported, released or disposed of in, on, under, above, from or affecting any such property,
except where such release, generation, treatment, storage, transportation, or disposal would not
have, either individually or in the aggregate, a Seller Material Adverse Effect; (iii) there is no
asbestos or any material amount of ureaformaldehyde materials in or on any property owned or
operated by Seller or Seller’s Subsidiaries or any Participation Facility and no electrical
transformers or
capacitors, other than those owned by public utility companies, on any such properties contain
any PCB’s; (iv) there are no underground or aboveground storage tanks and there have never been any
underground or aboveground storage tanks located on, in or under any properties currently or
formerly owned or operated by the Seller or any of Seller’s Subsidiaries or any Participation
Facility; (v) neither Seller nor Seller’s Subsidiaries have received any notice from any
governmental agency or third party notifying the Seller or Seller’s Subsidiaries of any
Environmental Claim; (vi) and there are no circumstances with respect to any properties currently
owned or operated by the Seller or any of Seller’s Subsidiaries or any Loan Property or
Participation Facility that could reasonably be anticipated (a) to form the basis for an
Environmental Claim against Seller or Seller’s Subsidiaries or any properties currently or formerly
owned or operated by the Seller or any of Seller’s Subsidiaries or any Loan Property or
Participation Facility or (b) to cause any properties currently owned or operated by the Seller or
any of Seller’s Subsidiaries or any Loan Property or Participation Facility to be subject to any
restrictions on ownership, occupancy, use or transferability under any applicable Environmental Law
or require notification to or consent of any Governmental Authority or third party pursuant to any
Environmental Law.

     The following definitions apply for purposes of this Section 2.13: (a) “Loan Property” means
any property in which the Seller or any of the Seller’s Subsidiaries holds a security interest, the
fair market value of which (based on the most recent appraisal or other information available to
the Seller or any Seller Subsidiary) exceeds $5,000,000, and, where required by the context, said
term means the owner or operator of such property; (b) “Participation Facility” means any facility
in which the Seller or any of the Seller’s Subsidiaries participates in the management and, where
required by the context, said term means the owner or operator of such property; and (c)
“Environmental Claims” shall mean any and all administrative, regulatory, judicial or private
actions, suits, demands, demand letters, notices, claims, liens, notices of non compliance or
violation, investigations, allegations, injunctions or proceedings relating in any way to (i) any
Environmental Law; (ii) any Hazardous Material including without limitation any abatements,
removal, remedial, corrective or other response action in connection with any Hazardous Material,
Environmental Law or order of a Governmental Authority; or (iii) any actual or alleged damage,
injury, threat or harm to health, safety, natural resources, wildlife, or

 

 

the environment, which
individually or in the aggregate would have a Seller Material Adverse Effect.

     2.14 Absence of Agreements. Neither the Seller nor any Seller Subsidiary is a party
to any agreement or memorandum of understanding with, or a party to any commitment letter or
similar undertaking to, or is subject to any order or directive by, or is a recipient of any
extraordinary supervisory letter which restricts materially the conduct of its business (including
any contract containing covenants which limit the ability of the Seller or of any Seller Subsidiary
to compete in any line of business or with any person or which involve any restriction of the
geographical area in which, or method by which, the Seller or any Seller Subsidiary may carry on
its business (other than as may be required by Law or applicable Regulatory Authorities)), or in
any manner relates to its capital adequacy, its credit policies or its management, nor has the
Seller been advised that any federal, state, or governmental agency is contemplating issuing or
requesting (or is considering the appropriateness of issuing or requesting) any such order, decree,
agreement,
memorandum of understanding, extraordinary supervisory letter, commitment letter or similar
submission.

     2.15 Taxes. The Seller and the Seller Subsidiaries have timely filed all Tax Returns
required to be filed by them on or prior to the date of this Agreement (all such returns being
accurate and complete in all material respects), and the Seller and the Seller Subsidiaries have
timely paid and discharged all Taxes due in connection with or with respect to the filing of such
Tax Returns, except such as are not yet due or are being contested in good faith by appropriate
proceedings and with respect to which the Seller is maintaining reserves adequate for their payment
or where the failure to make such filings or pay such taxes would not have a Seller Material
Adverse Effect. For purposes of this Agreement, “Tax” or “Taxes” shall mean taxes, charges, fees,
levies, and other governmental assessments and impositions of any kind, payable to any federal,
state, or local governmental entity or taxing authority or agency, including, without limitation,
(i) income, franchise, profits, gross receipts, estimated, ad valorem, value added, sales, use,
service, real or personal property, capital stock, license, payroll, withholding, disability,
employment, social security, workers compensation, unemployment compensation, utility, severance,
production, excise, stamp, occupation, premiums, windfall profits, transfer and gains taxes, (ii)
customs duties, imposts, charges, levies or other similar assessments of any kind, and (iii)
interest, penalties and additions to tax imposed with respect thereto; and “Tax Returns” shall mean
returns, reports, and information statements with respect to Taxes required to be filed with the
IRS or any other governmental entity or taxing authority or agency, including, without limitation,
consolidated, combined and unitary tax returns. For the purposes of this Section 2.15, references
to the Seller and the Seller Subsidiaries include former subsidiaries of the Seller for the periods
during which any such corporations were owned, directly or indirectly, by the Seller. To Seller’s
Knowledge, neither the IRS nor any other governmental entity or taxing authority or agency is now
asserting, either through audits, administrative proceedings or court proceedings, any deficiency
or claim for additional Taxes. Neither the Seller nor any of the Seller Subsidiaries has granted
any waiver of any statute of limitations with respect to, or any extension of a period for the
assessment of, any Tax. Except for statutory liens for current taxes not yet due, there are no
material tax liens on any assets of the Seller or any of the Seller Subsidiaries. Neither the
Seller nor any of the Seller Subsidiaries has received a ruling or entered into an agreement with
the IRS or any other taxing authority that would have a Seller Material Adverse Effect after the
Effective Time. No agreements relating to allocating or sharing of Taxes exist

 

 

among the Seller
and the Seller Subsidiaries and no tax indemnities given by the Seller or the Seller Subsidiaries
in connection with a sale of stock or assets remain in effect. Neither the Seller nor any of the
Seller Subsidiaries is required to include in income either (i) any amount in respect of any
adjustment under Section 481 of the Code or (ii) any installment sale gain. Neither the Seller nor
any of the Seller Subsidiaries has made an election under Section 341(f) of the Code. Neither the
Seller nor any of the Seller Subsidiaries (i) is a member of an affiliated, consolidated, combined
or unitary group, other than one of which the Seller was the common parent, or (ii) has any
liability for the Taxes of any Person (other than the Seller and the Seller Subsidiaries) under
Treasury Regulation Section 1-1502-6 (or any similar provision of state or local law) as a
transferee or successor, by contract or otherwise.

     2.16 Insurance. The Seller Disclosure Schedule lists all material policies of insurance of the Seller and
the Seller Subsidiaries currently in effect. Neither the Seller nor any of the Seller Subsidiaries
has any liability for unpaid premiums or premium adjustments not properly reflected on the Seller’s
financial statements for the nine months ended September 30, 2005.

     2.17 Brokers. No broker, finder or investment banker (other than Hovde Financial LLC)
is entitled to any brokerage, finder’s or other fee or commission in connection with the
transactions contemplated by this Agreement based upon arrangements made by or on behalf of the
Seller. Prior to the date of this Agreement, the Seller has furnished to the Company a complete
and correct copy of all agreements between the Seller and Hovde Financial LLC pursuant to which
such firm would be entitled to any payment relating to the transactions contemplated hereunder.

     2.18 Tax Matters. Neither Seller, nor any Seller Subsidiary, through the date of this
Agreement has taken or agreed to take any action that would prevent the Merger from qualifying as a
reorganization under Section 368(a)(1)(A) of the Code.

     2.19 Seller Material Adverse Effect. Since December 31, 2004, there has not been any
Effect that has had, individually or in the aggregate, a Seller Material Adverse Effect.

     2.20 Material Contracts. Except for (i) loan, credit or similar agreements entered
into by the Seller or any Seller Subsidiary in the ordinary course of business consistent with past
practice, or (ii) as disclosed in the Seller Disclosure Schedule, neither Seller nor any Seller
Subsidiary is a party to or obligated under any contract, agreement or other instrument or
understanding which obligates the Seller or any Seller Subsidiary for payments or other
consideration with a value in excess of $150,000, or would require disclosure by the Seller
pursuant to Item 601(b)(10) of Regulation S-K under the Exchange Act, other than contracts that are
terminable by the Seller or any Seller Subsidiary without additional payment or penalty within 60
days.

     2.21 Opinion of Financial Advisor. The Seller has received the written opinion of
Hovde Financial LLC on the date of this Agreement to the effect that, as of the date of this
Agreement, the consideration to be received in the Merger by the Seller’s stockholders is fair to
the Seller’s stockholders from a financial point of view, and the Seller will promptly, after the
date of this Agreement, deliver a copy of such opinion to the Company.

 

 

     2.22 Vote Required. The affirmative vote of a majority of the votes that holders of
the outstanding shares of Seller Common Stock are entitled to cast is the only vote of the holders
of any class or series of
the Seller capital stock necessary to approve this Agreement and the transactions contemplated
hereby, including the Merger.

     2.23 Stock Options. The assumption of the Option Plans and the Options issued
thereunder as provided in Section 5.7 of this Agreement by the Company are permitted by and
consistent with the terms of the Option Plans, the agreements under which the Options were issued
and applicable law.

     2.24 Rights Agreement. The Seller and the Seller’s Board of Directors have taken all
necessary action to render the Rights Agreement dated as of October 13, 1999 between the Seller and
American Stock Transfer & Trust Company (the “Rights Agreement”) inapplicable to this Agreement and
the transactions contemplated hereby, including the Merger, without any further action on the part
of the holders of Seller Common Stock or the Seller’s Board of Directors, and neither the execution
and delivery of this Agreement nor the consummation of any of the transactions contemplated hereby
will result in the occurrence of a Distribution Date (as defined in the Rights Agreement) or
otherwise cause the Rights (as defined in the Rights Agreement) to become exercisable by the
holders thereof. The First Amendment to the Rights Agreement dated as of February 24, 2004 has
been superseded by the Second Amendment to the Rights Agreement adopted by the Seller’s Board of
Directors.

ARTICLE III — REPRESENTATIONS AND WARRANTIES OF THE COMPANY

     Except as disclosed in the Company SEC Reports or in the disclosure letter (the “Company
Disclosure Schedule”) delivered by the Company to the Seller prior to the execution of this
Agreement (which letter sets forth items of disclosure with specific reference to the particular
Section or subsection of this Agreement to which the information in the Company Disclosure Schedule
relates; provided, however, that any information set forth in one section of the
Company Disclosure Schedule will be deemed to apply to each other Section or subsection of this
Agreement to which its relevance is reasonably apparent, the Company hereby represents and warrants
to the Seller as follows:

     3.1 Organization and Qualification; Subsidiaries.

     (a) The Company is a company duly organized, validly existing and in active status under the
laws of the State of Wisconsin and a registered bank holding company under the BHCA, and a
financial holding company under the GLB Act. Each subsidiary of the Company (a “Company
Subsidiary” or, collectively, “Company Subsidiaries”) is a bank, a corporation, a limited liability
company or another form of business entity duly organized, validly existing and in good standing
under the laws of the state of its organization or the United States of America. Each of the
Company and the Company Subsidiaries have the requisite corporate power and authority and are in
possession of all franchises, grants, authorizations, licenses, permits, easements, consents,
certificates, approvals and orders (“Company Approvals”) necessary to own, lease and operate their
respective properties and to carry on their respective business as
now being conducted, including appropriate authorizations from the Federal Reserve Board, the
FDIC, the DFI, the Office of Thrift Supervision (the “OTS”), or the Office of Comptroller of the

 

 

Currency (“OCC”) and neither Company nor any Company Subsidiary has received any notice of
proceedings relating to the revocation or modification of any Company Approvals, except in each
case where the revocations or modifications, the failure to be so organized, existing and in good
standing or to have such power, authority or Company Approvals would not, individually or in the
aggregate, have a Company Material Adverse Effect.

     (b) The Company and each Company Subsidiary is duly qualified or licensed as a foreign
business entity to do business, and is in good standing, in each jurisdiction where the character
of its properties owned, leased or operated by it or the nature of its activities makes such
qualification or licensing necessary, except for such failures to be so duly qualified or licensed
and in good standing that would not, either individually or in the aggregate, have a Company
Material Adverse Effect.

     (c) A true and complete list of all of the Company Subsidiaries as of September 30, 2005 is
set forth in the Company Disclosure Schedule.

     (d) As used in this Agreement, the term “Company Material Adverse Effect” means any Effect
that, individually or in the aggregate with other Effects, (i) is material and adverse to the
business, assets, liabilities, results of operations or financial condition of the Company and
Company Subsidiaries taken as a whole, or (ii) materially impairs the ability of the Company to
consummate the transactions contemplated hereby; provided, however, that the term
“Company Material Adverse Effect” shall not be deemed to include: (a) any Effect to the extent
resulting from the announcement of this Agreement or the transactions contemplated hereby, (b) any
Effect resulting from compliance with the terms and conditions of this Agreement, (c) any decrease
in the price or trading volume of the Company Common Stock (but not excluding any Effect underlying
such decrease to the extent such Effect would constitute a Company Material Adverse Effect), (d)
any Effect to the extent resulting from changes in Laws generally applicable to the banking
industry, (e) any Effect to the extent resulting from changes in generally accepted accounting
principles which the Company or any of the Company Subsidiaries is required to adopt, or (f)
changes attributable to or resulting from changes in general economic conditions affecting the
banking industry generally (unless such Effect would reasonably be expected to have a materially
disproportionate impact on the business, assets, liabilities, financial condition or results of
operations of the Company and Company Subsidiaries taken as a whole relative to other banking
industry participants).

     3.2 Articles of Incorporation and By-Laws. The Company has previously furnished or
made available to the Seller a complete and correct copy of the Company Articles and the Company
By-Laws. The Company Articles and Company By-Laws are in full force and effect. The Company is
not in breach of any of the provisions of the Company Articles or Company By-Laws.

     3.3 Capitalization.

     (a) The authorized capital stock of the Company consists of 700,000,000 shares of Company
Common Stock. As of November 4, 2005, (i) 244,432,552 shares of the Company’s Common Stock were
issued and outstanding, all of which were duly authorized, validly issued, fully paid and
non-assessable, except pursuant to Section 180.0622(2)(b) of the WBCL (such

 

 

sections, including
judicial interpretation thereof and Section 180.40(6), its predecessor statute, are referred to
herein collectively as “Section 180.0622(2)(b) of the WBCL”), and not issued in violation of any
preemptive right of any Company stockholder, (ii) 9,414,755 shares of Company Common Stock are held
in the treasury of the Company, (iii) no shares of Company Preferred Stock are issued and
outstanding, and (iv) 24,970,198 shares of Company Common Stock are subject to outstanding stock
options issued pursuant to the Company’s stock option plans. Except as set forth in clause (iv),
above, there are no outstanding options, warrants or other rights, agreements, arrangements or
commitments of any character, including, without limitation, voting agreements or arrangements,
relating to the issued or unissued capital stock or other equity interests of the Company or
obligating the Company to issue or sell any shares of capital stock or other equity interests of,
or other equity interests in, the Company.

     (b) The shares of Company Common Stock to be issued pursuant to the Merger will, upon issuance
in accordance with the provisions of this Agreement, be duly authorized, validly issued, fully paid
and non-assessable, except as otherwise provided by Section 180.0622(2)(b) of the WBCL.

     3.4 Authority. The Company has the requisite corporate power and authority to execute
and deliver this Agreement, and to perform its obligations hereunder and to consummate the
transactions contemplated hereby. The execution and delivery of this Agreement by the Company and
the consummation by the Company of the transactions contemplated hereby have been duly and validly
authorized by all necessary corporate action on the part of the Company, including, without
limitation, the Company’s Board of Directors, and no other corporate proceedings on the part of the
Company are necessary to authorize this Agreement or to consummate the transactions so contemplated
hereby. This Agreement has been duly and validly executed and delivered by the Company and
constitutes a valid and binding obligation of the Company and assuming the due authorization,
execution and delivery by the Seller, enforceable against the Company in accordance with its terms,
except as enforcement may be limited by laws affecting insured depository institutions, general
principles of equity, whether applied in a court of law or a court of equity, and by bankruptcy,
insolvency and similar laws affecting creditors’ rights and remedies generally.

     3.5 No Conflict; Required Filings and Consents.

     (a) The execution and delivery of this Agreement by the Company does not, and the performance
of this Agreement by the Company shall not, (i) conflict with or violate the Company Articles or
Company By-Laws or the Articles of Incorporation or By-Laws or other organizational documents, as
the case may be, of any Company Subsidiary, (ii) conflict with or violate any Laws applicable to
the Company or any Company Subsidiary or by which any of
their respective properties is bound or affected, or (iii) result in any breach of or
constitute a default (or an event which with notice or lapse of time or both would become a
default) under, or give to others any rights of termination, amendment, acceleration or
cancellation of, or result in the creation of a lien or encumbrance on any of the properties or
assets of the Company or any Company Subsidiary pursuant to, any note, bond, mortgage, indenture,
contract, agreement, lease, license, permit, franchise or other instrument or obligation to which
the Company or any Company Subsidiary is a party or by which the Company or any Company Subsidiary
or its or any of their respective properties is bound or affected, except in the case of clause
(ii) and (iii),

 

 

above, for any such conflicts, violations, breaches, defaults or other occurrences
that would not, individually or in the aggregate, have a Company Material Adverse Effect.

     (b) The execution and delivery of this Agreement by the Company do not, and the performance of
this Agreement by the Company shall not, require any consent, approval, authorization or permit of,
or filing with or notification to, any governmental or regulatory authority, domestic or foreign,
except (i) for applicable requirements, if any, of the Securities Act, the Exchange Act, Blue Sky
Laws, the BHCA, the SBL, the SBA, the filing and recordation of appropriate merger or other
documents as required by Kansas and Wisconsin law, and prior notification filings with the
Department of Justice under the HSR Act and (ii) where the failure to obtain such consents,
approvals, authorizations or permits, or to make such filings or notifications, would not prevent
or delay consummation of the Merger, or otherwise would not prevent or delay consummation of the
Merger, or otherwise prevent the Company from performing its obligations under this Agreement, and
would not have, or be reasonably expected to have, a Company Material Adverse Effect. No other
“business combination,” “control share acquisition,” “fair price” or other anti-takeover laws or
regulations enacted under Wisconsin state law applies to the execution, delivery or performance of
this Agreement or any of the transactions contemplated hereby by the Company, including the Merger.

     3.6 Compliance; Permits. Neither the Company nor any Company Subsidiary is in
conflict with, or in default or violation of, (i) any Law applicable to the Company or any Company
Subsidiary or by which its or any of their respective properties is bound or affected, or (ii) any
note, bond, mortgage, indenture, contract, agreement, lease, license, permit, franchise or other
instrument or obligation to which the Company or any Company Subsidiary is a party or by which the
Company or any Company Subsidiary or its or any of their respective properties is bound or
affected, except for any such conflicts, defaults or violations which would not, individually or in
the aggregate, have, or be reasonably expected to have, a Company Material Adverse Effect.

     3.7 Securities and Banking Reports; Financial Statements.

     (a) The Company and each Company Subsidiary have filed all forms, reports and documents
required to be filed with (x) the SEC since December 31, 2002, and as of the date of this Agreement
have delivered or made available to the Seller, in the form filed with the SEC, (i) its Annual
Reports on Form 10-K for the fiscal years ended December 31, 2002, 2003 and 2004, respectively,
(ii) all proxy statements relating to the Company’s meetings of shareholders
(whether annual or special) held since December 31, 2002, (iii) all Reports on Form 8-K filed
by the Company with the SEC since December 31, 2002, (iv) all other reports or registration
statements filed by the Company with the SEC since December 31, 2002, and (iv) all amendments and
supplements to all such reports and registration statements filed by the Company with the SEC since
December 31, 2002 (collectively, the “Company SEC Reports”) and (y) the FDIC, the OCC, the Federal
Reserve Board, the OTS, the DFI and any other applicable Federal or state securities or banking
authorities (all such reports and statements are collectively referred to with the Company SEC
Reports as the “Company Reports”). The Company Reports (i) were prepared in accordance with the
requirements of applicable Law and (ii) did not at the time they were filed, after giving effect to
any amendment thereto filed prior to the date hereof, contain any untrue statement of a material
fact or omit to state a material fact

 

 

required to be stated therein or necessary in order to make
the statements therein, in light of the circumstances under which they were made, not misleading,
except that information as of a later date (but before the date of this Agreement) will be deemed
to modify information as of an earlier date. The parties agree that failure of the Company’s Chief
Executive Officer or Chief Financial Officer to provide any certification required to be filed with
any document filed with the SEC shall constitute an event that has a Company Material Adverse
Effect.

     (b) Each of the audited and unaudited consolidated financial statements (including, if
applicable, any related notes thereto) contained in the Company SEC Reports have been prepared in
accordance with generally accepted accounting principles (“GAAP”) applied on a consistent basis
throughout the periods involved (except as may be indicated in the notes thereto or required by
reason of a concurrent change to GAAP) and each fairly presents in all material respects the
consolidated financial position of the Company and the Company Subsidiaries as of the respective
dates thereof and the consolidated results of its operations and cash flows and changes in
financial position for the periods indicated, except (i) for any statement therein or omission
therefrom which were corrected, amended or supplemented or otherwise disclosed or updated in a
subsequent Company SEC Report, and (ii) that any unaudited interim financial statements do not
contain the footnotes required by GAAP, and were or are subject to normal and recurring year-end
adjustments, which were not or are not expected to be material in amount, either individually or in
the aggregate. The Company has not had any dispute with any of its auditors regarding accounting
matters or policies during any of its past three full fiscal years or during the current fiscal
year-to-date requiring disclosure pursuant to Item 304 of Regulation S-K promulgated by the SEC.
To the Company’s Knowledge, the Company’s auditors will deliver to the Company an unqualified audit
opinion with respect to the Company’s financial statements as of and for the year ended December
31, 2005, and unqualified opinions with respect to the effectiveness of the Company’s internal
controls and with respect to the assessment of management of the Company regarding the
effectiveness of the Company’s internal controls.

     (c) To the Company’s Knowledge, the Company and each of its officers and directors are in
compliance with and have complied in all material respects with (A) the applicable provisions of
Sarbanes-Oxley and any related rules and regulations promulgated by the SEC thereunder and (B) the
applicable listing and corporate governance rules and regulations of the NYSE. With respect to
each Report on Form 10-K and Form 10-Q and each amendment of any such report filed by the Company
with the SEC since December 31, 2002, the Chief Executive Officer and Chief Financial Officer of
the Company have made all certifications required by Sarbanes-Oxley and the rules and regulations
promulgated thereunder at the time of such filing,
and to the Company’s Knowledge, the statements contained in each such certification were true
and correct when made. Further, the Company has established and maintains “disclosure controls and
procedures” (as defined in Rule 13a-15(e) promulgated under the Exchange Act) that are reasonably
designed to ensure that material information (both financial and non-financial) relating to the
Company and the subsidiaries required to be disclosed by the Company in the reports that it files
or submits under the Exchange Act is recorded, processed, summarized and reported within the time
periods specified in the rules and forms of the SEC, and that such information is accumulated and
communicated to the Company’s principal executive officer and principal financial officer, or
persons performing similar functions, as appropriate to allow timely decisions regarding required
disclosure and to make the certifications

 

 

of the principal executive officer and the principal
financial officer of the Company required by Section 302 of Sarbanes-Oxley with respect to such
reports.

     (d) The Company has established and maintains a system of “internal control over financial
reporting” (as defined in Rule 13a-15(f) promulgated under the Exchange Act) (“internal controls”).
To the Company’s Knowledge, based on its evaluation of internal controls prior to the date hereof,
such internal controls are sufficient to provide reasonable assurance regarding the reliability of
the Company’s financial reporting and the preparation of the Company’s financial statements for
external purposes in accordance with GAAP. The Company has disclosed, based on its most recent
evaluation of internal controls prior to the date hereof, to the Company’s auditors and audit
committee (i) any significant deficiencies and material weaknesses known to the Company in the
design or operation of internal controls which are reasonably likely to adversely affect in a
material respect the Company’s ability to record, process, summarize and report financial
information and (ii) any material fraud known to the Company that involves management or other
employees who have a significant role in internal controls. The Company has made available to the
Seller a summary of any such disclosure regarding material weaknesses and fraud made by management
to the Company’s auditors and audit committee since December 31, 2003.

     (e) There are no outstanding loans made by the Company or any Company Subsidiary to any
executive officer (as defined in Rule 3b-7 promulgated under the Exchange Act) or director of the
Company, other than loans that are subject to Regulation O under the Federal Reserve Act.

     (f) Except (i) for those liabilities that are fully reflected or reserved against on the
consolidated balance sheet of the Company included in the Company’s Quarterly Report on Form 10-Q
for the period ended September 30, 2005, and (ii) for the liabilities incurred in the ordinary
course of business consistent with past practice since September 30, 2005, neither Company nor any
Company Subsidiary has incurred any liability of any nature whatsoever (whether absolute, accrued,
contingent or otherwise and whether due or to become due), required to be disclosed on a balance
sheet prepared in accordance with GAAP that, either alone or when combined with all similar
liabilities, has had a Company Material Adverse Effect.

     (g) The Company has not been notified by its independent public accounting firm or by the
staff of the SEC that such accounting firm or the staff of the SEC, as the case may be, are of the
view that any financial statement included in any registration statement filed by the Company under
the Securities Act or any periodic or current report filed by the Company under
the Exchange Act should be restated, or that the Company should modify its accounting in
future periods in a manner that would have a Company Material Adverse Effect.

     (h) Since January 1, 2005, neither the Company nor the Company Subsidiaries nor, to the
Company’s Knowledge, any director, officer, employee, auditor, accountant or representative of the
Company or the Company Subsidiaries, has received any complaint, allegation, assertion or claim,
whether written or oral, regarding the accounting or auditing practices, procedures, methodologies
or methods of the Company or the Company Subsidiaries or their respective internal accounting
controls, including any complaint, allegation, assertion or claim that the Company or the Company
Subsidiaries has engaged in questionable accounting or auditing

 

 

practices. To the Company’s
Knowledge, no attorney representing the Company or the Company or Subsidiaries, whether or not
employed by the Company or the Company Subsidiaries, has reported evidence of a material violation
of securities laws, breach of fiduciary duty or similar violation by the Company or any of its
officers, directors, employees or agents to the Company’s Board of Directors or any committee
thereof or to any director or officer of the Company. Since January 1, 2005, there have been no
material internal investigations regarding accounting or revenue recognition discussed with,
reviewed by or initiated at the direction of the Chief Executive Officer, Chief Financial Officer,
general counsel, the Company’s Board of Directors or any committee thereof.

     3.8 Absence of Certain Changes or Events.

     (a) Except as disclosed in the Company SEC Reports filed prior to the date of this Agreement,
since December 31, 2004 to the date of this Agreement, the Company and the Company Subsidiaries
have conducted their businesses only in the ordinary course and in a manner consistent with past
practice and, since December 31, 2004, there has not been (i) any change in the financial
condition, results of operations or business of the Company or any of the Company Subsidiaries that
has had a Company Material Adverse Effect, (ii) any damage, destruction or loss (whether or not
covered by insurance) with respect to any assets of the Company or any of the Company Subsidiaries
that has had, or would be reasonably expected to have, a Company Material Adverse Effect, (iii) any
change by the Company in its accounting methods, principles or practices, (iv) any revaluation by
the Company of any of its assets in any material respect, (v) any strike, work stoppage, slow down
or other labor disturbance, (vi) the execution of any collective bargaining agreement, contract or
other agreement or understanding with a labor union or organization, or (vii) any union organizing
activities.

     3.9 Absence of Litigation.

     (a) Neither the Company nor any of the Company Subsidiaries is a party to any, and there are
no pending or, to the best of the Company’s Knowledge, threatened, legal, administrative, arbitral
or other proceedings, claims, actions or governmental or regulatory investigations of any nature
against the Company or any of the Company Subsidiaries or challenging the validity or propriety of
the transactions contemplated by this Agreement as to
which there is a reasonable probability of an adverse determination and which, if adversely
determined, would, individually or in the aggregate, have a Company Material Adverse Effect.

     (b) There is no injunction, order, judgment, decree or regulatory restriction imposed upon the
Company, any of the Company Subsidiaries or the assets of the Company or any of the Company
Subsidiaries which has had a Company Material Adverse Effect.

     (c) Neither the Company nor any Company Subsidiary has received any order, decree, notice or
other communication from any Governmental Authority asserting or claiming that the Company or any
Company Subsidiary is, and to Company’s Knowledge, no facts or circumstances exist which would
cause it or any of the Company Subsidiaries to be deemed to be, (i) operating in violation of the
Bank Secrecy Act, the Patriot Act, any order issued with respect to anti-money laundering by the
U.S. Department of the Treasury’s Office of Foreign Assets Control, or any other applicable
anti-money laundering statute, rule or regulation, except

 

 

where any such violation would not have a
Company Material Adverse Effect; or (ii) not in satisfactory compliance, with the applicable
privacy and customer information requirements contained in any federal and state privacy laws and
regulations, including, without limitation, in Title V of the GLB Act, as well as the provisions of
the information security program adopted pursuant to 12 C.F.R Part 40, except where the failure to
so comply would not have a Company Material Adverse Effect. The Company (or where appropriate the
Company Subsidiary) has adopted and implemented an anti-money laundering program that contains
adequate and appropriate customer identification verification procedures that comply with Section
326 of the Patriot Act and such anti-money laundering program meets the requirements in all
material respects of Section 352 of the Patriot Act and the regulations thereunder, and it (or such
other of the Company Subsidiaries) has complied in all material respects, except where the failure
to comply would not have a Company Material Adverse Effect, with any requirements to file reports
and other necessary documents as required by the Patriot Act and the regulations thereunder.

     3.10 Registration Statement; Proxy Statement/Prospectus. The information supplied by
the Company for inclusion or incorporation by reference in the registration statement of the
Company (the “Registration Statement”) pursuant to which the shares of Company Common Stock to be
issued in the Merger will be registered with the SEC shall not, at the time the Registration
Statement (including any amendments or supplements thereto) is declared effective by the SEC,
contain any untrue statement of a material fact or omit to state any material fact required to be
stated therein or necessary in order to make the statements therein, in light of the circumstances
under which they were made, not misleading. The information supplied by the Company for inclusion
or incorporation by reference in the Proxy Statement/Prospectus shall not, at the date the Proxy
Statement/Prospectus (or any amendment thereof or supplement thereto) is first mailed to
stockholders, at the time of the Seller Stockholders’ Meeting and at the Effective Time, be false
or misleading with respect to any material fact required to be stated therein, or omit to state any
material fact necessary in order to make the statements made therein, in light of the circumstances
under which they are made, not misleading. If at any time prior to the Effective Time any event
relating to the Company or any of its affiliates, officers or directors should be discovered by the
Company which should be set forth in an amendment to the Registration Statement or a supplement to
the Proxy
Statement/Prospectus, the Company will promptly inform the Seller. The Registration Statement
and the Proxy Statement/Prospectus shall comply in all material respects as to form with the
requirements of the Securities Act, the Exchange Act (to the extent applicable) and the rules and
regulations thereunder. Notwithstanding the foregoing, the Company makes no representation or
warranty with respect to any information about, or supplied or omitted by, the Seller which is
contained in any of the foregoing documents.

     3.11 Compliance; Permits. Neither the Company nor any Company Subsidiary is in
conflict with, or in default or violation of, (i) any Law applicable to the Company or any Company
Subsidiary or by which its or any of their respective properties is bound or affected, or (ii) any
note, bond, mortgage, indenture, contract, agreement, lease, license, permit, franchise or other
instrument or obligation to which the Company or any Company Subsidiary is a party or by which the
Company or any Company Subsidiary or any of its or any of their respective properties is bound or
affected, except for any such conflicts, defaults or violations which would not, individually or in
the aggregate, have a Company Material Adverse Effect.

 

 

     3.12 Title to Property. The Company and each of the Company Subsidiaries has good and
marketable title to all of their respective properties and assets, real and personal, free and
clear of all mortgage liens, and free and clear of all other liens, charges and encumbrances except
liens for taxes not yet due and payable, pledges to secure deposits and such minor imperfections of
title, if any, as do not materially detract from the value of or interfere with the present use of
the property affected thereby or which would not, individually or in the aggregate, have a Company
Material Adverse Effect; and all leases pursuant to which the Company or any of the Company
Subsidiaries lease from others material amounts of real or personal property are in good standing,
valid and effective in accordance with their respective terms, and there is not, under any of such
leases, any existing material default or event of default (or event which with notice or lapse of
time, or both, would constitute a material default and in respect of which the Company or such
Company Subsidiary has not taken adequate steps to prevent such a default from occurring).
Substantially all of the Company’s and each of the Company Subsidiaries’ buildings and equipment in
regular use have been reasonably maintained and are in good and serviceable condition, reasonable
wear and tear excepted.

     3.13 Brokers. No broker, finder or investment banker is entitled to any brokerage,
finder’s or other fee or commission in connection with the transactions contemplated by this
Agreement based upon arrangements made by or on behalf of the Company.

     3.14 Tax Matters. Neither the Company, nor any Company Subsidiary, has through the
date of this Agreement taken or agreed to take any action that would prevent the Merger from
qualifying as a reorganization under Section 368(a)(1)(A) of the Code.

     3.15 Company Material Adverse Effect. Since December 31, 2004, there has not been any
Effect that has had, individually or in the aggregate, a Company Material Adverse Effect.

ARTICLE IV — COVENANTS OF SELLER

     4.1 Affirmative Covenants. The Seller hereby covenants and agrees with the Company
that, except (i) as permitted by this Agreement, (ii) as disclosed in the Seller Disclosure
Schedule, (iii) as required by Law, or by a Governmental Authority of competent jurisdiction,
provided, that prior to failing to take any such action, the Seller notifies the Company
thereof and to the extent required by the Company, uses its reasonable best efforts to take any
such action otherwise subject to such Law or Governmental Authority, or (iv) as otherwise consented
to in writing by the Company, during the period from the date hereof to the earlier of the
Effective Time or the termination of this Agreement in accordance with its terms, it will, and it
will cause each Seller Subsidiary, to:

     (a) operate its business only in the usual, regular and ordinary course consistent with past
practices;

     (b) use all reasonable efforts to preserve intact its business organization and assets,
maintain its rights and franchises, retain the services of its officers and key employees and
maintain its relationships with customers;

     (c) use all reasonable efforts to maintain and keep its properties in as good repair and
condition as at present, ordinary wear and tear excepted;

 

 

     (d) use all commercially reasonable efforts to keep in full force and effect director and
officer liability insurance comparable in amount and scope of coverage to that now maintained by it
(the “Existing D&O Policy”), except as provided in Section 6.5;

     (e) perform in all material respects all obligations required to be performed by it under all
material contracts, leases, and documents relating to or affecting its assets, properties, and
business;

     (f) comply with and perform in all material respects all obligations and duties imposed upon
it by all applicable Laws, including, without limitation, all filing requirements under the
Securities Act and the Exchange Act; and

     (g) not to take any action or fail to take any action which, individually or in the aggregate,
can be expected to have a Seller Material Adverse Effect.

     4.2 Negative Covenants. Except (i) as permitted by this Agreement, (ii) as disclosed
in the Seller Disclosure Schedule, (iii) as required by Law, or by a Governmental Authority of
competent jurisdiction, provided that prior to taking any such action, the Seller notifies
the Company thereof and to the extent required by the Company, uses its reasonable best efforts to
avoid having to take such action required by such Law or Governmental Authority, or (iv) as
otherwise consented to in writing by the Company, during the period from the date hereof to the
earlier of the Effective Time or the termination of this Agreement in accordance with its terms,
the Seller shall not do, or permit any Seller Subsidiary to do, any of the following:

     (a) (i) except to maintain qualification pursuant to the Code, adopt, amend, renew or
terminate any Plan or any agreement, arrangement, plan or policy between the Seller or any Seller
Subsidiary and one or more of its current or former directors, officers or employees or (ii) except
for normal increases in the ordinary course of business consistent with past practice and subject
to the limitations set forth in Annex B, or increase in any manner the base salary, bonus,
incentive compensation or fringe benefits of any director, officer or employee or pay any benefit
not required by any plan or agreement as in effect as of the date hereof (including, without
limitation, the granting of stock options, stock appreciation rights, restricted stock, restricted
stock units or performance units or shares);

     (b) (i) except as provided below, declare or pay any dividend on, or make any other
distribution in respect of, its outstanding shares of capital stock or limited liability company
interests, except for (A) regular quarterly cash dividends on Seller Common Stock with usual record
and payment dates for such dividends with each such dividend payable at a rate not in excess of
$0.05 per share of Seller Common Stock and (B) dividends by a Seller Subsidiary either to the
Seller or another Seller Subsidiary;

     (i) declare or pay any dividends or make any distributions in any amount on Seller
Common Stock in or with respect to the quarter in which the Effective Time shall occur and
in which the stockholders of Seller Common Stock are entitled to receive dividends on the
shares of Company Common Stock into which the shares of Seller Common Stock have been
converted; provided, however, that it is the intent of this clause (ii) to
provide that the holders of Seller Common Stock will receive either the

 

 

payment of cash dividends on their shares of Seller Common Stock or the payment of cash
dividends as the holders of shares of Company Common Stock received in exchange for the
shares of Seller Common Stock pursuant to this Agreement for the calendar quarter during
which the Effective Time shall occur, but will not receive and will not become entitled to
receive for the same calendar quarter both the payment of a cash dividend as stockholders of
Seller Common Stock and the payment of a cash dividend as the holders of shares of Company
Common Stock received in exchange for the shares of Seller Common Stock pursuant to this
Agreement; and if the Seller does not declare and pay cash dividends in a particular
calendar quarter because of the Seller’s reasonable expectation that the Effective Time was
to have occurred in such calendar quarter wherein the holders of Seller Common Stock would
have become entitled to receive cash dividends for such calendar quarter on the shares of
Company Common Stock to have been exchanged for the shares of Seller Common Stock pursuant
to this Agreement, and the Effective Time does not in fact occur in such calendar quarter,
then, as a result thereof, the Seller shall be entitled to declare and pay a cash dividend
(within the limitations of this clause (ii)) on such shares of Seller Common Stock for such
calendar quarter by the declaration and payment of such cash dividends as soon as reasonably
practicable after the end of such calendar quarter;

     (c) except as contemplated by this Agreement, merge with or into any other person, permit any
other person to merge into it or consolidate with any other person, or effect any reorganization or
recapitalization;

     (d) purchase or otherwise acquire any substantial portion of the assets, or more than 5% of
any class of stock or other equity interests, of any person other than in the ordinary course of
business;

     (e) liquidate, sell, dispose of, or encumber any assets or acquire any assets outside of the
ordinary course of business;

     (f) repurchase, redeem or otherwise acquire, or issue, sell or deliver, split, reclassify,
combine or otherwise adjust, or agree to issue, sell or deliver, split, reclassify, combine or
otherwise adjust, any stock (except pursuant to exercise of those options described in the Seller
Disclosure Schedule), bonds or other corporate securities of which the Seller or any of the Seller
Subsidiaries is the issuer (whether authorized and unissued or held in treasury), or, grant or
issue, or agree to grant or issue, any options, warrants or other Rights (including convertible
Securities) calling for issue thereof;

     (g) propose or adopt any amendments to its articles of incorporation, by laws, articles of
organization, or operating agreement, as the case may be, in any way adverse to the Company;

     (h) change any of its methods of accounting in effect at December 31, 2004 or change any of
its methods of reporting income or deductions for federal income tax purposes from those employed
in the preparation of the federal income tax returns for the taxable year ending December 31, 2004,
except as may be required by GAAP; and

 

 

     (i) change any lending, investment, liability management or other material policies concerning
the business or operations of the Seller or any of the Seller Subsidiaries, except as required by
Law, including, without limitation:

     (i) acquire or sell any contracts for the purchase or sale of financial or other
futures or any put or call options, or enter into any hedges or interest rate swaps relating
to cash, securities, or any commodities whatsoever or enter into any other derivative
transaction, which would have gains or losses in excess of $2,000,000, or enter into,
terminate or exchange a derivative instrument with a notional amount in excess of $2,000,000
or having a term of more than five years;

     (ii) sell, assign, transfer, pledge, mortgage or otherwise encumber, or permit any
encumbrances to exist with respect to, any of its assets with a value in excess of $250,000
individually, except in the ordinary course of business consistent with past practice;

     (iii) make any investment with a maturity of five years or more;

     (iv) incur any material liabilities or material obligations, whether directly or by way
of guaranty, including any obligation for borrowed money (other than indebtedness of the
Seller or the Seller Subsidiaries to each other) in excess of an aggregate of $1,000,000
(for the Seller and the Seller Subsidiaries on a consolidated basis) except in the ordinary
course of business consistent with past practice;

     (v) enter into any agreement with respect to any acquisition of a material amount of
assets or securities or any discharge, waiver, satisfaction, release or relinquishment of
any material contract rights, liens, encumbrances, debt or claims, not in the ordinary
course of business and consistent with past practices (which shall include creation of
deposit liabilities, purchases of federal funds, advances from the Federal Reserve Bank or
Federal Home Loan Bank, and entry into repurchase agreements fully secured by U.S.
Government or agency securities), or impose, or suffer the imposition, on any material asset
of the Seller or any Seller Subsidiaries of any Lien or permit any such Lien to exist (other
than in connection with deposits, repurchase agreements, bankers acceptances, “treasury tax
and loan” accounts established in the ordinary course of business, the satisfaction of legal
requirements in the exercise of trust powers, and Liens in effect as of the date hereof that
are disclosed in the Financial Statements) and in no event with a value in excess of
$250,000 individually;

     (vi) settle any claim, action, suit, litigation, proceeding, arbitration, investigation
or controversy of any kind, for any amount in excess of $250,000 or in any manner which
would restrict in any material respect the operations or business of the Seller or any of
the Seller Subsidiaries;

     (vii) purchase any new financial product or instrument which involves entering into a
contract with a term of six months or longer;

     (viii) make any capital expenditure, except in the ordinary course and consistent with
past practice and in no event in excess of $250,000 individually; or

 

 

     (ix) take any action or fail to take any action which, individually or in the
aggregate, would be reasonably expected to have a Seller Material Adverse Effect; or

     (x) agree in writing or otherwise to do any of the foregoing.

     4.3 Letter of Seller’s Accountants. If requested in writing by the Company, the
Seller shall use its reasonable best efforts to cause to be delivered to the Company “comfort”
letters of KPMG, LLP, the Seller’s independent registered public accounting firm, dated the date on
which the Registration Statement shall become effective and the Effective Time, respectively, and
addressed to the Company, in a form reasonably satisfactory to the Company and reasonably customary
in scope and substance for letters delivered by independent registered public accounting firms in
connection with registration statements similar to the Registration Statement and transactions such
as those contemplated by this Agreement.

     4.4 No Solicitation of Transactions.

     (a) From and after the date of this Agreement until the Effective Time or termination of this
Agreement pursuant to Article VIII, the Seller and the Seller Subsidiaries will not, nor will they
authorize or permit any of their respective officers, directors, affiliates or employees or any
investment banker, attorney or other advisor or representative retained by any of them to, directly
or indirectly:

     (i) solicit, initiate, encourage or induce the making, submission or announcement of
any Acquisition Proposal,

     (ii) participate in any discussions or negotiations regarding, or furnish to any person
any material non-public information with respect to, or take any other action to facilitate
any inquiry or the making of any proposal that constitutes or may reasonably be expected to
lead to, any Acquisition Proposal, or

     (iii) enter into any contract, agreement, letter of intent or other arrangement
relating to any Acquisition Transaction:

provided, however, this Section 4.4(a) shall not prohibit the Seller or the
Seller’s Board of Directors from:

     (A) furnishing material nonpublic information (other than information regarding
the Company supplied to the Seller by the Company) regarding the Seller or the
Seller Subsidiaries to, or entering into a customary confidentiality agreement with
or entering or re-entering into discussions with, any person or group in response to
an Acquisition Proposal submitted by such person or group (and not withdrawn) if (x)
the Seller’s Board of Directors reasonably determines in good faith that such
Acquisition Proposal constitutes or is reasonably likely to result in a Superior
Offer, and (y) the Seller’s Board of Directors concludes in good faith, after
consultation with its outside legal counsel, that failure to take such action is
reasonably likely to result in a breach by the Seller’s Board of Directors of its
fiduciary obligations to the Seller’s stockholders under applicable Laws, provided
that in any such case neither the Seller nor any representative of

 

 

the Seller and the Seller Subsidiaries shall have violated any of the
restrictions set forth in this Section 4.4(a), or

     (B) taking the actions described in subsections (b) or (c), below, as permitted
thereby, provided that neither the Seller, the Seller Subsidiaries nor any
representatives of the Seller and the Seller Subsidiaries shall have violated any of
the restrictions set forth in this Section 4.4(a).

     At least five (5) days prior to furnishing any material nonpublic information to, or entering
into discussions or negotiations with, any person or group, the Seller shall:

     (i) give the Company written notice of the identity of such person or group and of the
Seller’s intention to furnish material nonpublic information to, or enter into discussions
or negotiations with, such person or group, and

     (ii) receive from such person or group an executed confidentiality agreement containing
customary limitations on the use and disclosure of all written and oral nonpublic
information furnished to such person or group by or on behalf of the Seller, and
contemporaneously with furnishing any such information to such person or group, the Seller
shall furnish such information to the Company (to the extent such information has not been
previously furnished by the Seller to the Company).

     Nothing in this Section 4.4(a) shall prevent the Seller or the Seller’s Board of Directors
from complying with Rules 14e-2 and 14d-9 promulgated under the Exchange Act with regard to an
Acquisition Proposal. The Seller and the Seller Subsidiaries will immediately cease, as of the
date hereof, any and all existing activities, discussions or negotiations with any parties
conducted heretofore with respect to any Acquisition Proposal, subject to the right to renew such
activities, discussions or negotiations in accordance with this Section 4.4. Without limiting the
foregoing, it is understood that any violation of the restrictions set forth in this Section 4.4 by
any officer or director of the Seller or any of the Seller Subsidiaries or any investment banker,
attorney or other advisor or representative of the Seller or any of the Seller Subsidiaries shall
be deemed to be a breach of this Section 4.4 by the Seller.

     For purposes of this Agreement, “Acquisition Proposal” shall mean any offer or proposal (other
than an offer or proposal by the Company) relating to any Acquisition Transaction. For the
purposes of this Agreement, “Acquisition Transaction” shall mean any transaction or series of
related transactions other than the transactions contemplated by this Agreement involving:

     (i) any acquisition or purchase from the Seller by any person or “group” (as defined
under Section 13(d) of the Exchange Act and the rules and regulations thereunder) of more
than a 15% interest in the total outstanding voting securities of the Seller or any of the
Seller Subsidiaries or any tender offer or exchange offer that if consummated would result
in any person or “group” (as defined under Section 13(d) of the Exchange Act and the rules
and regulations thereunder) beneficially owning 15% or more of the total outstanding voting
securities of the Seller or any of the Seller Subsidiaries, or any merger, consolidation,
business combination or similar transaction involving the Seller or any of the Seller
Subsidiaries;

 

 

     (ii) any sale, lease (other than in the ordinary course of business), exchange,
transfer, license (other than in the ordinary course of business), acquisition or
disposition of more than 15% of the assets of the Seller; or

     (iii) any liquidation or dissolution of the Seller.

     (b) Except as provided hereinbelow: (i) the Seller’s Board of Directors shall recommend that
the Seller’s stockholders vote in favor of and to adopt and approve this Agreement and the Merger
at the Seller Stockholders’ Meeting; (ii) the Proxy Statement/Prospectus shall include a statement
of the Seller’s Board of Directors Recommendation; and (iii) neither the Seller’s Board of
Directors nor any committee thereof shall withdraw, amend or modify, or propose or resolve to
withdraw, amend or modify in a manner adverse to the Company (a “Change of Recommendation”), the
Seller’s Board of Directors Recommendation; provided, however, that nothing in this
Agreement shall prevent the Seller’s Board of Directors from (i) withholding, withdrawing, amending
or modifying the Seller’s Board of Directors Recommendation or (ii) not including in the Proxy
Statement/Prospectus the Seller’s Board of Directors Recommendation if the Seller’s Board of
Directors reasonably determines in good faith, after consultation with outside counsel, that, due
solely to facts or circumstances coming to the attention of the Seller’s Board of Directors after
the date of this Agreement, the failure to take such action is reasonably likely to result in a
breach by the Seller’s Board of Directors of its fiduciary obligations to Seller’s stockholders
under applicable Law; and provided further, however, that neither the Seller nor
the Seller’s Board of Directors may take any of the actions described in clauses (i) or (ii) of the
immediately preceding proviso if prior thereto the Seller shall have received an Acquisition
Proposal that has not been withdrawn as of the time of such action of the Seller’s Board of
Directors;

     (c) Notwithstanding anything to the contrary contained in this Section 4.4, in the event that
the Seller’s Board of directors determines in good faith, after consultation with outside counsel,
that in light of a Superior Offer it is necessary to do so in order to comply with its fiduciary
duties to the Seller or the Seller’s stockholders under applicable law, the Seller’s Board of
Directors may terminate this Agreement in the manner contemplated by Section 8.1(h) solely in order
to concurrently enter into a definitive agreement with respect to a Superior Offer, but only after
the fifth day following the Company’s receipt of written notice advising the Company that the
Seller’s Board of Directors is prepared to accept a Superior Offer, and only if, during such
five-day period, if the Company so elects, the Seller and its advisors shall have negotiated in
good faith with the Company to make such adjustments in the terms and conditions of this Agreement
as would enable the Seller to proceed with the transactions contemplated herein on such adjusted
terms.

     For purposes of this Agreement, “Superior Offer” shall mean an unsolicited, bona fide written
offer made by a third party to consummate any of the following transactions or in one or a series
of related transactions:

     (i) a merger, consolidation, business combination, recapitalization, liquidation,
dissolution or similar transaction involving the Seller pursuant to which those shareholders
of the Seller immediately preceding such transaction will hold less than 51% of the equity
interest in the surviving or resulting entity of such transaction,

 

 

     (ii) a sale or other disposition by the Seller of substantially all of its assets, or

     (iii) the acquisition by any person or group (including by way of a tender offer or an
exchange offer or issuance by the Seller), directly or indirectly, of beneficial ownership
or a right to acquire beneficial ownership of shares representing in excess of 50% of the
voting power of the then outstanding shares of capital stock of the Seller;

     (iv) provided, however, that in each of case (i), (ii) or (iii)
immediately above, the Superior Offer shall be on terms that the Seller’s Board of Directors
determines, in its reasonable judgment to be more favorable to Seller stockholders (taking
into account all factors which the Seller’s Board of Directors may reasonably deem relevant,
including, without limitation, the relative value and form of the consideration offered, all
other terms and conditions of the respective offers, including, without limitation, the
presence of a financial contingency, the likelihood of obtaining financing on a timely basis
if a financing contingency is present, and the likelihood of obtaining any required
regulatory approvals) than the terms of the Merger (after receipt and consideration of
advice of a financial advisor of nationally recognized reputation).

     (d) In addition to the obligations of the Seller set forth in Section 4.4(a), Seller as
promptly as practicable shall advise the Company orally and in writing of any request received by
the Seller after the date hereof for information which the Seller reasonably believes would lead to
an Acquisition Proposal or of any Acquisition Proposal, or any inquiry received by the Seller after
the date hereof with respect to, or which the Seller reasonably believes would lead to any
Acquisition Proposal, the material terms and conditions of such request, Acquisition Proposal or
inquiry, and the identity of the person or group making any such request, Acquisition Proposal or
inquiry. The Seller will keep the Company informed in all material respects of the status and
details (including material amendments or proposed amendments) of any such request, Acquisition
Proposal or inquiry.

     4.5 Update Disclosure; Breaches.

     (a) From and after the date of this Agreement until the Effective Time, the Seller shall
update the Seller Disclosure Statement on a regular basis by written notice to the Company to
reflect any matters which have occurred from and after the date of this Agreement which, if
existing on the date of this Agreement, would have been required to be described therein; provided
that (i) to the extent that any information that would be required to be included in an update
under this Section 4.5(a) would have in the past been contained in internal reports prepared by the
Seller or any the Seller Subsidiary in the ordinary course, such update may occur by delivery of
such internal reports prepared in accordance with past practice, with appropriate steps taken by
the Seller to identify relevant information contained therein, and (ii) to the extent that updating
required under this Section 4.5 is unduly burdensome to the Seller, the Seller and the Company will
use their reasonable best efforts to develop alternate updating procedures using, wherever
possible, existing reporting systems.

     (b) The Seller shall, in the event it becomes aware of the impending or threatened occurrence
of any event or condition which would cause or constitute a material breach (or would have caused
or constituted a material breach had such event occurred or been known prior

 

 

to the date of this Agreement) of any of its representations or agreements contained or
referred to herein, give prompt written notice thereof to the Company and use its reasonable best
efforts to prevent or promptly remedy the same.

     4.6 Affiliates; Tax Treatment. Within thirty (30) days after the date of this
Agreement (a) the Seller shall deliver to the Company a letter identifying all persons who are then
“affiliates” of the Seller, including, without limitation, all directors and executive officers of
the Seller, for purposes of Rule 145 promulgated under the Securities Act and (b) the Seller shall
advise the persons identified in such letter of the resale restrictions imposed by applicable
securities laws. The Seller shall use its reasonable best efforts to obtain from each person
identified in such letter a written agreement, substantially in the form attached hereto as Exhibit
4.6. The Seller shall use its reasonable best efforts to obtain from any person who becomes the
Seller after the Seller’s delivery of the letter referred to above, on or prior to the Effective
Time, a written agreement, substantially in the form attached hereto as Exhibit 4.6 as soon as
practicable after such person attains such status. The Seller will use its reasonable best efforts
to cause the Merger to qualify as a reorganization under Section 368(a)(1)(A) of the Code.

     4.7 Delivery of Stockholder List. The Seller shall arrange to have its transfer agent
deliver to the Company or its designee, from time to time prior to the Effective Time, a true and
complete list setting forth the names and addresses of the Seller stockholders, their holdings of
stock as of the latest practicable date, and such other stockholder information as the Company may
reasonably request.

     4.8 Loan and Investment Policies. The Seller agrees to maintain and to cause the
Seller Subsidiaries to maintain their existing loan and investment policies and procedures designed
to ensure safe and sound banking practices, which shall remain in effect, except as otherwise
agreed in writing by the Company, for the period prior to the Effective Time. To the extent
permitted by applicable Law, such policies and procedures shall apply to, among other matters, the
following: (i) making or renewing any commitments or loans, or purchase or renewals of any
participations in loans, in excess of $5,000,000.00 for any commercial loan, $1,000,000.00 for any
single-family residential loan or $500,000.00 for any consumer loan; (ii) making, committing to
make or renewing any loan to any affiliate of the Seller or Seller Subsidiaries or any family
member of such affiliate or any entity in which such affiliate has a material interest; (iii)
making any investment or commitment to invest, or making any loan, in excess of $5,000,000.00 with
respect to any commercial real estate development project; (iv) making multiple commercial real
estate loans which are in the aggregate in excess of $10,000,000 to any one real estate developer;
or (v) entering into any contract, lease, or license under which the Seller or any Seller
Subsidiary will be bound to pay in excess of $250,000 over the life of such agreement or
voluntarily committing any act or omission which constitutes a breach or default by the Seller or
any Seller Subsidiary under any material contract, lease or license to which the Seller or any
Seller Subsidiary is a party or by which it or any of its properties are bound. To the extent
permitted by applicable Law, the Company shall have the right to designate at least two (2)
observers to attend all meetings of the Seller’s (i) senior credit committee, or similar committee
at any Seller Subsidiary designated by the Company, and (ii) investment committee or similar
committee at any Seller Subsidiary, and the Seller shall ensure that such representatives receive
all information given by the Seller or its agents to the Seller’s members of said committees.

 

 

     4.9 Access and Information. From the date hereof until the Effective Time, the Seller
will give the Company and its representatives, employees, counsel and accountants reasonable access
to the properties, books and records of the Seller and any other information relating to the Seller
that is reasonably requested by the Company for purpose of permitting the Company, among other
things, to: (a) conduct its due diligence review, (b) review the financial statements of the
Seller, (c) verify the accuracy of the representations and warranties of the Seller contained in
this Agreement, (d) confirm compliance by the Seller with the terms of this Agreement, and (e)
prepare for the consummation of the transactions contemplated by the Agreement. The parties hereto
acknowledge and agree that any investigation by the Company pursuant to this Section 4.9 shall not
unreasonably interfere with the business and operations of the Seller. The Company shall not,
without the consent of the Seller (which consent shall not be unreasonably withheld), contact any
customers or key employees of the Seller.

     4.10 Confidentiality Agreement. The Seller agrees that the Confidentiality Agreement
entered into between the Company and the Seller in effect prior to the date of this Agreement (the
“Confidentiality Agreement”), shall remain in full force and effect and binding upon the Seller and
shall survive termination of this Agreement.

     4.11 Rights Agreement. The Seller shall not (i) redeem the Rights (as defined in the
Rights Agreement), or amend or modify or terminate the Rights Agreement other than to delay the
Distribution Date (as defined in the Rights Agreement) or to render the Rights (as defined in the
Rights Agreement) inapplicable to the execution, delivery and performance of this Agreement and the
transactions contemplated hereby, including the Merger, or (ii) permit the Rights (as defined in
the Rights Agreement) to become non-redeemable at the redemption price currently in effect.

ARTICLE V — COVENANTS OF THE COMPANY

     5.1 Affirmative Covenants. The Company hereby covenants and agrees with the Seller
that, except (i) as permitted by this Agreement, (ii) as disclosed in the Company Disclosure
Schedule, (iii) as required by Law, or by a Governmental Authority of competent jurisdiction, or
(iv) as otherwise consented to in writing by the Seller, during the period from the date hereof to
the earlier of the Effective Time or the termination of this Agreement in accordance with its
terms, it will, and it will cause each Company Subsidiary, to:

     (a) maintain its corporate existence in good standing and maintain all books and records in
accordance with accounting principles and practices as used in the Company’s financial statements
applied on a consistent basis; and

     (b) conduct its business in a manner that does not violate any Law, except for possible
violations which, individually or in the aggregate, do not have, and would not reasonably be
expected to have, a Company Material Adverse Effect.

     5.2 Negative Covenants. Except as set forth in Section 5.2 of the Company Disclosure
Schedule or as otherwise contemplated by this Agreement, from the date of this Agreement until the
Effective Time, the Company shall not, or agree to commit to, or permit any Company Subsidiaries
to, without the prior written consent of the Seller, propose or adopt any

 

 

amendments to its Articles of Incorporation or By-laws in a manner which would adversely
affect in any manner the terms of the Company Common Stock or the ability of Company to consummate
the transactions contemplated hereby, or agree in writing to do any of the foregoing;
provided, however, that any such amendment to the Company Articles to increase the
authorized number of shares of Company Common Stock shall not be deemed to have such an adverse
effect.

     5.3 Breaches. The Company shall, in the event it becomes aware of the impending or
threatened occurrence of any event or condition which would cause or constitute a material breach
(or would have caused or constituted a material breach had such event occurred or been known prior
to the date of this Agreement) of any of its representations or agreements contained or referred to
herein, give prompt written notice thereof to the Seller and use its reasonable best efforts to
prevent or promptly remedy the same.

     5.4 Stock Exchange Listing. The Company shall use its reasonable best efforts to
cause the shares of Company Common Stock to be issued in the Merger to be approved for listing on
the NYSE prior to the Effective Time.

     5.5 Tax Treatment. The Company will use its reasonable best efforts to cause the
Merger to qualify as a reorganization under Section 368(a)(1)(A) of the Code.

     5.6 Confidentiality Agreement. The Company agrees that the Confidentiality Agreement
entered into between the Company and the Seller in effect prior to the date of this Agreement,
shall remain in full force and effect and binding upon the Company and shall survive termination of
this Agreement.

     5.7 Stock Options.

     (a) At the Effective Time, the Company will assume the option plans listed on Schedule 5.7(a)
of the Seller Disclosure Schedule (the “Option Plans”) and all of the Seller’s obligations
thereunder. At the Effective Time, each outstanding option issued pursuant to the Option Plans
(each, an “Option”) shall be deemed to constitute an option to acquire, on the same terms and
conditions as were applicable under such Option (including, without limitation, the time periods
allowed for exercise), a number of shares of Company Common Stock equal to the product of (i) the
sum of (A) the Stock Amount and (B) the Additional Stock Amount, if any, and (C) the quotient
calculated by (I) dividing the Cash Amount by (II) the Valuation Period Market Value (rounded to
the nearest ten-thousandth of a share), and (ii) the number of shares of Seller Common Stock
subject to such Option (provided that any fractional shares of Company Common Stock resulting from
such calculation shall be rounded up to the nearest whole share), at a price per share equal to the
aggregate exercise price for the shares of Seller Common Stock subject to such Option divided by
the number of shares of Company Common Stock subject to such assumed Option.

     (b) The Company shall take all corporate action necessary to reserve for issuance a sufficient
number of shares of Company Common Stock for delivery upon exercise of the Options adjusted in
accordance with this Section 5.7. The Company shall file one or more registration statements on
Form S-8 (or any successor form) or another appropriate form,

 

 

promptly after the Effective Time, with respect to the Company Common Stock subject to such
Options and shall use its reasonable efforts to maintain the effectiveness of such registration
statement or registration statements (and maintain the current status of the related prospectus or
prospectuses) for so long as such Options remain outstanding. With respect to those individuals
who subsequent to the Merger will be subject to the reporting requirements under Section 16(a) of
the Exchange Act, the Company shall administer the Option Plans assumed pursuant to this Section
5.7 in a manner that complies with Rule 16b-3 promulgated under the Exchange Act to the extent the
Option Plans complied with such rule prior to the Merger.

ARTICLE VI — ADDITIONAL AGREEMENTS

     6.1 Proxy Statement/Prospectus; Registration Statement; Board Recommendation. As
promptly as practicable after the execution of this Agreement, the Seller and the Company shall
prepare and file with the SEC the Proxy Statement/Prospectus and registration statement on Form S-4
promulgated under the Securities Act (or on such other form as shall be appropriate) relating to
the approval of this Agreement and the transactions contemplated hereby, including the Merger, by
the stockholders of the Seller and shall use all reasonable efforts to cause the Registration
Statement to become effective as soon thereafter as practicable. Each of the Seller and Company
shall furnish all information concerning itself and its Affiliates that is required to be included
in the Proxy Statement/Prospectus or, to the extent applicable, the other filings, or that is
customarily included in Proxy Statement/Prospectus or other filings prepared in connection with
transactions of the type contemplated by this Agreement. Each of the Seller and Company shall use
its reasonable best efforts to respond as promptly as practicable to any comments of the SEC with
respect to the Proxy Statement/Prospectus or the other filings, and the Seller shall use its
reasonable best efforts to cause the definitive Proxy Statement/Prospectus to be mailed to the
Seller’s stockholders as promptly as reasonably practicable after the date of this Agreement. Each
party shall promptly notify the other party upon the receipt of any comments from the SEC or its
staff or any request from the SEC or its staff for amendments or supplements to the Proxy
Statement/Prospectus or the other filings and shall provide the other party with copies of all
correspondence between it and its representatives, on the one hand, and the SEC and its staff, on
the other hand relating to the Proxy Statement/Prospectus or the other filings. If at any time
prior to the Seller Stockholders’ Meeting, any information relating to the Seller, Company or any
of their respective Affiliates, officers or directors, should be discovered by the Seller or
Company which should be set forth in an amendment or supplement to the Proxy Statement/Prospectus
or the other filings, so that the Proxy Statement/Prospectus or the other filings shall not contain
any untrue statement of a material fact or omit to state any material fact required to be stated
therein or necessary in order to make the statements therein, in light of the circumstances under
which they are made, not misleading, the party which discovers such information shall promptly
notify the other party, and an appropriate amendment or supplement describing such information
shall be filed with the SEC and, to the extent required by applicable Law, disseminated to the
stockholders of the Seller. Notwithstanding anything to the contrary stated above, prior to filing
or mailing the Proxy Statement/Prospectus or filing the other filings (or, in each case, any
amendment or supplement thereto) or responding to any comments of the SEC with respect thereto, the
party responsible for filing or mailing such document shall provide the other party an opportunity
to review and comment on such document or response and shall include in such document or response
comments reasonably proposed by the other party.

 

 

     6.2 Meeting of Seller’s Stockholders. Seller shall promptly after the date of this
Agreement take all action necessary in accordance with the KGCC and the Seller Articles and the
Seller By-Laws to convene the Seller Stockholders’ Meeting. Seller shall use its reasonable best
efforts to solicit from stockholders of Seller proxies in favor of the Merger and shall take all
other action necessary or advisable to secure the vote or consent of stockholders required by the
KGCC to approve the Merger, unless the Seller’s Board of Directors shall have determined in good
faith based on advice of counsel that such actions would reasonably be likely to result in
violation of its fiduciary duty to Seller’s stockholders under applicable Law.

     6.3 Appropriate Action; Consents; Filings. The Seller and the Company shall use their
reasonable best efforts to (i) take, or cause to be taken, all appropriate action, and do, or cause
to be done, all things necessary, proper or advisable under applicable Law to consummate and make
effective the transactions contemplated by this Agreement, (ii) obtain all consents, licenses,
permits, waivers, approvals, authorizations or orders required under Law (including, without
limitation, all foreign and domestic (federal, state and local) governmental and regulatory rulings
and approvals and parties to contracts) required in connection with the authorization, execution
and delivery of this Agreement and the consummation by them of the transactions contemplated
hereby, including, without limitation, the Merger, (iii) make all necessary filings, and thereafter
make any other required submissions, with respect to this Agreement and the Merger required under
(A) the Securities Act and the Exchange Act (to the extent applicable) and the rules and
regulations thereunder, and any other applicable federal or state securities laws, (B) the BHCA,
the SBL, the SBA and any other applicable federal or state banking laws and (C) any other
applicable Law; provided that, the Company and the Seller shall cooperate with each other in
connection with the making of all such filings, including providing copies of all such documents to
the non-filing party and its advisors prior to filing and, if requested, to accept all reasonable
additions, deletions or changes suggested in connection therewith. The Seller and the Company
shall furnish all information required for any application or other filing to be made pursuant to
the rules and regulations of any applicable Law (including all information required to be included
in the Proxy Statement/Prospectus and the Registration Statement) in connection with the
transactions contemplated by this Agreement. In case at any time after the Effective Time any
further action is necessary or desirable to carry out the purposes of this Agreement, the proper
officers and directors of each party to this Agreement shall use all reasonable efforts to take all
such necessary action.

     6.4 Employee Benefit Matters. Annex B hereto sets forth certain agreements with
respect to the Seller’s employee benefit matters.

     6.5 Directors’ and Officers’ Indemnification and Insurance.

     (a) By virtue of the occurrence of the Merger, the Company shall from and after the Effective
Time succeed to Seller’s obligations with respect to indemnification or exculpation now existing in
favor of the directors, officers, employees and agents of Seller and the Seller Subsidiaries as
provided in the Seller Articles, Seller By-Laws, indemnification agreements of Seller or the Seller
Subsidiaries or otherwise in effect as of the date of this Agreement with respect to matters
occurring prior to the Effective Time. Section 6.5 of the Seller Disclosure Schedule contains a
complete list of all indemnification arrangements to which Seller is a party

 

 

to on the date of this Agreement. Seller agrees not to amend or enter into new arrangements
or agreements from and after the date hereof.

     (b) From and after the Effective Time, the Company agrees to use reasonable best efforts to
maintain for a period of six years from and after the Effective Time an insurance policy (or
primary and secondary policies) for directors’ and officers’ liabilities (collectively, the “D&O
Policy”) for all present and former directors and officers of Seller covered by the Existing D&O
Policy on the date of this Agreement with terms (including coverage limits) substantially similar
in all respects to those currently in effect on the date of this Agreement with respect to acts,
omissions and other matters occurring prior to the Effective Time for which coverage is provided
under the Existing D&O Policy; provided, however, that in no event shall the
Company be required to expend on an annual basis more than 250% of the amount expended by the
Seller on such D&O Policy for the annual renewal period that commenced September 25, 2005, such
amount being reflected on the Seller Disclosure Schedule (the “Insurance Amount”) to maintain or
procure insurance coverage, and further provided, that if the Company is unable to maintain
or obtain the insurance called for by this Section 6.5(b), the Company shall use commercially
reasonable efforts to obtain as much comparable insurance as is available for the Insurance Amount.

     (c) In the event the Company or any of its successors or assigns (i) consolidates with or
merges into any other person and shall not be the continuing or Surviving Corporation or entity of
such consolidation or merger, or (ii) transfers or conveys all or substantially all of its
properties or assets to any person, then, and in each such case, to the extent necessary, proper
provision shall be made so that the successors and assigns of the Company assume the obligations
set forth in this Section 6.5.

     (d) The provisions of this Section 6.5 are intended to be for the benefit of, and shall be
enforceable by, each person who is now, or has been at any time prior to the date of this Agreement
or who becomes prior to the Effective Time, an officer or director of Seller or any Seller
Subsidiary (the “Indemnified Parties”) and his or her heirs and representatives.

     6.6 Notification of Certain Matters. The Seller shall give prompt notice to the
Company, and the Company shall give prompt notice to the Seller, of (i) the occurrence, or non
occurrence, of any event the occurrence or non occurrence of which would be likely to cause any
representation or warranty contained in this Agreement to be untrue or inaccurate, and (ii) any
failure of the Seller or the Company, as the case may be, to comply with or satisfy any covenant,
condition or agreement to be complied with or satisfied by it hereunder; provided,
however, that the delivery of any notice pursuant to this Section 6.6 shall not limit or
otherwise affect the remedies available hereunder to the party receiving such notice.

     6.7 Public Announcements. The Company and the Seller shall consult with each other
before issuing any press release or otherwise making any public statements with respect to the
Merger and shall not issue any such press release or make any such public statement prior to such
consultation, except as may be required by Law, including disclosures required under the federal
securities laws.

 

 

     6.8 Exemption From Liability Under Section 16(b). The Seller and the Company agree
that, in order to most effectively compensate and retain Insiders in connection with the Merger,
both prior to and after the Effective Time, it is desirable that Insiders be relieved of the risk
of liability under Section 16(b) of the Exchange Act to the fullest extent permitted by applicable
Law in connection with the conversion of shares of Seller Common Stock, Options, Seller stock-based
awards into shares of Company Common Stock and Company rollover options and other awards
denominated in shares of Company Common Stock in the Merger, and for that compensatory and
retentive purpose agree to the provisions of this Section 6.8. Following the delivery to the
Company of the Section 16 Information in a timely fashion, the Company Board, or a committee of
“Non-Employee Directors” thereof (as such term is defined for purposes of Rule 16b-3(d) under the
Exchange Act), will adopt a resolution providing that the receipt by Insiders of Company Common
Stock in exchange for or satisfaction of shares of Company Common Stock or Company stock-based
awards, and of Company rollover options upon conversion of Options, in each case, pursuant to the
transactions contemplated by this Agreement and to the extent such securities are listed in the
Section 16 Information, are intended to be exempt from liability pursuant to Section 16(b) under
the Exchange Act. “Section 16 Information” will mean information accurate in all material respects
regarding Insiders, the number of shares of Seller Common Stock held by each such Insider and
expected to be exchanged for Company Common Stock in the Merger, and the number and description of
Options and Seller stock-based awards held by each such Insider and expected to be converted into
Company rollover options and exchanged for Company Common Stock or awards denominated therein in
connection with the Merger; provided, however, that the requirement for a
description of any Options and Seller stock-based awards will be deemed to be satisfied if copies
of all Seller stock plans and other Seller benefit plans, and forms of agreements evidencing grants
thereunder, under which such Options and Seller stock-based awards, respectively, have been granted
to Insiders, have been made available to the Company. “Insiders” will mean those officers and
directors of Seller who are subject to the reporting requirements of Section 16(a) of the Exchange
Act and who are listed in the Section 16 Information.

     6.9 Customer Retention. To the extent permitted by law or applicable regulation, the
Seller shall use all reasonable efforts to assist the Company in its efforts to retain the Seller’s
customers for the Surviving Corporation. Such efforts shall include making introductions of the
Company’s employees to such customers, assisting in the mailing of information prepared by the
Company and reasonably acceptable to the Seller to such customers and actively participating in any
“transitional marketing programs” as the Company shall reasonably request.

     6.10 Directorships. Promptly after the Effective Time, the Company shall take such
action as may be reasonably required to cause the Company’s Board of Directors to be expanded by
one member and to appoint the person serving as the Chief Executive Officer of the Seller as of the
date of this Agreement to the class of the Company’s directors with terms expiring at the Company’s
2008 Annual Meeting of Shareholders.

 

 

ARTICLE VII — CONDITIONS OF MERGER

     7.1 Conditions to Obligation of Each Party to Effect the Merger. The respective
obligations of each party to effect the Merger shall be subject to the satisfaction at or prior to
the Effective Time of the following conditions:

     (a) Effectiveness of the Registration Statement. The Registration Statement shall
have been declared effective by the SEC under the Securities Act. No stop order suspending the
effectiveness of the Registration Statement shall have been issued by the SEC and no proceedings
for that purpose shall, on or prior to the Effective Time, have been initiated or, to the Knowledge
of the Company or the Seller, threatened by the SEC. The Company shall have received all other
Federal or state securities permits and other authorizations necessary to issue Company Common
Stock in exchange for Seller Common Stock and to consummate the Merger.

     (b) Shareholder Approval. This Agreement and the Merger shall have been approved and
adopted by the requisite vote of the stockholders of the Seller.

     (c) Federal Reserve Board. The Merger shall have been approved by the Federal Reserve
Board, which approval shall not contain any condition that would significantly adversely affect the
Company, all conditions required to be satisfied prior to the Effective Time imposed by the terms
of such approval shall have been satisfied and all waiting periods relating to such approval shall
have expired.

     (d) Other Approvals. All statutory waiting periods under the HSR Act shall have
expired and the Company shall not have received any objections thereunder from either the Federal
Trade Commission or the U.S. Department of Justice. All conditions required to be satisfied prior
to the Effective Time imposed by the terms of such approval shall have been satisfied and all
waiting periods relating to such approval shall have expired.

     (e) State Approval. The Merger shall have been approved by the Kansas Office of the
State Bank Commissioner, the Missouri Division of Finance, the Oklahoma Office of State Finance and
the Florida Office of Financial Regulation, which approvals shall not contain any condition that
would have a Company Material Adverse Effect. All conditions required to be satisfied prior to the
Effective Time imposed by the terms of such approval shall have been satisfied and all waiting
periods relating to such approval shall have expired.

     (f) No Order. No Governmental Authority, or federal or state court of competent
jurisdiction, shall have enacted, issued, promulgated, enforced or entered any Law or Order which
is in effect preventing or prohibiting consummation of the transactions contemplated by this
Agreement or restricting the consummation of the transactions contemplated by this Agreement in a
manner that would have a Seller Material Adverse Effect or a Company Material Adverse Effect.

     (g) NYSE Listing. The shares of Company Common Stock to be issued at the Effective
Time shall have been authorized for listing on the NYSE, subject to official notice of issuance.

 

 

     7.2 Additional Conditions to Obligations of the Company. The obligations of the
Company to effect the Merger are also subject to the following conditions:

     (a) Representations and Warranties. Without giving effect to any update to the Seller
Disclosure Schedule or notice to the Company under Sections 4.5 or 6.6, above, and except for
Section 2.19, above, which is provided for in subsection (j), below, (i) each of the
representations and warranties of the Seller contained in this Agreement that is qualified by
reference to “materiality” or Seller Material Adverse Effect shall be true and correct as of the
date of this Agreement and as of the Effective Time, except to the extent such representations and
warranties are made as of another date, in which case such representations and warranties shall be
true and correct as of such other date; and (ii) each of the representations and warranties of the
Seller that is not qualified by reference to “materiality” or Seller Material Adverse Effect shall
be true and correct in all material respects as of the date of this Agreement and as of the
Effective Time, except, to the extent such representations and warranties are made as of another
date, in which case such representations and warranties shall be true and correct as of such other
date, and except in the case of either clause (i) or (ii), above, where any failure of such
representations and warranties to be true and correct, either individually or in the aggregate,
would not have a Seller Material Adverse Effect. The Company shall have received a certificate
signed on behalf of the Seller by the Chief Executive Officer and the Chief Financial Officer of
the Seller to the foregoing effect.

     (b) Agreements and Covenants. The Seller shall have performed or complied in all
material respects with all agreements and covenants required by this Agreement to be performed or
complied with by it on or prior to the Effective Time.

     (c) Consents Obtained. All Seller Approvals and all filings required to be made by
Seller for the authorization, execution and delivery of this Agreement and the consummation by it
of the transactions contemplated hereby shall have been obtained and made by Seller.

     (d) No Challenge. There shall not be pending any action, proceeding or investigation
before any court or administrative agency or by a government agency or any other person (i)
challenging or seeking material damages in connection with, the Merger or the conversion of Seller
Common Stock into Company Common Stock pursuant to the Merger or (ii) seeking to restrain, prohibit
or limit the exercise of full rights of ownership or operation by the Company or the Company
Subsidiaries of all or any portion of the business or assets of Seller, which in either case is
reasonably likely to have a Seller Material Adverse Effect or a Company Material Adverse Effect.

     (e) Tax Opinion. An opinion of Godfrey & Kahn, S.C., independent counsel to the
Company, dated as of the Closing Date, in form and substance reasonably satisfactory to the
Company, on the basis of facts, representations and assumptions set forth in such opinion which are
consistent with the state of facts existing as of the Closing Date, to the effect that (i) the
Merger will be treated for federal income tax purposes as a reorganization within the meaning of
Section 368(a) of the Code, and (ii) each of the Seller and the Company will be a “party to the
reorganization” within the meaning of Section 368(a) of the Code. In rendering such opinion,
Godfrey & Kahn, S.C. may require and be entitled to rely upon customary representations and
covenants contained in certificates of officers of the Company and the Seller.

 

 

     (f) Opinion of Counsel. The Company shall have received from Stinson Morrison Hecker
LLP, or other independent counsel for the Seller reasonably satisfactory to the Company, an opinion
dated the Closing Date, in form and substance reasonably satisfactory to the Company, covering the
matters set forth in Annex D hereto, which opinion shall be based on such assumptions and
containing such qualifications and limitations as are appropriate and reasonably satisfactory to
the Company.

     (g) Comfort Letters. If requested by the Company as provided in Section 4.3, the
Company shall have received from KPMG, LLP, the “comfort” letters referred to in Section 4.3.

     (h) Affiliate Agreements. The Company shall have received from each person who is
identified in the affiliate letter as an “affiliate” of the Seller a signed affiliate agreement in
the form attached hereto as Exhibit 7.2(h).

     (i) Burdensome Condition. There shall not be any action taken, or any statute, rule,
regulation or order enacted, entered, enforced or deemed applicable to the Merger, by any federal
or state governmental entity which, in connection with the grant of any regulatory approval,
imposes any condition or restriction upon the Company or the Seller or their respective
subsidiaries (or the Surviving Corporation or its subsidiaries after the Effective Time), which
would materially adversely impact the economic or business benefits of the transactions
contemplated by this Agreement in such a manner as to render inadvisable the consummation of the
Merger.

     (j) No Material Adverse Changes. Since the date of the Agreement, there shall have
been no Seller Material Adverse Effect, and there has not been any Effect, that, either
individually or in the aggregate, would have a Seller Material Adverse Effect. The Company shall
have received a certificate of the Chief Executive Officer and the Chief Financial Officer of the
Seller to that effect.

     7.3 Additional Conditions to Obligations of the Seller. The obligation of the Seller
to effect the Merger is also subject to the following conditions:

     (a) Representations and Warranties. Without giving effect to any notice to the Seller
under Sections 5.3 or 6.6, above, and except for Section 3.14, above, which is provided for in
subsection (f), below, (i) each of the representations and warranties of the Company contained in
this Agreement that is not qualified as to “materiality” or Company Material Adverse Effect shall
be true and correct in all material respects as of the date of this Agreement and as of the
Effective Time, except to the extent that such representations and warranties are made as of
another date, in which case such representations and warranties shall be true and correct in all
material respects as of such other date; and (ii) each of the representations and warranties of the
Company that is qualified as to “materiality” or Company Material Adverse Effect shall be true and
correct in all material respects as of the date of this Agreement and as of the Effective Time,
except to the extent such representations and warranties are made as of another date, in which case
such representations and warranties shall be true and correct as of such other date, and except in
the case of either clause (i) or (ii), above, where any failure of such representations and
warranties to be true and correct, either individually or in the aggregate, would not have a
Company Material Adverse Effect. The Seller shall have received a certificate signed on behalf

 

 

of the Company by the Chief Executive Officer and the Chief Financial Officer of the Company
to the foregoing effect.

     (b) Agreements and Covenants. The Company shall have performed or complied in all
material respects with all agreements and covenants required by this Agreement to be performed or
complied with by it on or prior to the Effective Time.

     (c) Consents Obtained. All material consents, waivers, approvals, authorizations or
orders required to be obtained, and all filings required to be made by the Company for the
authorization, execution and delivery of this Agreement and the consummation by it of the
transactions contemplated hereby shall have been obtained and made by the Company, except where the
failure to obtain any consents, waivers, approvals, authorizations or orders required to be
obtained or any filings required to be made would not have a Company Material Adverse Effect.

     (d) Tax Opinion. The Seller shall have received an opinion of Stinson Morrison Hecker
LLP, in form and substance reasonably satisfactory to the Seller, dated as of the Closing Date, on
the basis of facts, representations and assumptions set forth in such opinion which are consistent
with the state of facts existing as of the Closing Date, to the effect that the Merger will be
treated for federal income tax purposes as a reorganization within the meaning of Section 368(a) of
the Code and that, accordingly, for federal income tax purpose:

     (i) No gain or loss will be recognized by the Seller as a result of the Merger;

     (ii) No gain or loss will be recognized by the stockholders of the Seller who exchange
their Seller Common Stock to the extent exchanged for Company Common Stock pursuant to the
Merger (except with respect to cash received as part of the Per Share Merger Consideration
and cash received in lieu of a fractional share interest in Company Common Stock); and

     (iii) The aggregate tax basis of the Company Common Stock received by stockholders who
exchange their Seller Common Stock for Company Common Stock pursuant to the Merger will be
the same as the aggregate tax basis of the Seller Common Stock surrendered in exchange
therefor (reduced by any amount allocable to cash received as part of the Per Share
Consideration to a fractional share interest for which cash is received).

     In rendering such opinion, the Seller’s counsel may require and rely upon representations and
covenants contained in certificates of officers of the Company, the Seller and others.

     (e) Opinion of Counsel. The Seller shall have received from Godfrey & Kahn, S.C., or
other independent counsel for the Company reasonably satisfactory to the Seller, opinions dated the
Closing Date, in form and substance reasonably satisfactory to the Seller, covering the matters set
forth in Annex D hereto, which opinion shall be based on such assumptions and contain such
qualifications and limitations as are appropriate and reasonably satisfactory to the Seller.

 

 

     (f) No Material Adverse Changes. Since the date of the Agreement, there shall have
been no Company Material Adverse Effect, that either individually or in the aggregate, would be
reasonably expected to have a Company Material Adverse Effect. The Seller shall have received a
certificate of the President and the Chief Financial Officer of the Company to that effect.

ARTICLE VIII — TERMINATION

     8.1 Termination. This Agreement may be terminated at any time prior to the Effective
Time, whether prior to or after the stockholders of the Seller adopt this Agreement:

     (a) by mutual written consent duly authorized by the Boards of Directors of the Company and
the Seller;

     (b) by either Seller or the Company if the Merger shall not have been consummated by September
30, 2006, unless extended by the Boards of Directors of Seller and the Company for any reason;
provided, however, that the right to terminate this Agreement under this Section
8.1(b) shall not be available to any party whose action or failure to act has been a principal
cause of or resulted in the failure of the Merger to occur on or before such date if such action or
failure to act constitutes a breach of this Agreement;

     (c) by either the Seller or the Company if a court of competent jurisdiction or Governmental
Authority shall have issued a non-appealable final order, decree or ruling or taken any other
action having the effect of permanently restraining, enjoining or otherwise prohibiting the Merger;

     (d) by either the Seller or the Company if: (i) the Seller Stockholders’ Meeting (including
any adjournments thereof) shall have been held and completed and the stockholders of the Seller
shall have taken a final vote on a proposal to adopt this Agreement and (ii) the required approval
of the stockholders of the Seller contemplated by this Agreement shall not have been obtained;
provided, however, that the right to terminate this Agreement under this Section
8.1(d) shall not be available to the Seller where the failure to obtain approval by the Seller
stockholders shall have been caused by the action or failure to act of the Seller, and such action
or failure to act constitutes a breach by the Seller of any provision of this Agreement;

     (e) by the Seller, upon a breach of any covenant or agreement on the part of the Company set
forth in this Agreement, or if any representation or warranty of the Company shall have been untrue
when made or shall have become untrue, in either case such that the conditions set forth in Section
7.3(a), above, would not be satisfied as of the time of such breach or as of the time such
representation or warranty shall have become untrue, provided, that if such inaccuracy in
the Company’s representations and warranties or breach by the Company was unintentional and is
curable by the Company through exercise of commercially reasonable efforts, then the Seller may not
terminate this Agreement pursuant to this Section 8.1(e) for ten (10) days after delivery of
written notice from the Seller to the Company of such breach, provided, that the Company
continue to exercise commercially reasonable efforts to cure such breach (it being understood that
the Seller may not terminate this Agreement pursuant to this Section 8.1(e) if such breach by the
Company is cured during such ten-day period);

 

 

     (f) by the Company upon a breach of any covenant or agreement on the part of the Seller set
forth in this Agreement, or if any representation or warranty of the Seller shall have been untrue
when made or shall have become untrue, in either case such that the conditions set forth in Section
7.2(a), above, would not be satisfied as of the time of such breach or as of the time such
representation or warranty shall have become untrue, provided, that if such inaccuracy in
the Seller’s representations and warranties or breach by the Seller was unintentional and is
curable by the Seller through exercise of its commercially reasonable efforts, then the Company may
not terminate this Agreement pursuant to this Section 8.1(f) of ten (10) days after delivery of
written notice from the Company or the Seller of such breach, provided, that the Seller
continues to exercise commercially reasonable efforts to cure such breach (it being understood that
the Company may not terminate this Agreement pursuant to this Section 8.1(f) if such breach by the
Seller is cured during such ten-day period);

     (g) by the Company if the Seller’s Board of Directors or any committee thereof shall have
withdrawn, or amended or modified in a manner adverse to the Company, its approval or
recommendation of this Agreement or the Merger, or fails to include the Seller’s Board of Directors
Recommendation in the Proxy Statement/Prospectus;

     (h) by the Seller prior to the vote of the stockholders, without further action, if the Seller
shall have entered into a definitive agreement with respect to a Superior Offer pursuant to and in
accordance with Section 4.4(c), above; provided, however, that such determination
and the right to terminate under this Section 8.1(h) shall not be effective until the Seller has
made payment to the Company of the amounts required to be paid pursuant to Section 8.3(b)(i);

     (i) by the Company

     (i) if any of the conditions to the obligations of the Company to effect the Merger set
forth in Sections 7.1 or 7.2, above, have not been satisfied or waived by the Company at
Closing or the Company reasonably determines that the timely satisfaction of any condition
to the obligations of the Company to effect the Merger set forth in Sections 7.1 or 7.2,
above, has become impossible (other than as a result of any failure on the part of the
Company to comply with or perform any covenant or obligation of the Company set forth in
this Agreement); or

     (ii) in the event there has been a Seller Material Adverse Effect;

     (j) by the Seller

     (i) if any of the conditions to the obligations of the Seller to effect the Merger set
forth in Sections 7.1 or 7.3, above, have not been satisfied or waived by the Seller at
Closing or the Seller reasonably determines that the timely satisfaction of any condition to
the obligations of the Seller to effect the Merger set forth in Sections 7.1 or 7.3, above,
has become impossible (other than as a result of any failure on the part of the Seller to
comply with or perform any covenant or obligation of the Seller set forth in this
Agreement); or

     (ii) in the event there has been a Company Material Adverse Effect; or

 

 

     (k) by the Seller if the condition in (i), below, exists on the day preceding the anticipated
Effective Time and the Company has not elected to exercise its right as set forth in (ii), below:

     (i) The Valuation Period Market Value is less than $32.11.

     (ii) The Company shall have the right, but not the obligation, by providing written
notice thereof to the Seller, to issue a number of shares of Company Common Stock (the
“Additional Stock Amount”) with respect to each share of Seller Common Stock converted in
accordance with Section 1.6 hereof such that the product obtained by multiplying (x) the
Valuation Period Market Value, and (y) the sum of (A) 0.4319 plus (B) the Additional Stock
Amount is an amount equal to $13.87.

     8.2 Notice of Termination; Effect of Termination. Any termination of this Agreement
under Section 8.1, above, will be effective immediately upon (or if termination is pursuant to
Sections 8.1(e) or 8.1(f), above, and the proviso therein is applicable, ten (10) days after) the
delivery of written notice thereof by the terminating party to the other Parties. In the event of
termination of this Agreement as provided in Section 8.1, above, this Agreement shall be of no
further force or effect, with no liability of Party to the other Parties, except (i) the provisions
set forth in this Section 8.2, Section 8.3 and Article IX (General Provisions), shall survive the
termination of this Agreement, and (ii) nothing herein shall relieve any Party from liability for
any intentional or willful breach of this Agreement.

     8.3 Fees and Expenses.

     (a) Except as set forth in Section 8.2, above, and this Section 8.3, all fees and expenses
incurred in connection with this Agreement and the transactions contemplated hereby shall be paid
by the Party incurring such fees and expenses whether or not the Merger is consummated.

     (b) (i) Seller shall pay to the Company in immediately available funds, within one (1)
business day after demand by the Company an amount equal to $20,000,000 (the “Termination Fee”) if
this Agreement is terminated by Seller pursuant to Section 8.1(h), above.

     (ii) If this Agreement is terminated by the Company pursuant to Section 8.1(g), above,
and within twelve (12) months following the termination of this Agreement an Acquisition
Proposal is consummated or Seller enters into an agreement or binding letter of intent
providing for an Acquisition Proposal, then Seller shall pay or cause to be paid to the
Company in immediately available funds an amount equal to the Termination Fee.

     (iii) If (A) this Agreement is terminated by the Company or Seller, as applicable,
pursuant to Section 8.1(b), above (and prior to such termination Seller shall not have held
a meeting of its stockholders pursuant to Section 6.1, above) or Section 8.1(d), above, (B)
prior to such termination an Acquisition Proposal shall have been publicly disclosed and not
withdrawn, and (C) within twelve (12) months following the termination of this Agreement an
Acquisition Proposal is consummated or Seller enters into an agreement or binding letter of
intent providing for an Acquisition Proposal,

 

 

then Seller shall pay or cause to be paid to the Company in immediately available funds
an amount equal to the Termination Fee within one business day after Seller enters into such
agreement or binding letter of intent.

     (iv) Each of Seller, and the Company acknowledges that the agreements contained in
this Section 8.3(b) are an integral part of the transactions contemplated by this Agreement,
and that, without these agreements, the Company and Seller would not enter into this
Agreement; accordingly, if Seller fails to pay in a timely manner the amounts due pursuant
to this Section 8.3(b) and, in order to obtain such payment, the Company or Seller, makes a
claim that results in a judgment against Seller or the Company for the amounts set forth in
this Section 8.3(b), Seller shall pay to the Company its reasonable costs and expenses
(including reasonable attorneys’ fees and expenses) in connection with such suit, together
with interest on the amounts set forth in this Section 8.3(b) at the Wall Street Journal
prime rate in effect on the date such payment was required to be made. Payment of the fees
described in this Section 8.3(b) shall be the exclusive remedy for a termination of this
Agreement as specified in this Section 8.3(b) and shall be in lieu of damages incurred in
the event of any such termination of this Agreement.

ARTICLE IX — GENERAL PROVISIONS

     9.1 Non-Survival of Representations, Warranties and Agreements. The representations,
warranties and agreements in this Agreement shall terminate at the Effective Time, except that the
agreements set forth in Article I and Sections 6.5 and 6.10, above, shall survive the Effective
Time indefinitely.

     9.2 Notices. All notices and other communications given or made pursuant hereto shall
be in writing and shall be deemed given if delivered personally, mailed by registered or certified
mail (postage prepaid, return receipt requested), delivered by an express courier (with
confirmation), or telecopied (with confirmation) to the parties at the following addresses or
telecopy numbers, as the case may be (or at such other address or telecopy number for a party as
shall be specified by like changes of address or telecopy number) and shall be effective upon
receipt:

     (a) If to the Seller:

Gold Banc Corporation, Inc.

11301 Nall Avenue

Leawood, KS 66211

Attention: Malcom M. Aslin

Facsimile: (913) 451-8004

 

 

With a copy to:

Stinson Morrison Hecker LLP

1201 Walnut, Suite 2900

Kansas City, MO 64106-2150

Attention: John A. Granda

                Mike W. Lochmann

Facsimile: (816) 691-3495

If to the Company:

Marshall & Ilsley Corporation

770 North Water Street

Milwaukee, WI 53202

Attention: Randall J. Erickson

Facsimile: (414) 765-7899

With a copy to:

Godfrey & Kahn, S.C.

780 North Water Street

Milwaukee, WI 53202

Attention: Christopher B. Noyes

                Dennis F. Connolly

Facsimile: (414) 273-5198

     9.3 Certain Definitions. For purposes of this Agreement, the term:

     “Affiliate” means a person that directly or indirectly, through one or more intermediaries,
controls, is controlled by, or is under common control with, the first mentioned person; including,
without limitation, any partnership or joint venture in which any person (either alone, or through
or together with any other subsidiary) has, directly or indirectly, an interest of 5% or more;

     “Business day” means any day other than a day on which banks in Wisconsin are required or
authorized to be closed;

     “Consent” shall mean any consent, approval, authorization, clearance, exemption, waiver, or
similar affirmation by any Person pursuant to any Contract, Law, Order or Permit.

     “Contract” shall mean any agreement, arrangement, authorization, commitment, contract,
indenture, instrument, license, lease, obligation, plan, practice, restriction, understanding, or
undertaking of any kind or character, or other document to which any Person is a party or that is
binding on any Person or its capital stock, assets or business.

     “Control” shall mean the possession, direct or indirect, of the power to direct or cause the
direction of management and policies of a person, whether through the ownership of voting
securities, by Contract, or otherwise.

 

 

     “Default” shall mean (i) any breach or violation of or default under any Contract, Order, or
Permit, (ii) any occurrence of any event that with the passage of time or the giving of notice or
both would constitute a breach or violation of or default under any Contract, Order, or Permit, or
(iii) any occurrence of any event that with or without the passage of time or the giving of notice
would give rise to a right to terminate or revoke, change the current terms of, or renegotiate, or
to accelerate, increase or impose any Liability under, any Contract, Order or Permit.

     “Financial Statements” shall mean (i) the unaudited consolidated balance sheet as of September
30, 2005 and the audited consolidated balance sheet as of December 31, 2004 (including related
notes and schedules, if any) of Seller; (ii) the unaudited consolidated statements of income and
statements of shareholders’ equity for the period ended September 30, 2005 and the audited
consolidated statements of income, cash flows and shareholders equity for the year ended December
31, 2004 (including related notes and schedules, if any) of Seller; (iii) all bank financial
reports, including any amendments thereto, filed with any Regulatory Authorities by each bank
subsidiary for the year ended December 31, 2004 and the nine month period ended September 30, 2005,
and all bank financial reports to be filed after the date hereof until the Closing, together with
any correspondence among each Subsidiary and any Regulatory Authority concerning any of the
foregoing financial statements or the financial position of any Bank Subsidiary and (iv) each other
consolidated balance sheet, income statement and statement of shareholders’ equity, contained in
the Seller SEC Reports for the periods on or after January 1, 2000.

     “Knowledge” as used with respect to an entity (including references to such entity being aware
of a particular matter) shall mean those facts that are actually known by the Chairman, Chief
Executive Officer, President, Chief Financial Officer of such entity, or any other executive
officer who is subject to the reporting requirements of Section 16 of the Securities Act.

     “Law” shall mean any code, law, ordinance, regulation, reporting or licensing requirement,
rule, or statute applicable to a Person or its assets, Liabilities or business, including those
promulgated, interpreted, or enforced by any Regulatory Authority.

     “Liability” shall mean any direct or indirect, primary or secondary, liability, indebtedness,
obligation, penalty, cost, or expense (including costs of investigation, collection, and defense),
claim, deficiency, guaranty, or endorsement of or by any Person (other than endorsements of notes,
bills, checks, and drafts presented for collection or deposit in the ordinary course of business)
of any type, whether accrued, absolute or contingent, liquidated or unliquidated, matured or
unmatured, or otherwise.

     “Lien” shall mean any conditional sale agreement, default of title, easement, encroachment,
encumbrance, hypothecation, infringement, lien, mortgage, pledge, reservation, restriction,
security interest, title retention, or other security arrangement, or any adverse right or
interest, charge, or claim of any nature whatsoever of, on, or with respect to any property or
property interest, other than (i) Liens for current Taxes upon the assets or properties of a Party
or its subsidiaries which are not yet due and payable, and (ii) for depository institution
Subsidiaries of a Party, pledges to secure deposits and other Liens incurred in the ordinary course
of the banking business.

 

 

     “Litigation” shall mean any action, arbitration, cause of action, claim, complaint, criminal
prosecution, demand letter, governmental or other examination or investigation, hearing, inquiry,
administrative or other proceeding, or notice by any Person alleging potential Liability of a
Party, or invoking or seeking to invoke legal process to obtain information relating to or
affecting a Party, which affects such Party’s business assets (including Contracts related to it),
or obligations under the transactions contemplated by this Agreement, but shall not include
regular, periodic examinations of depository institutions and their Affiliates by Regulatory
Authorities.

     “Material Contract” shall mean (1) any Contract which involves aggregate payments to or by the
Seller within any twelve month period in excess of $125,000, or (2) any Contract entered into
other than in the ordinary course of business, (3) any Contract included in the Disclosure
Memorandum, (4) any Contract of which the breach of or default thereof would result in a Company
Material Adverse Effect or Seller Material Adverse Effect or (5) any Contracts that are required to
be filed as an exhibit pursuant to Section 601 of Rule S-K.

     “Order” shall mean any administrative decision or award, decree, injunction, judgment, order,
ruling, or writ of any Governmental Authority.

     “Permit” shall mean any federal, state, local, and foreign governmental approval,
authorization, certificate, easement, filing, franchise, license, notice, permit, or right to which
any Person is a party or that is or may be binding upon or inure to the benefit of any Person or
its securities, assets or business.

     “Person” means an individual, corporation, partnership, association, trust, unincorporated
organization, limited liability company, other entity or group (as defined in Section 13(d) of the
Exchange Act); and

     “Regulatory Authorities” shall mean, collectively, the Federal Trade Commission, the United
States Department of Justice, the Board of the Governors of the Federal Reserve System, the Federal
Deposit Insurance Corporation, the Office of the Comptroller of Currency, the Office of Thrift
Supervision, the Kansas State Banking Department, Oklahoma State Banking Department, Florida State
Banking Department, Securities and Exchange Commission, and all other federal and state regulatory
agencies and public authorities having jurisdiction over the Parties and their respective
Subsidiaries.

     “Rights” shall mean all arrangements, calls, commitments, Contracts, options, rights to
subscribe to, scrip, warrants, or other binding obligations of any character whatsoever by which a
Person is or may be bound to issue additional shares of its capital stock or other Rights, or
securities or Rights convertible into or exchangeable for, shares of the capital stock of a Person.

     “Subsidiary” or “Subsidiaries” of the Seller, the Company, the Surviving Corporation, or any
other person, means any corporation, limited liability company, partnership, joint venture or other
legal entity of which the Seller, the Company, the Surviving Corporation or such other person, as
the case may be (either alone or through or together with any other subsidiary), owns, directly or
indirectly, 10% or more of the stock or other equity interests the holders of which are generally
entitled to vote for the election of the board of directors or other governing body of such
corporation or other legal entity.

 

 

     9.4 Headings. The headings contained in this Agreement are for reference purposes
only and shall not affect in any way the meaning or interpretation of this Agreement.

     9.5 Severability. If any term or other provision of this Agreement is invalid,
illegal or incapable of being enforced by any rule of law or public policy, all other conditions
and provisions of this Agreement shall nevertheless remain in full force and effect so long as the
economic or legal substance of the transactions contemplated hereby is not affected in any manner
adverse to any party. Upon such determination that any term or other provision is invalid, illegal
or incapable of being enforced, the parties hereto shall negotiate in good faith to modify this
Agreement so as to effect the original intent of the parties as closely as possible in an
acceptable manner to the end that transactions contemplated hereby are fulfilled to the extent
possible.

     9.6 Entire Agreement. This Agreement (including the documents and instruments
referred to in this Agreement) constitutes the entire agreement of the parties and supersedes all
prior agreements and understandings, both written and oral, between the parties, or any of them,
with respect to the subject matter hereof and, except as otherwise expressly provided herein, are
not intended to confer upon any other person any rights or remedies hereunder.

     9.7 Assignment. This Agreement shall not be assigned by operation of law or
otherwise, except that the Company may assign all or any of its rights hereunder and thereunder to
any affiliate, provided that no such assignment shall relieve the assigning party of its
obligations hereunder.

     9.8 Parties in Interest. Subject to Section 9.7, above, this Agreement (including
Annex B hereto) shall be binding upon and inure solely to the benefit of each party hereto, and
nothing in this Agreement, express or implied, is intended to or shall confer upon any other person
any right, benefit or remedy of any nature whatsoever under or by reason of this Agreement, other
than Section 6.5, above (which is intended to be for the benefit of the Indemnified Parties and may
be enforced by such Indemnified Parties).

     9.9 Governing Law. Except to the extent that the laws of the State of Kansas are
mandatorily applicable to the matters arising under or in connection with this Agreement, this
Agreement shall be governed by, and construed in accordance with, the laws of the State of
Wisconsin, regardless of the laws that might otherwise govern under applicable principles of choice
of law or conflicts of law.

     9.10 Counterparts. This Agreement may be executed in two or more counterparts, all of
which shall be considered one and the same agreement and shall become effective when counterparts
have been signed by each of the parties and delivered to the other party, it being understood that
each party need not sign the same counterpart.

     9.11 Time is of the Essence. Time is of the essence of this Agreement.

     9.12 Specific Performance. The parties hereto acknowledge that monetary damages would
not be a sufficient remedy for breach of this Agreement. Therefore, upon breach of this Agreement
by any party, the aggrieved party may proceed to protect its rights and enforce this Agreement by
suit in equity, action at law or other appropriate proceeding, including an action

 

 

for the specific performance of any provision herein or any other remedy granted by law,
equity or otherwise, in each case without posting a bond. Any action for specific performance
hereunder shall not be deemed exclusive and may also include claims for monetary damages as may be
warranted under the circumstances. The prevailing party in any such suit, action or other
proceeding arising out of or related to this Agreement shall be entitled to recover its costs,
including attorney’s fees, incurred in such suit, action or other proceeding.

     9.13 Interpretation. When a reference is made in this Agreement to Articles,
Sections, Exhibits or Schedules, such reference will be to an Article or Section of or Exhibit or
Schedule to this Agreement unless otherwise indicated. The table of contents contained in this
Agreement are for reference purposes only and will not affect in any way the meaning or
interpretation of this Agreement. Whenever the words “include,” “includes” or “including” are used
in this Agreement, they will be deemed to be followed by the words “without limitation.” Unless
the context otherwise requires (i) “or” is disjunctive but not necessarily exclusive, (ii) words in
the singular include the plural and vice versa, (iii) the use in this Agreement of a pronoun in
reference to a party hereto includes the masculine, feminine or neuter, as the context may require,
and (iv) terms used herein that are defined in GAAP have the meanings ascribed to them therein. No
provision of this Agreement will be interpreted in favor of, or against, any of the parties to this
Agreement by reason of the extent to which any such party or its counsel participated in the
drafting thereof or by reason of the extent to which any such provision is inconsistent with any
prior draft hereof, and no rule of strict construction will be applied against any party hereto.
The Seller Disclosure Schedule and the Company Disclosure Schedule, as well as all other schedules
and all exhibits hereto, will be deemed part of this Agreement and included in any reference to
this Agreement. This Agreement will not be interpreted or construed to require any Person to take
any action, or fail to take any action, if to do so would violate any applicable Law. References
to the “other party” or “either party” will be deemed to refer to Seller or the Company, as the
case may be.

[Signatures on next page]

 

 

     IN WITNESS WHEREOF, the Company and the Seller have caused this Agreement to be executed as of
the date first written above by their respective officers thereunto duly authorized.

	 	 	 	 	 
	 	GOLD BANC CORPORATION, INC.

 	 
	 	By:  	/s/  Malcolm M. Aslin
 	 
	 	 	Malcolm M. Aslin, President and Chief Executive Officer	 
	 	 		 
	 

	 	 	 	 	 
	 	MARSHALL & ILSLEY CORPORATION

 	 
	 	By:  	/s/  Dennis J. Kuester
 	 
	 	 	Dennis J. Kuester, Chairman and Chief 	 
	 	 	Executive Officer 	 

 

 

	 	 	 	 	 

ANNEX A

	 	 	 	 	 
	 	 	Domestic	 	 
	Name	 	Jurisdiction	 	Ownership Interests
	Gold Banc Trust III

	 	Delaware
	 	100% certificate of
beneficial
ownership owned by
Seller
	 
	 	 	 	 
	Gold Banc Trust IV

	 	Delaware
	 	100% certificate of
beneficial
ownership owned by
Seller
	 
	 	 	 	 
	Gold Banc Capital Trust V

	 	Delaware
	 	100% certificate of
beneficial
ownership owned by
Seller
	 
	 	 	 	 
	Gold Banc Acquisition Corporation VIII, Inc.

	 	Kansas
	 	100% of the
outstanding capital
stock owned by
Seller
	 
	 	 	 	 
	Gold Banc Acquisition Corporation X, Inc.

	 	Kansas
	 	100% of the
outstanding capital
stock owned by
Seller
	 
	 	 	 	 
	Regional Holding Company, Inc.

	 	Kansas
	 	100% of the
outstanding capital
stock owned by
Seller
	 
	 	 	 	 
	Gold Banc Mortgage, Inc.

	 	Kansas
	 	100% indirect
ownership of the
outstanding capital
stock owned by
Regional Holding
Company, Inc.
	 
	 	 	 	 
	Realty Escrow Services, Inc.

	 	Kansas
	 	100% indirect
ownership of the
outstanding capital
stock owned by
Regional Holding
Company, Inc.
	 
	 	 	 	 
	GBC Kansas, Inc.

	 	Kansas
	 	100% of the
outstanding capital
stock owned by
Seller
	 
	 	 	 	 
	Gold Bank — Kansas

	 	Kansas
	 	100% indirect
ownership of the
outstanding capital
stock owned by GBC
Kansas, Inc.
	 
	 	 	 	 
	Gold IHC-I, LLC

	 	Delaware
	 	100% indirect
ownership of the
membership
interests owned by
Gold Bank
	 
	 	 	 	 
	Gold RE Holdings-I, LLC

	 	Delaware
	 	100% indirect
ownership of the
common membership
interests and 85%
indirect ownership
of the preferred
membership
interests owned by
Gold IHC-I, LLC
	 
	 	 	 	 
	Gold Financial Services, Inc.

	 	Kansas
	 	100% of the
outstanding capital
stock owned by
Seller
	 
	 	 	 	 
	Gold Capital Management, Inc.

	 	Kansas
	 	100% indirect
ownership of the
outstanding capital
stock owned by Gold
Financial Services,
Inc.
	 
	 	 	 	 
	Gold Trust Company

	 	Missouri
	 	100% indirect
ownership of the
outstanding capital
stock owned by Gold
Financial Services,
Inc.
	 
	 	 	 	 
	Gold Merchant Banc, Inc.

	 	Kansas
	 	100% indirect
ownership of the
outstanding capital
stock owned by Gold
Financial Services,
Inc.
	 
	 	 	 	 
	Regional Properties, Inc.

	 	Kansas
	 	100% indirect
ownership of the
outstanding capital
stock owned by Gold
Bank
	 
	 	 	 	 
	Central Oklahoma Leasing Authority, Inc.

	 	Oklahoma
	 	100% of the
outstanding capital
stock owned by Gold
Bank
	 
	 	 	 	 
	GBS Holding Company, LLC

	 	Kansas
	 	100% direct
ownership of the
membership
interests owned by
Gold Financial
Services, Inc.

 

 

	 	 	 	 	 
	 	 	Domestic	 	 
	Name	 	Jurisdiction	 	Ownership Interests
	Gold Insurance Agency, Inc.

	 	Kansas
	 	100% direct
ownership of the
outstanding capital
stock owned by Gold
Financial Services
	 
	 	 	 	 
	Gold Investment Advisors, Inc.

	 	Kansas
	 	100% direct
ownership of the
outstanding capital
stock owned by Gold
Financial Services

 

 

ANNEX B

EMPLOYEE BENEFIT MATTERS

1. Conduct of Business Between Date of Signing the Agreement and the Effective Time.
Between the date of signing of the Agreement and the Effective Time (i) there will be no increases
in base salary for employees of Seller or Seller Subsidiaries with employment agreements except in
the dollar amounts specified in such agreements, or, if none are specified, increases in base
salary on an employee’s annual review date consistent with past practice; (ii) there will be no
increases in base salary for other employees of Seller or Seller Subsidiaries except for increases
in base salary on an employee’s annual review date consistent with past practice; (iii) unless
otherwise agreed between Seller and the Company, no bonuses or incentive payments will be paid to
employees of Seller or Seller Subsidiaries, except for those pursuant to (A) established commission
and other objective, performance-based plans and (B) established, subjective performance-based
plans; provided, however, that the aggregate amount of bonuses paid pursuant to all
established, subjective performance-based plans shall not, unless otherwise agreed between Seller
and the Company, exceed an amount that is one million dollars ($1,000,000) greater than the
aggregate amount of bonuses paid or accrued under the Seller’ or Seller Subsidiary’s subjective
performance plans in the prior calendar year; (iv) no new programs, plans or agreements providing
compensation or benefits for employees or directors of Seller or Seller Subsidiaries will be
adopted or implemented, existing programs, plans or agreements will not be amended or modified
except as required by applicable law, or as provided herein or in agreements executed by employees
in connection herewith, and no further grants or awards will be made under existing plans, programs
or agreements of Seller or Seller Subsidiaries, except as may be agreed to by the Company; (v)
there will be no officer title promotions without the Company’s consent, except that if an officer
position becomes vacant, another officer may be promoted to that position if he or she assumes the
former employee’s job responsibilities; (vi) no new consulting agreements or employment
continuation agreements will be granted to employees of Seller or Seller Subsidiaries and the
existing agreements will not be amended, except as provided herein or in agreements executed
simultaneously herewith; (vii) in no event will Seller make employer contributions to its
retirement programs except to the extent consistent with past practice, and Seller will not make
any amendments or modifications to its retirement programs, without first obtaining the consent of
the Company, other than amendments required to maintain the tax-qualified status of any such
retirement programs; and (viii) Seller or Seller Subsidiaries will only pay severance to those
employees who are terminated by their employer and then only in amounts and for a period consistent
with past practice of the employer.

          2. General.

(a) Transferred Employees. Those individuals who are employed by the Seller or any of
the Seller Subsidiaries as of the Effective Time shall be hereinafter referred to as the
“Transferred Employees.”

(b) Credit for Past Service. After the Effective Time, the Company and the Company
Subsidiaries shall give the Transferred Employees full credit for their prior service with

 

 

the Seller and the Seller Subsidiaries (or any service credited as such in connection with a
previous acquisition by the Seller or any Seller Subsidiary): (i) for purposes of
eligibility (including without limitation initial participation and eligibility for current
benefits) and vesting under any qualified or nonqualified retirement or profit sharing plans
maintained by the Company in which Transferred Employees may be eligible to participate; and
(ii) for all purposes under any welfare benefit plans, “cafeteria plans” (as defined in Code
Section 125), vacation plans and similar arrangements maintained by the Company.
Notwithstanding anything contained herein to the contrary, the Company will not give credit
for prior service to Transferred Employees as regards the Company’s retiree health plan.

(c) Waiver of Certain Limitations. The Company will, or will cause the Company’s
affiliates or the Seller Subsidiaries to, waive all limitations as to preexisting conditions
and waiting periods with respect to participation and coverage requirements applicable to
the Transferred Employees under any welfare benefit plans that such employees may be
eligible to participate in after the Effective Time, other than limitations or waiting
periods that are already in effect with respect to such employees and that have not been
satisfied as of the Effective Time under any welfare plan maintained for the Transferred
Employees immediately prior to the Effective Time. Notwithstanding the foregoing, the
Transferred Employees still have to meet the service requirements (recognizing past service
credit given in Section 2(b), above) and other eligibility criteria under the Company’s
plans, except that Transferred Employees, regardless of service, will be entitled to receive
a matching contribution on amounts contributed to the Company’s 401(k) plan, if they
otherwise meet all the other criteria for the match under the plan terms.

(d) Company’s Ability to Amend, Modify or Terminate Plans. Nothing contained in
this Annex shall limit the right of the Company or its affiliates, at any time and from time
to time, to amend, modify or terminate, in whole or in part, any of the plans referenced in
this Annex, except that no such amendment shall nullify the provisions of this Annex B, and
the Company hereby reserves such right.

3. Employee Welfare Plans. The Seller’s existing health and dental plans and other
employee welfare benefit plans shall remain in effect at least until the Effective Time.
Thereafter, Transferred Employees will be integrated into the Company’s health and dental plans and
other employee welfare plans at a time determined on a plan-by-plan basis by the Company in its
sole discretion. If integration occurs during a plan year, Transferred Employees shall receive
credit for co-pays, deductibles and similar limits. Until the Transferred Employees are integrated
into the Company plans, the respective Seller plans shall remain in effect.

4. 401(k) Plan. The Seller’s 401(k) plan shall be merged into the Company’s 401(k) plan as
soon as practicable after the Effective Time. No employee or employer contributions shall be paid
to the Seller’s 401(k) plan from or on account of compensation paid after the Effective Time.

 

 

5. ESOP. The Seller’s employee stock ownership plan (the “ESOP”) shall terminate as of the
Effective Time. Prior to the Effective Time the Seller’s Board of Directors shall approve such
termination and any amendments necessary to incorporate the terms of this paragraph, such approvals
to be conditioned upon closing of the Merger. The assets remaining in the ESOP’s suspense account,
after repayment by the ESOP of its remaining debts, shall be allocated among the accounts of
Transferred Employees who are ESOP participants at the Effective Time in proportion to their
compensation for the period from January 1, 2006 to the Effective Time, provided, however, that the
amount of compensation to be considered for any participant shall not exceed the annual amount of
$220,000 prorated for such compensation measurement period. The specific method of allocation
(including the treatment of any allocations in excess of Code limitations) may be adjusted if
required in order to secure a favorable determination letter from the Internal Revenue Service
regarding the tax-qualified status of the ESOP upon its termination and/or a favorable private
letter ruling from the Internal Revenue Service to the effect that repayment of the ESOP debts with
proceeds of the exchange of the unallocated shares for cash will not violate the requirements for
exemption under Code Section 4975(d)(3) and that the allocation of assets remaining in the ESOP’s
suspense account after such repayment will not constitute annual additions for purposes of Code
Section 415. Distributions to ESOP participants shall be made as soon as practicable after the
later to occur of the Effective Time and the receipt of such determination letter and/or private
letter ruling.

 

 

ANNEX C

FORM OF OPINION OF COUNSEL TO SELLER

     1. The Seller is a corporation duly incorporated, validly existing and in good standing under
the laws of the State of Kansas, and has the requisite corporate power and authority to carry on
its business as now being conducted as described in the Proxy Statement/Prospectus. Each Seller
Subsidiary is a state banking association, corporation, limited liability company, limited
partnership, charitable foundation or trust duly formed, validly existing and in good standing
under the laws of the state of its incorporation or formation. Each Seller Subsidiary has the
requisite power and authority as a corporation or other legal entity to carry on its business as it
is now being conducted as described in the Proxy Statement/Prospectus.

     2. The Seller and each Seller Subsidiary is duly qualified or licensed as a foreign
corporation or other foreign legal entity, as the case may be, to do business, and is in good
standing, in each jurisdiction where the character of its properties owned, leased or operated by
it or the nature of its activities makes such qualification or licensing necessary, except for
qualification or licensing in any such jurisdiction in which the failure to be so qualified or
licensed would not, individually or in the aggregate, have a Seller Material Adverse Effect.

     3. The Seller has the requisite corporate power and authority to execute and deliver the
Merger Agreement and to perform its obligations thereunder and to consummate the transactions
contemplated thereby (other than, with respect to the Merger, the approval and adoption of this
Agreement by the Seller’s stockholders in accordance with the KGCL and the Seller Articles and the
Seller Bylaws).

     4. The execution and delivery of the Merger Agreement by the Seller and the consummation by
the Seller of the transactions contemplated thereby have been duly and validly authorized by all
necessary corporate action on the part of the Seller (other than, with respect to the Merger, the
approval and adoption of this Agreement by the Seller’s stockholders in accordance with the KGCL
and the Seller Articles and the Seller Bylaws).

     5. The Merger Agreement has been duly and validly executed and delivered by the Seller and,
assuming the due execution and delivery thereof by the Company, constitutes a legal, valid and
binding obligation of the Seller, enforceable against the Seller in accordance with its terms, (a)
except as such enforceability may be subject to the effect of any laws affecting insured depository
institutions, applicable bankruptcy, insolvency (including, without limitation, all laws relating
to fraudulent transfers), reorganization, receivership, moratorium or similar laws affecting
creditors’ rights generally and to the effect of general principles of equity, including, without
limitation, concepts of materiality, reasonableness, good faith and fair dealing (regardless of
whether considered in a proceeding in equity or at law) and (b) except as the enforceability of the
indemnity provisions may be limited by federal or state securities laws or the public policy
underlying such laws or may otherwise be limited by applicable provisions of the KGCC.

     6. The authorized capital stock of the Seller consists, immediately prior to the Effective

 

 

Time, of 50,000 shares of Seller Common Stock and 50,000 shares of the Seller Preferred Stock.

     7. The execution and delivery of the Merger Agreement by the Seller do not, and the
consummation of the transactions contemplated by the Merger Agreement by the Seller will not,
conflict with or violate (a) the Seller Articles or Seller By-Laws, each as amended to the date
hereof or (b) any statute, rule or regulation of the United States of America or the State of
Kansas applicable to the Seller or any Seller Subsidiary or by which any of their respective
properties is bound or affected or (c) to our knowledge, any order, judgment or decree applicable
to the Seller or any Seller Subsidiary or by which any of their respective properties is bound or
affected, the conflict with which or the violation of which would, in our judgment, be reasonably
expected to result in a Seller Material Adverse Effect.

     8. To our knowledge, except as otherwise set forth in the Seller Disclosure Schedule, there is
no litigation or governmental proceeding pending against the Seller or any Seller Subsidiary before
any court, governmental agency or arbitrator or overtly threatened against the Seller or any Seller
Subsidiary in writing which (a) questions, directly or indirectly, the validity or enforceability
of the Merger Agreement or (b) is, either individually or in the aggregate, reasonably likely, in
our judgment, to have a Seller Material Adverse Effect.

     9. Except as otherwise set forth in the Seller Disclosure Schedule, the Seller and/or one or
more of the Seller Subsidiaries owns of record, and to our knowledge, owns beneficially, all of the
outstanding shares of capital stock or other equity interests of each of the Seller Subsidiaries.

     10. The proxy statement portion of the Proxy Statement/Prospectus (excluding the financial
statements and other financial and statistical information included or incorporated therein or
omitted therefrom, and all information about, or supplied or omitted by, the Company for use in the
Proxy Statement/Prospectus, as to all of which we do not express any opinion), at the time it was
first mailed to holders of Seller Common Stock and at the date of the Seller Stockholders’ Meeting,
complied as to form in all material respects with the requirements of the Exchange Act.

* * * * * *

     We have participated in the preparation of the Proxy Statement/Prospectus and the Registration
Statement and, in the course of such preparation, in conferences with certain officers and
employees of the Seller with respect thereto. Although we are not passing upon or assuming any
responsibility for the accuracy, completeness or fairness of the statements contained or
incorporated in the Proxy Statement/Prospectus or the Registration Statement, during the course of
such participation, no facts have come to our attention which would lead us to believe that the
Proxy Statement/Prospectus at the time it was first mailed to holders of Seller Common Stock and at
the time of the Seller Stockholders’ Meeting, or the Registration Statement at the time it became
effective and at the Effective Time, contained any untrue statement of a material fact or omitted
to state any material fact required to be stated therein or necessary to make the statements
therein not misleading (except that we do not comment with respect to the financial statements and
other financial and statistical information included therein

 

 

or omitted therefrom, or any information about, or supplied or omitted by, the Company for use
in the Proxy Statement/Prospectus or the Registration Statement).

 

 

ANNEX D

FORM OF OPINION OF COUNSEL TO COMPANY

     1. The Company is a corporation duly incorporated and validly existing under the laws of the
State of Wisconsin and is in active status, meaning that it has filed its most recent required
annual report and has not filed articles of dissolution, with the Wisconsin Department of Financial
Institutions. The Company has the requisite corporate power and authority to carry on its business
as now being conducted as described in the Registration Statement.

     2. The Company is duly qualified or licensed as a foreign corporation or other foreign legal
entity, as the case may be, to do business, and is in good standing, in each jurisdiction where the
character of its properties owned, leased or operated by it or the nature of its activities makes
such qualification or licensing necessary, except for qualification or licensing in any such
jurisdiction in which the failure to be so qualified or licensed would not, individually or in the
aggregate, have a Company Material Adverse Effect.

     3. The Company has the requisite corporate power and authority to execute and deliver the
Merger Agreement and to perform its obligations thereunder and to consummate the transactions
contemplated thereby.

     4. The execution and delivery of the Merger Agreement by the Company and the consummation by
the Company of the transactions contemplated thereby have been duly and validly authorized by all
necessary corporate action on the part of the Company.

     5. The Merger Agreement has been duly and validly executed and delivered by the Company and,
assuming the due execution and delivery thereof by Seller, constitutes a legal, valid and binding
obligation of the Company, enforceable against the Company in accordance with its terms, (a) except
as such enforceability may be subject to the effect of any laws affecting insured depository
institutions, applicable bankruptcy, insolvency (including, without limitation, all laws relating
to fraudulent transfers), reorganization, receivership, moratorium or similar laws affecting
creditors’ rights generally and to the effect of general principles of equity, including, without
limitation, concepts of materiality, reasonableness, good faith and fair dealing (regardless of
whether considered in a proceeding in equity or at law) and (b) except as the enforceability of the
indemnity provisions may be limited by federal or state securities laws or the public policy
underlying such laws or may otherwise be limited by applicable provisions of the WBCL.

     6. The shares of Company Common Stock to be delivered in exchange for the outstanding shares
of Seller Common Stock, as set forth in the Merger Agreement, are duly authorized and, when issued
as contemplated by the Merger Agreement, will be validly issued, fully paid and nonassessable,
except as otherwise provided by Section 180.0622(2)(b) of the WBCL (including judicial
interpretations thereof and any successor to said Section 180.0622(2)(b)).

 

 

     7. The execution and delivery of the Merger Agreement by the Company do not, and the
consummation of the transactions contemplated by the Merger Agreement by the Company will not,
conflict with or violate (a) the Company’s Restated Articles of Incorporation or the Company’s
By-Laws, each as amended to the date hereof, or (b) any statute, rule or regulation of the United
States of America or the State of Wisconsin applicable to the Company or by which any of its
respective properties is bound or affected or (c) to our knowledge, any order, judgment or decree
applicable to the Company or by which any of its respective properties is bound or affected, the
conflict with which or the violation of which would, in our judgment, be reasonably expected to
result in a Company Material Adverse Effect.

     8. To our knowledge, except as otherwise set forth in the Company Disclosure Schedule, there
is no litigation or governmental proceeding pending against the Company before any court,
governmental agency or arbitrator or overtly threatened against the Company in writing which (a)
questions, directly or indirectly, the validity or enforceability of the Merger Agreement or (b)
is, either individually or in the aggregate, reasonably likely, in our judgment, to have a Company
Material Adverse Effect.

     9. The Registration Statement has become effective under the Securities Act and, to our
knowledge, no stop order suspending the effectiveness of the Registration Statement has been issued
and no proceedings for that purpose have been instituted or are pending under the Securities Act.

     10. The Registration Statement as of the effective date thereof (excluding the financial
statements and other financial and statistical information included or incorporated therein or
omitted therefrom, and all information about, or supplied or omitted by, the Seller for use in the
Registration Statement, as to all of which we do not express any opinion) at the time it was first
mailed to holders of Seller Common Stock on the date of the Seller Stockholders’ Meeting complied
as to form in all material respects with the requirements of the Securities Act and the Exchange
Act.

* * * * * *

     We have participated in the preparation and filing of the Proxy Statement/Prospectus and the
Registration Statement and, in the course of such preparation, in conferences with certain officers
and employees of the Company with respect thereto. Although we are not passing upon or assuming
any responsibility for the accuracy, completeness or fairness of the statements contained or
incorporated in the Proxy Statement/Prospectus or the Registration Statement, during the course of
such participation, no facts have come to our attention which would lead us to believe that the
Proxy Statement/Prospectus at the time it was first mailed to holders of Seller Common Stock and at
the time of the Seller Stockholders’ Meeting, or the Registration Statement at the time it became
effective and at the Effective Time, contained any untrue statement of a material fact or omitted
to state any material fact required to be stated therein or necessary to make the statements
therein not misleading (except that we do not comment with respect to the financial statements and
other financial and statistical information included therein or omitted therefrom, or any
information about, or supplied or omitted by, the Seller for use in the Proxy Statement/Prospectus
or the Registration Statement).

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00093-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00093-of-00352.parquet"}]]